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ABSTRACT
Trypanosoma cruzi, the causative agent of Chagas disease, is transmitted by blood 
feeding triatomine bugs. As T. cruzi cycles between the insect vector and vertebrate 
host, it goes through several distinct developmental stages. The molecular mecha­
nism that regulates these differentiation steps is poorly understood. We have initiated 
a systematic dissection o f  metacyclogenesis, the differentiation step from replicating 
non-infective epimastigotes to non-replicating infective metacyclic trypomastigotes. 
Our aim is to functionally characterise novel stage-regulated genes, using transfec­
tion-based approaches. We demonstrate that one of these genes, MET3, encodes a 
protein that localises to the nucleus and associates with nucleolar antigens. During 
metacyclogenesis the structure of the nucleus is modified: heterochromatin spreads 
as the nucleus changes shape from round to elongated, and nucleolar antigens are 
dispersed in the metacyclic nucleus. Our data show that while dispersal of nucleolar 
antigens occurs in all cells of a stationary phase culture, MET3 protein is expressed 
only in the subset of cells that have differentiated to metacyclics or to intermediate 
forms. By expressing MET3-GFP fusion proteins in the parasite, we identified two 
sequence elements that can independently direct localisation. To address function, 
we generated MET3 null mutants. These knockout cells produced significantly fewer 
fully developed metacyclics than wild-type controls. However, this phenotype could 
not be complemented with an ectopic copy of MET3. The reduced rate of metacyclo­
genesis may therefore be unrelated to the loss of MET3. The knockout cells are able 
to complete the entire life-cycle in vitro. This demonstrates that MET3 is not essen­
tial for development o f  the infective stage. RNA transcripts of the second gene, 
(MET2) are induced during metacyclogenesis. Recombinant MET2 protein associ­
ates with the kinetoplast when expressed in epimastigotes. We analysed in detail its 
genomic locus near a putative centromere on chromosome 3, and generated deletion 
mutants for further investigating its role in differentiation.
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1. INTRODUCTION
Trypanosoma cruzi, the causative agent of Chagas disease, is a protozoan flagellate 
of the order Kinetoplastida, subfamily Trypanosomatidae. Among the trypanoso- 
matids, there are a number of important parasites that cause disease in humans and 
their domestic animals. Different species of Leishmania, which are transmitted by 
phlebotomine sandflies cause cutaneous and visceral Leishmaniasis. Trypanosoma 
brucei, causes sleeping sickness and the cattle disease Nagana. The last 30 years 
have seen a re-emergence of sleeping sickness in Sub Saharan Africa, where tsetse 
flies, which transmit the parasite, are endemic. The World Health Organisation esti­
mates that together, these three parasites cause the deaths of over 120,000 people 
every year, and disable millions, mostly in the poorest parts of the world (WHO, 
World Health Report 2002).
Trypanosomes are parasites of huge medical importance. They are also biologically 
fascinating. Kinetoplastids diverged early from the main eukaryotic lineage and their 
biochemistry and genetics differs in many ways from that of higher eukaryotes. The 
study of trypanosomes has led to the discovery of several interesting and novel bio­
logical phenomena, including unusual mechanisms of gene expression. The relative 
ease with which they can be cultured and their genetic tractability have made them 
the focus of research in many laboratories.
1.1 TRYPANOSOMA CRUZI AND CHAGAS DISEASE
Chagas disease is endemic in large parts of Latin America. The disease was first 
described in 1909 by the Brazilian doctor Carlos Chagas (Chagas, 1909). Remarka­
bly, Chagas also discovered both the causative agent, named Trypanosoma cruzi in 
honour of his mentor Oswaldo Cruz, and the insect vector responsible for transmis­
sion of the parasite, and was the first to describe the parasite’s life-cycle. Today, 
Chagas disease is considered the most significant parasitic disease in Latin America, 
posing a direct risk to 25% of the population. It is estimated that 11-18 million 
people are infected, with 3-5 million symptomatic cases. The WHO estimates that
12
every year 13,000 people die of the disease, and a further 200,000 people are newly 
infected (Barrett et al., 2003; WHO, 2003).
Chagas disease has three phases in humans (Bogitsh and Cheng, 1990). The first, 
acute phase of the disease is characterised by high parasitemia and can last for 
several weeks. Although it develops in just a few percent of patients, it can be fatal, 
especially in small children. The disease can then go unnoticed for many years, 
during which patients remain asymptomatic. Approximately 10-30% of patients 
proceed to the chronic form of the disease which ultimately leads to death. Classical 
symptoms of the chronic phase include premature and progressive heart disease and 
swelling of the oesophagus and colon (mega syndromes). The factors that trigger 
development of the chronic phase of the disease remain controversial. An important 
disputed question is whether the pathogenesis of the chronic disease requires the 
continued presence of the parasite, or whether the condition is an autoimmune 
response that occurs even in the absence of parasite (Tarleton, 2003). A recent study 
demonstrates integration of T. cruzi DNA into the host genome, and thus suggests a 
potential mechanism for pathology in the absence of persistent infection. As this 
appears to occur at random, it could provide an explanation for the differential 
activation of the chronic disease (Nitz et al., 2004). Other evidence strongly suggests 
that the persistence of the parasite is necessary and sufficient for chronic disease 
pathology (Tarleton et al., 1997). It will be important to resolve this issue, as it has 
direct implications for determining research priorities.
Trypanosoma cruzi, the causative agent of Chagas disease is transmitted by blood­
sucking triatomine bugs (order Hemiptera, family Reduviidae, subfamily Triatomi- 
nae). T. cruzi has a digenetic life-cycle (section 1.3), cycling between the insect 
vector and a wide range of mammalian host species, which include humans, domes­
tic and wild mammals. Amphibians and birds are refractory to persistent T. cruzi 
infections (Brener, 1973). Over 100 species of triatomine are important in the 
sylvatic cycle of the disease but few infest houses. Important vectors of Chagas 
disease in the domestic cycle include Rhodnius prolixus (Figure 1.1) and Triatoma 
infestans (Kollien and Schaub, 2000). T. cruzi can also be transmitted congenitally
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from infected mother to child, and via transfusions with infected blood (WHO, 
2003).
Chagas disease is very much associated with poverty. Grass thatched huts with 
cracked stone or mud walls are often highly infested with triatomine bugs, which will 
transmit the parasites when they feed on the inhabitants. Public health measures to 
control the vector, improved housing conditions and the introduction of a more effec­
tive health system play decisive roles in stopping transmission to humans. This is 
illustrated by the success of the ‘Southern Cone Initiative’. This initiative, launched 
in 1991 by seven South American countries (Argentina, Bolivia, Brazil, Chile, Para­
guay, Peru and Uruguay), aimed to eliminate the main vector by large scale spraying 
of houses with insecticides, and to interrupt transfusional transmission by screening 
blood donors (Moncayo, 1999). As a result, Uruguay and Chile, central and southern 
Brazil, and parts of Argentina and Paraguay are now certified free of transmission 
(Miles et al„ 2003). Yet, there are still 11-18 million people already infected with the 
parasite, who urgently require less toxic and more efficient drugs.
Figure 1.I; Adult Rhodnius prolix us taking a blood meal through human skin 
( Image: WHO/TDR/Stammers)
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There is no immediate prospect of a vaccine against T. cmzi, and only two drugs are 
available to treat the acute phase of Chagas disease, nifurtimox and benznidazole. 
These drugs have been used for the treatment of Chagas patients since the early 
1970s. Both have limited efficacy and often cause severe side effects (Rodriques 
Coura and de Castro, 2002). Comparative biochemistry and genomics research has 
discovered a number of interesting differences between trypanosomatid and human 
cells. These represent potential targets for the rational development of new drugs 
(Barrett et al., 2003; Rodriques Coura and de Castro, 2002). Sadly, the pharma­
ceutical industry has little economic incentive to invest in research and development 
projects that focus on parasitic diseases that affect the poorest people. A joining of 
forces between the pharmaceutical industry, the WHO and non-governmental 
organisations, and the launch of the ‘Drugs for Neglected Diseases Initiative’ 
(www.dndi.org) offers hope that progress will be made in the development of new 
drugs on a not-for-profit basis (Barrett et al., 2003).
1.2 BIOLOGY OF T. CRUZI 
1.2.1 Classification of T. cruzi strains
T. cruzi is a highly divergent species. Strains differ in their biological properties and 
genome organisation. A number of methods have been used to compare and classify 
different T .cruzi strains (Devera et al., 2003). These include isoenzyme patterns, 
restriction maps of minicircle DNA (Morel et al., 1980) and ribosomal RNA se­
quences. The current nomenclature divides the species into two principal groups: 
T. cruzi I (sylvatic strains) and T. cruzi II (peridomestic strains) (Anonymous, 1999). 
Recent immunological evidence suggests that chronic disease in human infections is 
caused predominantly by T. cruzi subgroup II (Di Noia et al., 2002).
The reference organism for the genome sequencing project is T. cruzi C L Brener 
(Zingalcs et al., 1997c). The CL Brener strain was originally cloned from the blood 
of mice infected with the CL strain. The rationale for choosing CL Brener as the 
genome reference strain was that it exhibits the following characteristics that make it 
a relevant model, (i) the strain was isolated from a strictly domiciliary vector (Tria-
15
toma infestans); (ii) it preferentially parasitizes heart and muscle cells; (iii) it shows a 
clear acute phase in human patients; (iv) it is highly susceptible to the drugs benzni- 
dazole and nifurtimox (Zingales et al., 1997a; Zingales et al., 1997b). Phylogenetic 
analysis later showed that CL Brener appears to be a hybrid of two distantly related 
lineages of T. cruzi II (Machado and Ayala, 2001). This has had major implications 
in terms of completing the genome project (see below).
1.2.2 The unusual cell biology of T. cruzi
T. cruzi epimastigote cells are polar with a single flagellum at the anterior end and a 
single mitochondrion (Figure 1.2; de Souza, 1999). Like other eukaryotic cells they 
possess a membrane bounded nucleus, Golgi apparatus and endoplasmic reticulum 
(ER). In addition, T. cruzi shares with other trypanosomatids some unique features 
not found in higher eukaryotes (de Souza, 2002; de Souza, 2003). A brief overview 
is presented below.
Unique vesicular organelles. The most extensively studied vesicles of trypanoso­
matids are the glycosomes, which contain the first seven enzymes of the glycolytic 
pathway and other metabolic enzymes (Parsons, 2004). Acidocalcisomes are acidic 
vacuoles which contain a Ca2+ - H+ translocating ATPase activity and a high Ca2+ 
concentration (Docampo et al., 1995; Vercesi et al., 1994). Their physiological role 
is not well understood. Reservosomes contain cysteine proteinase, and endocytosed 
macromolecules (de Souza, 2002). In T. cruzi they are developmental^ regulated 
and have been implicated in the process of metacyclogenesis (section 1.4.2).
16
Figure 1.2: Trypanosoma cruzi epimasligole
Schematic drawing, based on information obtained with the transmission electron microscope, show­
ing the various structures found in the epimastigotc form of T. cruzi (from dc Souza, \999).
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Flagellum. The single flagellum of trypanosomatids has the classical 9+2 pattern of 
axonemal microtubules, but also contains an unusual structure known as the para- 
flagellar rod. At the base of the flagellum, where it emerges from the cell, a special­
ised structure is formed, called the flagellar pocket. This is the site where all vesicu­
lar traffic to and from the cell surface occurs (Bastin et al., 2000b). The membrane of 
the flagellar pocket also contains receptor molecules, such as the transferrin receptor 
(Borst and Fairlamb, 1998). Components of signal transduction pathways, an 
adenylyl cyclase of T. brucei (Paindavoine et al., 1992) and a cAPM-dependent 
phosphodiesterase of T. cruzi (D'Angelo et al., 2004) were found to be concentrated 
in the flagellar membrane. Thus, the flagellum of trypanosomes has multiple func­
tions (Bastin et al., 2000b). It confers motility, it mediates attachment to surfaces 
(Kleffmann et al., 1998), and these structures are thought to play important roles in 
environmental sensing.
Cytoskeleton. The cytoskeleton of trypanosomatids is characterised by a corset of 
subpellicular microtubules, localised below the plasma membrane, which confer 
rigidity and dictate cell shape (Kohl and Gull, 1998). Different life-cycle stages are 
defined by distinctive morphologies. The position of kinetoplast and flagellum rela­
tive to the nucleus are easily recognised by microscopic observation and commonly 
used as markers. Two recent studies have provided new insights into the underlying 
mechanisms of morphogenesis and shown that cytoskeletal components are impor­
tant determinants of trypanosomatid cell morphology. During cell division of 
T. brucei, a specialised structure at the tip of the flagellum, called the flagellar 
attachment zone, is connected to cytoskeletal components. Thus as the new flagellum 
grows, the old cell guides the morphology of the daughter cell (Moreira-Leite et al., 
2001). Kinetoplast repositioning during differentiation of T. brucei bloodstream 
forms was demonstrated to be a microtubule-dependent process. Treatment of differ­
entiating cells with the drug rhizoxin (an inhibitor of microtubule assembly) resulted 
in an almost complete inhibition of kinetoplast movement (Matthews et al., 1995).
Mitochondrion. The mitochondrion is active throughout the life-cycle of T. cruzi 
(Brener, 1973). In this respect T. cruzi differs from T. brucei, where the mitochon­
drion is repressed in bloodstream forms, which obtain their energy from glycolysis
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alone (Vickerman, 1985). The mitochondrion of T. cruzi cells has been shown to 
have a dynamic structure, however, whose complexity depends on the developmental 
stage and the cell cycle. The simplest conformation is found in trypomastigotes, and 
the most complex in replicating epimastigotes (Tyler and Engman, 2001).
The mitochondrial genome. The mitochondrial DNA (kDNA), which represents 
about 20% of total cellular DNA in T. cruzi, is contained in a specialised structure, 
the kinetoplast. The kDNA is organised in a network of intercatenated circular mole­
cules. T. cruzi harbours about 30 maxicircles (23 kb), and 20-30,000 minicircles (1.4 
kb) (de Souza, 2003). The maxicircles encode some of the genes for mitochondrial 
proteins. A peculiar feature of trypanosomes is that in order to generate functional 
mRNA from these genes, the cryptic transcripts need to undergo extensive modifica­
tion (RNA editing), which involves posttranscriptional addition or deletion of uridine 
residues (Estevez and Simpson, 1999). This RNA editing is directed by small RNAs 
(guide RNAs) which are encoded on both the maxi- and minicircles and mediated by 
a multi-protein editing complex, the editosome (Stuart and Panigrahi, 2002).
The structure of the T. cruzi kinetoplast and packing of kDNA differs between repli­
cating and non-replicating cells. In epimastigotes, the kinetoplast is disc shaped, with 
compactly organised kDNA, whereas in trypomastigote forms it appears spherical, 
and the kDNA is less densely packed (Brack, 1968; de Souza, 1999; de Souza, 
2003).
Nucleus. The trypanosome nucleus is 2 pm in diameter with a single nucleolus. It is 
enclosed by a double membrane which is continuous with that of the ER, and con­
tains nuclear pore complexes that are similar to those of other eukaryotes (Rout and 
Field, 2001). During mitosis the nuclear envelope stays intact (closed mitosis) (De 
Souza and Meyer, 1974; Ersfeld et al., 1999).
The architecture of the T. cruzi nucleus changes markedly during the course of the 
life-cycle (Belli, 2000; Elias et al., 2001b), a fact that was already noted in Chagas’ 
original recordings (Chagas, 1909). An important determinant of nuclear architecture 
is chromatin structure (Amey and Fisher, 2004). In trypanosomes, the degree of
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chromatin condensation and histone profiles, modifications, and abundance vary 
between different developmental stages (Alsford and Horn, 2004; Belli, 2000; Rout 
and Field, 2001). In T. cruzi epimastigotes and amastigotes, heterochromatin is found 
at the nuclear periphery. Through an as yet unknown mechanism it becomes dis­
persed in metacyclics and cell-derived trypomastigotes, where continuous and inter­
connected patches o f heterochromatic material take up most of the nucleoplasmic 
space (Elias et al., 2001b). Analysis of T. cruzi histone HI, which in is the most 
divergent histone in trypanosomes, provided evidence of stage regulated modifica­
tions. A phosphorylated form of histone HI, identified by its distinct mobility pattern 
in triton-acid-urea polyacrylamide gels, was found to be specifically associated with 
non-replicating stages. (Marques Porto et al., 2002). Rearrangement of nuclear 
structure was correlated with decreased transcription rates o f RNA polymerase 1 and 
II (Elias et al., 2001b). The significance o f these changes is not yet fully understood, 
but it is expected that epigenetic mechanisms play a role in the control of trypano­
some gene expression. Work on other organisms has clearly established that during 
most differentiation processes the nuclear architecture is dramatically altered. How 
exactly this affects gene expression is an area of intense investigation in many labo­
ratories (Dundr and Misteli, 2001; Manuelidis, 1990).
Nucleolus. The trypanosome nucleolus is visible by fluorescence microscopy as a 
single 1 pm area o f weak DNA staining in the interphase nucleus. In higher eu­
karyotes, nucleoli are arranged in three morphologically and functionally distinct 
regions: (i) fibrillar centres (FC), which contain the rDNA, (ii) dense fibrillar centres 
(DFC) where rRNA transcription occurs, and (iii) granular centres (GC) where ribo- 
nucleoprotein particles are assembled (Melese and Xue, 1995). Similarly, in EM 
images of T. hrucei, GC and fibrillar centres FC can be distinguished, but DFC are 
not clearly distinct from FC (Ogbadoyi et al., 2000). During the mitotic cycle in 
T. hrucei, the nucleolus elongates, but persists throughout division. In contrast, the 
nucleolus has been seen to disappear during division of T. cruzi amastigotes (Dc 
Souza and Meyer, 1974). Dispersal of nucleolar antigens was also found to occur in 
non-replicating trypomastigotc stages of T. cruzi (Elias et al., 2001b).
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Karyotype. Chromosomes of trypanosomes do not condense during mitosis, and 
pulse field gel electrophoresis techniques are commonly used to determine the 
karyotype. According to the latest estimate, the nuclear genome of T. cruzi CL 
Brener is organised in approximately 55 chromosomes which range in size from 0.4 
to 4.5 Mb (Andersson, 2004). T. cruzi is generally considered to be diploid. The 
haploid DNA content of T. cruzi CL Brener is 40 Mb of DNA and it contains 10- 
14,000 genes (Andersson, 2004; Taylor and Kelly, 2002).
In nuclei of replicating T. cruzi cells, the position of the chromosomes was shown to 
change as a function of the cell cycle. During S-phase and G2, chromosomes were 
found to localise to the nuclear periphery. During G1 phase they became dispersed 
and apparently randomly distributed. A random distribution was also observed in 
non-replicating forms (Elias et al., 2002).
The mechanism of chromosome segregation is incompletely understood. Results 
from ultrastructural studies indicate that separation of the genetic material and 
movement to the daughter nuclei is mediated by nuclear microtubules, analogous to 
the process in higher eukaryotes. Ultrastructural studies on the T. cruzi amastigote 
nucleus have revealed the presence of intranuclear spindle microtubules. These were 
found to be associated with electron dense plaques, which could represent kineto- 
chore-like structures (de Souza, 2003; De Souza and Meyer, 1974). In T. brucei, 
whose nucleus contains three size classes of chromosomes (Ersfeld et al., 1999), the 
two larger classes were shown to be segregated via interaction with the mitotic spin­
dle (Ogbadoyi et al., 2000). An intriguing problem is how trypanosomatids manage 
to faithfully segregate their chromosomes, given the observation that the number of 
kinetochores (visible by EM), is always much smaller than the total number of chro­
mosomes (Ogbadoyi et al., 2000).
Reading the blueprint: the T. cruzi genome project. The T. cruzi genome project 
started in 1994, as part of the WHO-sponsored Parasite Genome Initiative (Zingales 
et al., 1997c). Since T. cruzi is a highly divergent species, one reference clone (CL 
Brener, section 1.2.1) was chosen for the project. The initial part of the genome 
project was dedicated to the construction of genomic BAC, YAC and cDNA libraries
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and the generation of over 5000 ESTs from a normalised epimastigote cDNA library 
(Porcel et al., 2000). Large scale shotgun sequencing began in 2000. An annotated 
version of the genome is expected to be published in 2004, together with the 
genomes of T. brucei and L. major. The most immediate impact of this rich source of 
information on all three trypanosomatid parasites has been the ease with which new 
genes can be discovered in silico, at the click of a button. As in other organisms, a 
large proportion of open reading frames shows no similarity to previously character­
ised genes. For example, the function of 62% of the predicted protein coding 
sequences on T. brucei chromosome I is currently unknown (Hall et al., 2003). The 
functional analysis of these novel genes will be a major challenge for future research. 
Interestingly, comparative genomic analysis revealed a high level of synteny (con­
served gene order) between the three trypanosomatid species (Bringaud et al., 1998; 
Ghedin et al., 2004).
Genome. The genome of T. cruzi is highly repetitive (Aguero et al., 2000). This is 
due to non-coding repeat sequences, tandemly repeated housekeeping genes, and 
multi-copy gene families. There are, for example, more than 600 genes of the trans- 
sialidase super family (Cross and Takle, 1993) dispersed throughout the genome. 
These include the metacyclic specific gp90 and gp82, and the trypomastigote specific 
gp85 genes. The mucin gene family (Salazar et al., 1996) is represented by over 700 
genes. The genes for the major cysteine proteinase cruzipain are arranged in large 
clusters of tandemly repeated genes and total nearly 100. The challenging task of 
assembling such a repetitive genome is made considerably more difficult by the fact 
that the genome of CL Brener is highly polymorphic. This is due to the hybrid origin 
of the strain (Machado and Ayala, 2001) which is a likely explanation for the un­
usually high sequence divergence between allelic loci, and the considerable size 
difference (up to 2 Mb) between homologous chromosomes (Andersson, 2004).
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1.3 THE LIFE-CYCLE OF T. CRUZI
1.3.1 Overview
T. cruzi cycles between the insect vector and mammalian host and alternates between 
replicating forms and non-replicating forms (which are adapted for transmission). 
Each developmental stage is characterised by a distinct morphology (de Souza, 1999; 
Elias et al., 2001b; Tyler and Engman, 2000), and differentiation is concomitant with 
changes in metabolism (Adroher et al., 1990; Urbina, 1994; Vickerman, 1985) and 
gene expression (Krieger et al., 1999). Molecular approaches are beginning to shed 
new light on development of the parasite and its remarkable ability to persist and 
proliferate under the potentially most hostile conditions. The following is a broad 
overview of the T. cruzi life-cycle (Figure 1.3). A detailed account of metacyclo­
genesis, which is the subject of this study, is presented in section 1.4.
h'ij(ure 1.3: The life-cycle o fT . cruzi
(I) Epimastigotes multiply in the midgut of the triatominc insect vector. (2) Metacyclics develop in 
the hindgut, and get excreted with the faeces. (3) Metacyclics that enter through the bite wound cause 
initial infection of the mammalian host. (4) Parasites multiply intracellularly as amastigotes. (5) Cell- 
derived trypomastigotes enter the peripheral bloodstream and infect other cells. (6) Infected blood is 
taken up by a feeding triatominc. Image adapted from WHO/TDR.
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Development in the vector. When a triatomine bug feeds on an infected mammal, it 
takes up T. cruzi trypomastigotes with the bloodmeal. As the parasites travel via the 
foregut and stomach to the bug's midgut, the trypomastigotes transform into epimas- 
tigotes, which divide and proliferate by binary fission. Some epimastigotes reach the 
hindgut where they continue to proliferate, and after about 4 weeks, depending on 
the temperature, they reach about 106 cells per insect. Epimastigotes in the hindgut 
have elongated flagella and are found attached to the rectal cuticle lining via non­
specific interaction between the hydrophobic cuticle wax and proteins on the parasite 
flagellum. Up to 50% of the attached epimastigotes differentiate into infective meta- 
cyclic trypomastigotes (referred to in this text as metacyclics), which are excreted 
with the faeces and urine when the bugs feeds on a mammal (Kollien and Schaub, 
2000) .
Development in the host. Through contamination of the bite wound or mucous mem­
brane with the bug faeces, metacyclics enter the mammalian host, where they can 
invade a wide range of nucleated cells. The mechanisms and signal transduction 
events involved in host cell invasion have been characterised in considerable detail 
(Burleigh and Andrews, 1995; Tan and Andrews, 2002). The parasite enters the host 
cell through receptor-mediated attachment. Attachment causes parasite-induced Ca2f 
signalling, resulting in recruitment of host cell lysosomes to the point of attachment 
(Burleigh and Andrews, 1995; Caler et al., 1998). The lysosome fuses with the 
plasma membrane, allowing the parasite entry into the resulting vacoular compart­
ment. Inside the acidified parasitophorous vacuole, the trypomastigote secretes a 
porin-like molecule, TcTOX, and escapes into the host cell cytoplasm, where it 
differentiates to the amastigote form (Andrews et al., 1990). This differentiation 
takes about 3h. Following a lag phase of 35-48 h after differentiation, amastigotes 
start to divide (Elias et al., 2001b; Vickerman, 1985). Amastigotes proliferate in the 
cytoplasm by binary fission. At high densities, after 4 to 5 days, amastigotes differ­
entiate to trypomastigotes. The infected cell lyses, releasing parasites into blood and 
lymph. These cell-derived trypomastigotes then perpetuate the cycle of infection in 
the host by invasion of new cells, preferentially those of the heart and smooth muscle 
of the digestive tract. The life-cycle is completed when some trypanosomes are taken 
up from the peripheral blood by a feeding triatominc (Tyler and Engman, 2001).
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1.3.2 Dissection of the trypanosome life-cycle — a molecular approach
The basic aspects of the T. cruzi life-cycle have been known for nearly a century, but 
a number of unresolved questions still need to be answered. Surprisingly, it has 
remained controversial how many distinct life-cycle stages actually exist, and at 
which point one form becomes committed to a certain developmental pathway 
(Brack, 1968; Tyler and Engman, 2001).
One of the central questions regarding parasite differentiation is how the cell senses 
its environment, and how this information is transduced. The review of the literature 
on trypanosome signal transduction pathways, presented in section 1.5, shows that 
the mechanisms have remained almost completely obscure. How the elusive signals 
are processed to result in changes of gene expression is equally in the dark. It will 
therefore be of importance to functionally analyse stage-specific genes and dissect 
the mechanisms that regulate their expression. Given the many unusual features of 
trypanosome gene expression (section 1.6) it is likely that the study of developmental 
regulation will uncover more mechanisms that are distinct from those operating in 
other eukaryotes. It is hoped that a detailed understanding of these mechanisms will 
suggest ways to break the cycle, and block replication and/or transmission of the 
parasite.
1.3.3 A model case of trypanosome differentiation
At present, the best characterised model for trypanosome differentiation is the differ­
entiation of T. brucei bloodstream to procyclic forms (Hendriks et al., 2000; 
Matthews, 1999; Matthews et al., 2004). Slender bloodstream forms proliferate in the 
blood of the mammalian host. During increasing parasitemia, the proportions of 
intermediate forms and non-dividing stumpy bloodstream forms increase. These 
stumpy forms are apparently pre-adapted for differentiation to the procyclic form 
(which occurs in the midgut of the tsetse fly).
Differentiation involves the repositioning of the kinetoplast from a posterior location 
to a position closer to the nucleus (Matthews et al., 1995), a complete change of the
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surface glycoproteins (Roditi et al., 1989), re-activation of mitochondrial respiration 
and a switch from using glucose to using proline as the main energy source 
(Vickerman, 1985). Bloodstream forms carry on their surface a dense coat of variant 
surface glycoprotein (VSG), and only one VSG variant out of a large repertoire of 
VSG genes is expressed. A mechanism of antigenic variation allows some cells to 
escape the mammalian immune response by switching to the expression of a differ­
ent VSG variant (Vanhamme and Pays, 1995). During differentiation to the procyclic 
form, the VSG coat is shed by an active process, involving a zinc metalloprotease 
and glycosylphosphatidylinositol (GPI) hydrolysis, (Gruszynski et al., 2003). The 
coat is replaced with two types of procyclin protein (Roditi et al., 1989), which are 
important for development in the tsetse fly (Ruepp et al., 1997).
The molecular and cell biology of this differentiation step has been dissected in 
considerable detail (Matthews et al., 2004), thanks to the development of a synchro­
nous in vitro differentiation system, (Ziegelbauer et al., 1990) a catalogue of cellular 
and molecular markers (Hendriks et al., 2000; Matthews et al., 2004), and the avail­
ability o f  genetic manipulation techniques (Clayton, 1999). Analysis of the strict 
stage-specificity of VSG and procyclin expression has revealed important mecha­
nisms by which trypanosomes control gene expression (Vanhamme and Pays, 1995; 
section 1.6). Importantly, this research is also beginning to provide molecular expla­
nations for the observed changes in cellular morphology (Matthews et al., 1995). It 
has also identified molecules that are involved in life-cycle regulation such as protein 
kinases (Vassella et al., 2001) and novel RNA binding proteins (Hendriks et al., 
2001) .
The study of T. cruzi differentiation is less advanced. Robust in vitro differentiation 
assays have yet to be established, and very few specific molecular markers are 
known. A major advantage of studying T. cruzi, however, is that its life-cycle can be 
completely reproduced in vitro (Miles, 1993). Cell cultures of phagocytic or non- 
phagocytic cells can be used to grow T. cruzi amastigotes and bloodstream trypo- 
mastigotes. Shifting supernatants from infected cell cultures from 37°C to 27°C 
causes the amastigotes to differentiate to epimastigotes, which can be readily grown 
in axenic culture, using semi-defined or commercially available cell culture medium.
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Tiansformation of epimastigotes to metacyclics occurs spontaneously in stationary 
phase epimastigote cultures of some strains of T. cruzi. While some culture media 
have been reported to enhance metacyclogenesis (section 1.4.2), the factors that 
induce this transition stage remain poorly understood, and no method has yet been 
devised that reliably induces metacyclogenesis in a wide variety of strains.
1.4 T. CRUZI METACYCLOGENESIS
The development of metacyclics is central to the T. cruzi life-cycle, as this form 
initiates the infection in the mammalian host. Metacyclics differ from epimastigotes 
in their morphology, their infectivity, resistance to mammalian serum, and their 
inability to replicate. The factors that trigger this differentiation, and the changes and 
mechanisms associated with metacyclogenesis at the molecular level have yet to be 
determined.
1.4.1 Metacyclogenesis in the insect vector
In the vector, the rate of metacyclogenesis depends on environmental factors such as 
nutritional state of the vector and temperature, as well as on the T. cruzi strain 
(Kollien and Schaub, 2000). Quantitative studies of metacyclogenesis in the vector 
(Schaub, 1989) have revealed that the proportion of metacyclics in the vector hindgut 
does not exceed 50%, and that metacyclics can develop in three different ways. They 
can develop through differentiation of a sphaeromastigote cell (flagellated spherical 
cells whose role in the life-cycle is incompletely understood), through differentiation 
of a slender epimastigote cell, or through unequal division during the growth phase. 
Attachment of the trypanosome to the insect appears only to be necessary for the 
differentiation from slender epimastigotes, but not for the others. A complete account 
of metacyclogenesis has to explain the role of these various morphologically distinct 
cells, as well as the persistence of non-dividing epimastigotes (Brack, 1968; 
Vickerman, 1985).
27
1.4.2 Factors that affect metacyclogenesis in vitro
Over the past three decades, attempts have been made to establish robust in vitro 
systems that cause epimastigotes to differentiate to metacyclics, so that a system in 
which factors that influence metacyclogenesis and the associated physiological 
changes in the parasite can be studied experimentally. There are three commonly 
used methods to obtain metacyclics: purification of spontaneously differentiated cells 
from old epimastigote cultures using a DEAE-column (Alvarenga and Brener, 1979), 
transfer o f epimastigotes to Grace's Insect Medium (Sullivan, 1982), or transfer to a 
minimal medium supplemented with amino acids (Contreras et al., 1985b). Unfortu­
nately, none of these methods is universally applicable, and the factors that control 
metacyclogenesis have remained elusive.
Grace's Insect Medium. A simple procedure for in vitro metacyclogenesis o f T. cruzi, 
using a commercially available medium was developed by Sullivan (1982): Transfer 
of epimastigotes of the Brazilian strain from liver infusion tryptone (LIT) medium 
(pH 7.2) to Grace's Insect Tissue Culture Medium (pH 6.6; a defined medium) 
yielded an average of 72% metacyclics after 5 days. A variation in the level of trans­
formation achieved by other strains or isolates of T. cruzi was noted. Ucros (1983) 
confirmed that Grace's medium supported metacyclogenesis in the Peru, Y and CL 
strains. However, contrary to the findings of Sullivan and others, maximal transfor­
mation was observed at pH 9.0.
Triatomine artificial urine (TAG). A chemically defined minimal medium capable of 
supporting T. cruzi metacyclogenesis was developed by Contreras et al. (1985b). 
TAU is a simple salt solution based on the composition of triatomine urine. When 
epimastigotes are transferred to TAU supplemented with L-proline (TAUP), the cells 
attach to the walls of the culture flask, and within 3 to 5 days transform to meta­
cyclics, which are released into the medium. The best results were obtained with the 
Dm28c strain (87 ± 4% metacyclics within 3 days). Initial differentiation rates were 
considerably less with other strains, but in a second cycle of incubation in TAUP, 
following treatment of differentiated cells with fresh guinea pig serum (thereby
28
eliminating remaining epimastigotes), all parasite strains showed differentiation rates 
of 60 to 90%.
Detailed studies in other laboratories have confirmed that TAU supplemented with a 
carbon source can induce metacyclogenesis. However, three important differences to 
the above findings have been noted. First, attachment appeared not to be required for 
differentiation. Second, the yield of metacyclics is usually 30-50% rather than 80- 
90%. Third, TAU supplemented with glucose can also induce differentiation, albeit 
at a lower rate than L-proline (Homsy et al., 1989). Using TAU, the effects and 
mechanisms of action of a number of factors that potentially affect metacyclogenesis 
have been studied in great detail in a variety of T. cruzi strains. A summary of these 
findings is presented below.
Energy' metabolism. The highest transformation rates are invariably obtained when 
TAU is supplemented with L-proline, but metacyclogenesis is also induced in the 
presence o f D-glucose, D-fructose, L-glutamate, L-glutamine, L-asparagine, L-pro­
line + sodium acetate, L-glutamine + L-hydroxyproline, D-fructose + L-hydroxy- 
proline. However, major differences between T. cruzi strains have been observed 
(Krassner et al., 1990). The tricarbolic acid cycle intermediates oxaloacetate, iso­
citrate and a-ketoglutarate do not induce transformation on their own, and inhibit 
proline-induced transformation (Homsy et al., 1989). It was also noted that the amino 
acids capable of inducing metacyclogenesis can be metabolised by eukaryotic cells 
to pyrroline-5-carboxylate (P5C), the first product of proline catabolysm, whereas 
leucine and isoleucine, which both inhibit P5C dehydrogenase also inhibited proline 
and glutamate induced transformation. Results of further studies using inhibitors and 
intermediates of proline metabolism are consistent with a proline-P5C cycle induced 
cascade system for cell activation. However, ornithine and arginine, which are com­
mon precursors for proline did not stimulate transformation, and hexoses, which are 
not readily metabolised to P5C, induced metacyclogenesis suggesting that alternative 
explanations must be considered (Krassner et al., 1990).
The importance of energy metabolism in metacyclogencsis was recently underlined, 
when it was shown that reduced levels o f  glucose trigger flagellar elongation in
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proliferating epimastigotes, and subsequent attachment to a hydrophobic surface 
(Tyler and Engman, 2000). The authors propose the following model for differentia­
tion: attachment generates the signal to differentiate. Differentiation itself requires 
the remaining glucose to be above a threshold. If the glucose concentration is below 
the threshold, cells cannot differentiate and they die (Tyler and Engman, 2001). 
Further studies are required to validate this model, and it will be interesting to deter­
mine how attachment generates a signal to differentiate.
A potential role fo r the reservosome in energy metabolism and metacyclogenesis. 
The studies discussed above suggest that depletion of glucose combined with height­
ened tricarbolic acid cycle activity is concomitant with transformation (Krassner et 
al., 1990). The growth of epimastigotes in culture after depletion of carbohydrates is 
most likely supported by catabolic breakdown of amino acids (Urbina, 1994). A 
possible amino acid source are the proteins stored in reservosomes, (acidic [pH 6.0] 
compartments located at the posterior end o f epimastigote cells, but absent in meta- 
cyclics) (de Souza et al., 2000). A role for reservosomes in metacyclogenesis has 
been proposed (Soares, 1999), and is supported by the following studies which used 
transfection-based approaches to study reservosome-associated proteins.
Reservosomes contain cruzipain, the major cysteine proteinase of T. cruzi. Cruzipain 
enzyme levels are developmental^ regulated (Tomas and Kelly, 1996). Enzyme 
activity is highest in epimastigote cultures, and the activity increases as epimasti­
gotes reach the stationary phase of growth (Tomas et al., 1997). Interestingly, over­
expression of cruzipain leads to a 3-4 fold increase in the number of metacyclics 
produced by the Silvio X10/6 strain in stationary phase cultures (Tomas et al., 1997). 
Conversely, metacyclogenesis is blocked in the presence of cysteine-protease in­
hibitors (Bonaldo et al., 1991).
A second reservosome-associated protein whose involvement in metacyclogenesis 
has been demonstrated is Tc52. Tc52 plays a role in the regulation of the intracellular 
thiol-disulphide redox balance by reducing glutathione disulphide and it appears to 
be localised in the reservosome. Tc52 expression is developmentally regulated and 
the highest levels were observed in stationary phase epimastigote cultures (Ouaissi et
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al., 1995). Monoallelic disruption of the Tc52 gene significantly reduced develop­
ment of metacyclics. Overexpression of Tc52 on the other hand did not enhance 
metacyclogenesis (Allaoui et al., 1999).
Calcium and other ions. In view of the role played by K+ and Ca2+ ions in many 
signal transduction pathways, the action of inorganic ions was investigated in TAU. 
It was shown that calcium, potassium, phosphate and carbonate ions stimulate, while 
chloride ions inhibit metacyclogenesis in a concentration and strain dependent man­
ner (Krassner et al., 1991). External Ca2+ ions were not required for transformation 
and, surprisingly, the calcium chelator EGTA in calcium free medium stimulated 
transformation. High external [Ca2+] inhibited transformation, but this inhibition was 
reversed when the divalent cation ionophore A23187 was added (Krassner et al., 
1993). Induction of metacyclogenesis in the CL strain was not accompanied by 
changes in cytosolic [Ca2+] and thus no supporting evidence for participation of a 
protein kinase C (PKC) mediated phosphoinositide cascade in metacyclogenesis was 
found (Krassner et al., 1993). Thus, the importance of Ca2+ signalling in metacyclo­
genesis is unclear at present.
Cyclic AMP. An effect of cyclic AMP (5'-3'-cyclic adenosine monophosphate; 
cAMP) on metacyclogenesis in TAU was suggested by the frequently cited study of 
Gonzales-Perdomo et al. (1988). Under conditions which induce metacyclogenesis, 
addition of membrane permeable cAMP analogues increased the yield of metacyclics 
of the Dm28c strain in TAUP during the first two days, but did not affect the final 
yield after 4 days. Activators of mammalian adenylyl cyclases (cholera toxin, epi­
nephrine) slightly stimulated the kinetics of metacyclogenesis compared to controls 
in TAUP (but not to the same extent as cAMP analogues). Compounds 48/80 and 
R24571, which both inhibit phosphodiesterase activation by calmodulin, suppressed 
metacyclogenesis in TAUP. When proline was replaced with glucose (TAUG), 
conditions which on their own did not support metacyclogenesis, differentiation was 
induced when cAMP analogues were added. Similarly, a non-hydrolysable GTP 
analogue, pNHppG, and adenosine supported metacyclogenesis even in the absence 
of proline. Based on these results, the existence of heterotrimeric G-proteins in-
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volved in the activation of T. e n d  adenylyl cyclase and a function for cAMP in 
differentiation were proposed.
More recent reports on the characterisation of the components of the trypanosomatid 
cAMP signalling pathway (section 1.5.2) have cast serious doubts on the interpreta­
tion of the results o f this and other studies, which rely on the use of substances that 
are known to inhibit components of the mammalian cAMP signalling pathway. In 
short, every component of the cAMP signalling pathway that has been investigated 
in trypanosomes has been found to be significantly different from its mammalian 
counterpart (Bieger and Essen, 2001; Naula et al., 2001; Shalaby et al., 2001; Taylor 
et al., 1999; Zoraghi et al., 2001). Heterotrimeric G-proteins, which regulate the 
activity of mammalian adenylyl cyclases, are completely absent from the trypano­
some genomes. A near complete catalogue of T. cmzi genes, as well as the tools for 
genetic analysis, are now available to re-address the question of whether cAMP 
signalling plays a role in metacyclogenesis.
An exogenous factor that induces metacyclogenesis? Another controversial series of 
reports suggested that a factor present in the intestine of recently fed triatomine bugs 
induces metacyclogenesis by interacting with an epimastigote membrane receptor 
(de Isola et al., 1986; de Isola et al., 1981). This factor was later identified with a 
proteolytic cleavage product of a^-globin from chicken blood, termed GDF 
(Fraidenraich et al., 1993). Furthermore it was reported that GDF activates the T. 
cruzi adenylyl cyclase and stimulates metacyclogenesis in vitro (Fraidenraich et al., 
1993) and in vivo (Garcia et al., 1995). Attempts to replicate these findings inde­
pendently have been unsuccessful.
In summary, there are many contradicting reports in the literature as to the conditions 
that induce metacyclogenesis in T. cruzi. The emerging consensus is that stress con­
ditions, including starvation, favour metacyclogenesis, but that sufficient energy 
sources must be available to sustain differentiation. Clearly, studies with individual 
strains or isolates o f T. cruzi may yield results that arc not universally applicable. A 
description of events associated with metacyclogenesis in molecular terms, and 
experimental manipulation using reverse genetic approaches should allow us to
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define more clearly which factors are essential for induction of metacyclogenesis, 
and which are merely contingent. Advances that have been made in both fields are 
discussed in sections 1.4.3 and 1.7.
1.4.3 Molecular events associated with metacyclogenesis
Well characterised molecular markers for specific T. cruzi life-cycle stages are still 
scarce. Qualitative and quantitative differences between proteins expressed in the 
various life-cycle stages have been demonstrated on ID and 2D protein gels and 
Western blots (Contreras et al., 1985a; Lanar and Manning, 1984; Rangel-Aldao et 
al., 1986). However the identity of most of these molecules remains to be deter­
mined. With the technological advances that have been made since those early 
studies were conducted 2 0  years ago, and the advent of high throughput functional 
genomics approaches (section 1.7.2), it is now feasible to identify such stage-specific 
gene products on a large scale. A brief overview of the current knowledge of mo­
lecular events associated with metacyclogenesis is presented below.
Expression o f  metacyclic-specific surface glycoproteins gp82 and gp90. The best 
characterised stage-specific T. cruzi genes code for surface proteins, including the 
epimastigote-specific small mucin genes TcSMUG (Di Noia et al., 2000), the 
amastigote-specific amastin (Teixeira et al., 1994) and proteins of the gp85/sialidase 
multi-gene family expressed in cell-derived trypomastigotes. The latter belong to the 
trans-sialidase gene superfamily (Cross and Takle, 1993; Schenkman et al., 1994). 
Two proteins that belong to this family, gp82 and gp90, have been identified as the 
major surface glycoproteins specific to metacyclics (Araya et al., 1994; Ruiz et al., 
1998). As yet, gp82 represents the only well characterised protein marker for meta­
cyclics in a wide variety of T. cruzi strains. Expression of gp90 on the other hand is 
strain-specific (Beard et al., 1988; Ruiz et al., 1998). The genes coding for gp82 and 
gp90 have been cloned and shown to belong to multi-gene families, dispersed 
throughout the T. cruzi genome. The protein sequences are 40-60% identical to those 
of the gp85/sialidase family. Steady state levels of gp82 and gp90 mRNA are 
developmental^ regulated. Transcript levels are high in metacyclics, very low in
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epimastigotes, and absent from other life-cycle stages (Araya et al., 1994; Carmo et 
al., 1999; Franco et al., 1993).
Gp82 has been implicated in the process of host cell invasion and in the initiation of 
signalling cascades, both in the parasite and in the target cell. It functions as a para­
site surface receptor that binds to an unidentified target cell molecule. This initiates a 
signalling cascade in the parasite cell, that involves tyrosine phosphorylation of a 
175 kDa protein, and leads to invasion of the target cell (Favoreto et al., 1998). The 
mechanism of transduction from the GPI-anchored gp82 into the cell is unclear. 
Binding of gp82, and to a lesser extent gp90 induces Ca2+ mobilisation in the target 
cell, and target cell extracts trigger Ca2+ mobilisation in metacyclics. Parasite Ca2+ 
mobilisation can be induced by monoclonal antibodies against gp82, but not by 
antibodies against gp90 (Ruiz et al., 1998). Interestingly, analysis of ten different 
strains o f T. cruzi revealed an inverse correlation between the infectivity of a T. cruzi 
strain and the level of gp90 expression. While gp90 was found to be one of the major 
surface components in the poorly invasive G strain, the antibody failed to detect the 
protein in the highly invasive CL and Y strains (Ruiz et al., 1998).
Changes in chromatin. A general decrease in transcription rates (Elias et al., 2001b), 
and phosphorylation of histone HI (Marques Porto et al., 2002) occurs concomi­
tantly with extensive nuclear reorganisation when replicating forms differentiate to 
the non-replicating and infective forms (including metacyclics). This is detailed in 
section 1 .2 .2 .
Differential gene expression during metacyclogenesis. Prior to in vitro differentiation 
in TAU, epimastigotes of the Dm28c strain adhere to the culture flask, and these 
cpimastigotes express specific surface antigens (Bonaldo et al., 1988). Recent dis­
coveries may provide the first clue as to the molecules and control mechanisms 
involved in this process. To identify genes expressed transiently during metacyclo­
genesis, a method has been devised recently (Krieger et al., 1999; Krieger and 
Goldenberg, 1998), called representation of differential expression (RDE). RDE is 
based on PCR amplification of cDNA sequences unique to a cell population (tester) 
after subtractive hybridisation with DNA sequences of a related cell population
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(driver). Using as driver the polysomal RNA fractions from replicating epimas- 
tigotes. and as tester the polysomal RNA fractions from epimastigotes induced to 
differentiate in TAU, several transcripts have been shown to be specific to adhered 
(and by implication, differentiating) cells. Interestingly, these studies suggest that 
mRNA mobilisation to the polysomes may be one of the post-transcriptional mecha­
nisms for regulating gene expression in trypanosomes.
The RDE method has so far led to the identification of two types of surface proteins 
thought to be involved in the differentiation process. This will be discussed in the 
following two sections. In addition, several novel upregulated transcripts of unknown 
function await further characterisation.
Chitin-binding-like protein (CBLP). During metacyclogenesis in TAU, transcripts 
were shown to be mobilised to the polysomal fraction that code for a family of small 
cysteine-rich proteins with sequence similarity to the chitin-binding domain of wheat 
germ agglutinin. Maximal transcript levels were detected 24 hours after initiation of 
differentiation. Consistent with this, the levels of a 7 kDa protein detected by a poly­
clonal antiserum raised against recombinant CBLP1, are highest in adhered epimas­
tigotes after 24 hours (Dallagiovanna et al., 2001).
Metacyclogenin. A second putative surface protein specifically expressed in differ­
entiating epimastigotes is metacyclogenin (Avila et al., 2001). Metacyclogenin 
mRNA is associated with the polysomes of 24 hours adhered epimastigotes. The 
T. cruzi genome contains at least 3 copies of the gene arranged in a tandem repeat 
with an 'associated' gene (AG) and a cytosolic tryparedoxin peroxidase gene (CPX). 
The AG gene shows an expression pattern similar to metacyclogenin (Avila et al., 
2001). The 13 kDa metacyclogenin protein is detected exclusively in adhered 
epimastigotes and it appears to be associated with the parasite cell membrane, as 
determined by immunocytochemical electron microscopy. The function of metacyc­
logenin is unknown.
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Using reverse genetic approaches it should be feasible to determine the role that 
these proteins play in differentiation and how commitment to differentiation and 
attachment of the parasite are linked.
1.5 DISSECTING SIGNAL TRANSDUCTION 
IN TRYPANOSOMES
Throughout their life-cycle, trypanosomes are confronted with environments that 
differ dramatically in their physico-chemical and biological properties (e.g. tem­
perature, pH, osmolarity and Ca2+ content, nutrient supply, haemolytic factors, 
agglutinins, digestive enzymes, components of cellular and immune defence systems 
from a variety of species). The trypanosome responds to these changes with equally 
dramatic changes in its cellular architecture and metabolism, and cycles between 
proliferating and non-proliferating, infective and non-infective, motile and non- 
motile stages (Vickerman, 1985). The parasite must therefore have mechanisms by 
which external signals are transduced and integrated to give rise to altered gene 
expression at the appropriate time. For the parasite cell these adaptive responses are 
essential in order to survive and proliferate. To the parasitologist they suggest the 
presence of essential pathways and potential targets for therapeutic interference. It is 
therefore a major task for the future to identify the components of these signal trans­
duction pathways and discover how changes in gene expression are regulated.
Mechanisms by which extracellular signals are detected and transduced by eukary­
otic cells to give rise to altered patterns of gene expression have been studied in great 
detail. Generally, an extracellular signal (including peptide ligands, ions, electric 
currents, certain wavelengths of light) alters the conformation of a membrane bound 
receptor, some of which function as ion-channels or have intrinsic enzymatic 
activity. They can be associated with intracellular kinases directly, or indirectly via 
heterotrimeric G-proteins. Transduction of the signal via the receptor protein causes 
synthesis of second messenger molecules, including cyclic AMP (cAMP), cyclic 
GMP (cGMP), inositol 1,4,5-triphosphate (IP3), 1,2-diacylglycerol (DAG), the 
release of Ca2+ from intracellular stores, and/or cascades of protein phosphorylation 
and dephosphorylation. This leads to the modulation of the activity of relevant
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enzymes and transcription factors by allosteric regulation. Positive and negative 
feedback loops and crosstalk between different pathways provides the cell with 
complex mechanisms to adapt gene expression and metabolism to environmental 
conditions and developmental requirements (Lodish et al., 1995).
While some components of the cellular signal transduction pathways known from 
higher eukaryotes are conserved in trypanosomatids (Parsons and Ruben, 2000; 
Ruben et al., 2002), their exact mechanisms and functions have remained mostly 
unexplored. Since the predominant mechanism for control of gene expression in 
kinetoplastids appears to be post-transcriptional (Clayton, 2002; Vanhamme and 
Pays, 1995), it is expected that signal transduction pathways result in changed RNA 
turnover or processing rather than changes in transcription (Parsons and Ruben, 
2000).
1.5.1 Protein kinases and phosphatases
Reversible protein phosphorylation is a mechanism common to many signal trans­
duction pathways. A considerable number o f serine and threonine kinases (but no 
tyrosine kinases) from trypanosomatids have been purified and biochemically 
characterised (Boshart and Mottram, 1997). The high degree of sequence conser­
vation found in kinases and phosphatases has allowed isolation of relevant genes, 
including mitogen activated protein (MAP) kinase homologues, cdc2-related kinases, 
protein kinase A (PKA), and protein phosphatases type 1, type 2A and 2C. Studies 
from Leishmania (Dell and Engel, 1994) and T. brucei (Parsons et al., 1993), using 
metabolic labelling, specific antibodies or in vitro kinase assays, have provided 
evidence that kinetoplastids have a full set of serine/threonine and tyrosine protein 
kinases and phosphatases. However, there is no firm evidence for receptor protein 
kinases and phosphatases, which in multi-cellular organisms represent an important 
group of signalling molecules. Completion of the trypanosomatid genome projects 
now allows the assembly of a complete catalogue of the relevant genes.
Several protein kinases and phosphatases show distinct cell-cycle (Gale et al., 1994) 
or life-cycle specific activity (Aboagye-Kwarteng et al., 1991; Bakalara et al., 1995;
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Dell and Engel, 1994; Parsons et al., 1993; Parsons et al., 1991). Some kinases have 
been shown to play a role in parasite development, but factors regulating their acti­
vity, and their downstream targets are still largely unknown. For example, a novel 
zinc finger kinase, ZFK, has recently been shown to play a role in T. brucei 
differentiation. Deletion of ZFK resulted in cells that showed an increased rate of 
differentiation from slender to stumpy bloodstream forms (Vassella et al., 2001).
The only well characterised T. cruzi trypomastigote specific phosphoprotein to date 
is histone HI, which is phosphorylated in the non-replicating trypomastigote stages, 
but not in replicating epimastigotes (Marques Porto et al., 2002). The kinase activi­
ties and phosphorylation profiles associated with T. cruzi metacyclogenesis are un­
known.
1.5.2 cAMP signalling
The second messenger cAMP plays a major role in controlling gene expression and 
metabolism in prokaryotes and eukaryotes. Its functions range from simple environ­
mental responses in lower eukaryotes, such as the photo-avoidance response in 
Euglena (Iseki et al., 2002), and fruiting body formation in the slime mould 
Dictyostelium discoideum in response to starvation (Weeks, 2000), to more complex 
functions, including the response to ethanol intoxication in Drosophila (Moore et al., 
1998) and odour perception in humans (Zufall et al., 1994). Its proposed role in 
T. cruzi metacyclogenesis remains controversial (section 1.4.2).
The paradigm o f cAMP signalling in eukaryotes. In response to an extracellular 
signal, cAMP is synthesised by the enzyme adenylyl cyclase (AC). Most AC iso­
forms of higher eukaryotes are integral membrane proteins with two intracellular 
pseudo-symmetrical domains and two hydrophobic domains each consisting of six 
transmembrane helices. The two catalytic domains dimerise to form the active en­
zyme (Hurley, 1998). The activity of mammalian ACs is controlled by a G-protein- 
coupled receptor. Binding of an external ligand leads to the dissociation of the G„ 
from the Gpr subunits in the associated G-protein and subsequent activation or inhi­
bition of the AC (Bentley and Beavo, 1992; Hurley, 1998; Levin and Reed, 1995).
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The most extensively studied downstream target for cAMP is cAMP-dependent 
protein kinase (PKA), a tetrameric protein consisting of two catalytic and two regu­
latory subunits. Binding of cAMP to the regulatory subunits of PKA releases the 
catalytic subunits, which then phosphorylate a diverse range of proteins including 
transcription factors such as the cAMP response element binding protein CREB 
(Fimia and Sassone-Corsi, 2001). Other downstream targets o f  cAMP include cyclic 
nucleotide gated ion channels, drug efflux channels, and the recently discovered 
cAMP binding protein Epac, which acts as a guanine-nucleotide-exchange factor for 
Rapl (de Rooij et al., 1998). The cAMP signal is terminated by the activity of 
cAMP-dependent phosphodiesterases (PDE) which break down cAMP to AMP by 
hydrolysis of the 3'-ester bond. The differential sensitivity o f various PDEs to spe­
cific inhibitors has made them important drug targets.
cAMP signalling in trypanosomes. Production of cAMP was one of the first bio­
chemical reactions described in T. brucei (Strickler and Patton, 1975). Meanwhile, 
abundant evidence suggests that cAMP plays a role in growth and differentiation in 
trypanosomatids (Naula and Seebeck, 2000; Seebeck et al., 2001). The differentia­
tion o f proliferating long slender bloodstream forms of T. brucei to the non pro­
liferating short stumpy forms, which are infective to tsetse flies, is thought to be 
mediated by a density sensing mechanism, in which release of a 'stumpy inducing 
factor' (SIF) by trypanosomes acts via the cAMP pathway to induce cell cycle arrest 
and subsequent differentiation (Vassella et al., 1997). Distinct peaks of AC activity 
were also observed during the in vitro differentiation of T. brucei bloodstream to 
procyclic (insect-stage) forms (Rolin et al., 1993). In T. cruzi, differentiation of 
metacyclics to amastigotes appears to be initiated when proteolytic cleavage frag­
ments of fibronectin activate the trypanosomal AC (Ouaissi et al., 1992). Tissue 
culture-derived T. cruzi trypomastigotes contain 4.3 times more cAMP than epimas- 
tigotes, and homogenates of trypomastigotes have a 2.6 fold higher cAMP binding 
activity than epimastigotes (Rangcl-Aldao et al., 1987). Evidence suggesting a role 
for cAMP signalling in the differentiation of T. cruzi epimastigotes to metacyclics 
was discussed in more detail in section 1.4.2.
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Trypanosomal adenylyl cyclases. In trypanosomatids ACs exist as multi-gene fami­
lies. T. cruzi contains about 30 genes (Taylor et al., 1999), and T. brucei has several 
hundred different AC genes (Alexandre et al., 1996; Naula et al., 2001; Seebeck et 
al., 2001). All trypanosomatid ACs analysed so far are structurally distinct from 
mammalian-type ACs. They consist of a large variable, presumably extracellular N- 
terminal domain, a single transmembrane segment and a conserved C-terminal cata­
lytic domain, which is active as a dimer of two AC molecules (Naula et al., 2001; 
Taylor et al., 1999). Some isoforms of T. brucei and T. cruzi AC appear to be local­
ised to the flagellum (Paindavoine et al.; 1992, Martin Taylor, unpublished).
The structure of trypanosomal ACs is reminiscent of receptor form mammalian 
guanylyl cyclases which are activated directly by external ligands. It has therefore 
been suggested that trypanosomatid ACs may act directly as receptors and, unlike 
mammalian ACs, trypanosomal ACs are not regulated by G-protein coupled recep­
tors. Putative AC activating ligands have been reported (Fraidenraich et al., 1993; 
Ouaissi et al., 1992) but the linkage between ligand binding and cAMP production 
has not been unequivocally demonstrated. Consistent with the proposed receptor 
function of trypanosomal ACs, heterotrimeric G protein subunit genes homologues 
have not been identified by any of the three trypanosomatid genome projects. 
Sequence analysis o f T. cruzi ACs (Taylor et al., 1999) and the recently solved 
crystal structure for two T. brucei ACs (Bieger and Essen, 2001) clearly show that 
the regions known to be involved in binding to the Gpr subunit of heterotrimeric 
G-proteins in the mammalian ACs, as well as the binding site for the AC activator 
forskolin, are not present.
Phosphodiesterases. Recently the cloning and biochemical characterisation of dif­
ferent T. brucei and T. cruzi cyclic AMP dependent phosphodiesterases has been 
reported (D'Angelo et al., 2004; Gong et al., 2001; Kunz et al., 2004; Zoraghi et al., 
2001). Inhibitor studies revealed that these trypanosomal phosphodiesterases display 
a pharmacology quite distinct from previously characterised PDEs. Importantly, the 
enzyme activity was not inhibited by 3-isobutyl- 1-methylxanthine (1BMX), which is 
commonly used to inhibit mammalian PDEs. Interestingly, substances that inhibited 
the T. brucei protein TbPDE2A in vitro, such as trequinsin, dipyridamole, sildenafil,
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and ethaverine inhibited growth of T. brucei in culture (Zoraghi et al., 2001). Dele­
tion of the gene for another T. brucei phosphodiesterase, TbPDEl, has not resulted in 
a discernible phenotype (Gong et al., 2001), and the function of the different PDE 
isoforms in T. brucei remains unclear. The subcellular location of a T. cruzi phos­
phodiesterase, TcPDEl, was investigated by subcellular fractionation of epimas- 
tigotes and immunofluorescence microscopy, using an antibody raised against the 
recombinant protein. TcPDEl was found to be membrane associated and concen­
trated on the flagellum of epimastigotes (D’Angelo et al., 2004).
Downstream effectors o f cAMP. The mechanism by which cAMP exerts its effects in 
trypanosomes is unknown. It has consistently proven difficult to correlate cAMP 
binding activities with kinase activities. One line of evidence suggested that T. cruzi 
contains a single cAMP binding protein, CARPT, which is not associated with phos­
photransferase activity (Rangel-Aldao et al., 1985; Rangel-Aldao et al., 1983). A 
short cDNA fragment of CARPT has been cloned (GenBank:S79626), but it shows 
no similarity to any other known cAMP binding protein and further characterisation 
has not been reported. A PKA-like kinase activity which is specifically activated by 
cAMP was later purified from T. cruzi epimastigotes, and the purified holoenzyme is 
recognised by antibodies against bovine PKA (Ochatt et al., 1993; Ulloa et al., 1988). 
The T. cruzi PKA is the only kinase activity from trypanosomatids described to date, 
which was shown to be stimulated by cAMP. A recently characterised PKA regu­
latory subunit from T. brucei shares structural similarity with the mammalian homo- 
logues, but, unexpectedly, the T. brucei PKA is activated by cGMP but not by cAMP 
(Shalaby et al., 2001). The physiological relevance of this cGMP activation is 
unclear, as there is no evidence for guanylate cyclase genes or enzyme activity in 
trypanosomes. Thus, a clear picture o f the downstream effectors of cAMP in try­
panosomes has not yet emerged.
cAMP induction ofTc26. A single cAMP-inducible RNA transcript termed Tc26 has 
been identified in T. cruzi (Heath et al., 1990). Tc26 transcripts are specific to meta- 
cyclics, and not found in cpimastigotcs, unless membrane permeable cAMP ana­
logues (dibutyryl cAMP or 8-BrcAMP) are added to the medium. Tc26 was later 
found to be part of a non-LTR retrotransposon (LITc), widely dispersed in the
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T. cruzi genome (Allen and Kelly, 2001), and it appears unlikely that it plays a direct 
role in the cAMP response.
1.5.3 Ca2+ signalling
Eukaryotic cells maintain a low Ca2+ concentration in the cytoplasm. This is medi­
ated by Ca2+ transport out of the cell and sequestration in internal compartments, the 
most important of which are the mitochondrion and ER. A signal is generated by a 
rise in cytosolic [Ca2+], and activation of specific Ca2+ -binding proteins. In trypano­
somes similar mechanisms are thought to function, and several of the Ca2+ regulators 
and effectors such as Ca2+ pumps and Ca2+ -binding proteins have been identified 
(Ruben et al., 2002). In addition to Ca2+ sequestration in the mitochondrion, kineto- 
plastids and apicomplexans store Ca2+ in a specialised acidic compartment, the aci- 
docalcisome (de Souza et al., 2000). The exact role of the acidocalcisome is unclear. 
Ca2+ binding proteins in the ER (e.g. BiP, calreticulin) have been shown to have a 
function in translation, protein folding and protein trafficking. A wide variety of Ca2+ 
binding proteins containing the EF-hand motif have been identified and cloned from 
T. brucei and T. cruzi. These include calmodulin (Chung and Swindle, 1990), which 
modulates the activity of target proteins in response to Ca2\  and EF-hand proteins 
associated with the flagellum, such as the T. cruzi flagellar calcium binding protein 
FCaBP (Maldonado et al., 1997), whose function is unknown.
In higher eukaryotes the inositol-lipid signalling pathway is activated by interaction 
of a ligand with a G-protein coupled receptor. Subsequent activation of phospho­
lipase C (PLC) leads to cleavage of phosphatidyl inositol 4,5-biphosphate (PIP2) to 
IP3 and DAG. IP3 causes Ca2+ release from ER into the cytoplasm through binding to 
specific channels in the membrane of the ER. DAG and elevated cytosolic Ca2+ in 
turn activate PKC (Nishizuka, 1992). Several components of this pathway are found 
in trypanosomes. A PLC orthologue cloned from T. cruzi shows some unique fea­
tures, such as lack of an apparent pleckstrin homology (PH) domain. Its expression is 
upregulated under conditions that stimulate the in vitro differentiation of T. cruzi 
trypomastigotes to amastigotes (Furuya et al., 2000). PKC-like activities have been
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reported (Gomez et al., 1989; Keith et al., 1990), but no gene from the PKC family 
has been identified in the kinetoplastids.
Ca2* signalling plays an important part in the invasion of mammalian cells by trypo- 
mastigotes (Burleigh and Andrews, 1998; Tan and Andrews, 2002). During invasion, 
Ca2* dependent signalling cascades, are triggered both in the parasite and in the host 
cell. These are mediated by the metacyclics specific surface glycoprotein gp82 (sec­
tion 1.4.3) and depend on the activity o f the T. cruzi serine hydrolase oligopeptidase 
B (Burleigh and Andrews, 1995; Caler et al., 1998).
Although some signalling effectors have been identified in trypanosomes, their up­
stream receptors and downstream targets remain mostly unclear. The discovery that 
parasite enzymes often do not respond to inhibitors or activators in the same way as 
their counterparts in higher eukaryotes (Zoraghi et al., 2001) bodes well for potential 
therapeutic interference. However, those early studies on signal transduction in 
trypanosomes that were based on the assumption that inhibitors and activators of 
mammalian enzymes would equally affect the trypanosome enzyme (for example 
Gonzales-Perdomo et al., 1988; Heath et al., 1990) must be reviewed and probably 
revised. One of the challenges of post-genomics research will be to link individual 
signalling molecules, and to determine their function in the parasite life-cycle.
1.6 UNUSUAL MECHANISMS OF GENE EXPRESSION 
IN TRYPANOSOMES
Most organisms that have been studied, from E. coli to humans, regulate the expres­
sion of genes predominantly by controlling transcription initiation. As detailed in 
every molecular biology textbook (Lodish et al., 1995), transcription factors bind to 
DNA elements (promoters) upstream o f individual protein coding genes which leads 
to recruitment of RNA polymerase II and assembly o f the transcription initiation 
complex. All evidence to date indicates that this is not the case in trypanosomatids. 
In these organisms, constitutive transcription is the norm and the expression of 
individual genes is controlled at various stages post transcription (Clayton, 2002; 
Vanhammc and Pays, 1995). The mechanisms by which trypanosomes regulate
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stage-specific gene expression patterns are thus distinct from those in most other 
organisms that have been studied.
1.6.1 Organisation of genes in polycistronic transcription units
Gene organisation and expression in kinetoplastids differs that of higher eukaryotes 
in several respects. Genes on kinetoplastid chromosomes are arranged in large direc­
tional clusters (Andersson et al., 1998; Hall et al., 2003). Typically, genes lack 
introns, with the first reported exception to this rule being the genes for poly(A) 
polymerase (Mair et al., 2000). Detailed analysis of the transcripts produced from a 
number of genes, including the calmodulin (Tschudi and Ullu, 1988) and phospho- 
glycerate kinase loci (Gibson et al., 1988) revealed the presence of large RNA tran­
scripts that contain the coding sequence of several neighbouring genes as well as 
intergenic sequences not found in the mature mRNA. This research established that 
genes are transcribed into large polycistronic pre-mRNA, from which mature mono- 
cistronic mRNAs are subsequently produced by RNA processing (see below). The 
selective advantage of polycistronic transcription is not clear. There is no evidence to 
date to suggest that functionally linked genes are routinely organised in common 
transcription units. However, given the large proportion of genes of unknown func­
tion in the kinetoplastid genomes (Hall et al., 2003), the existence of such co­
regulated units cannot yet be ruled out.
1.6.2 RNA polymerases, promoters and transcription
Genes for the core subunits of trypanosomal RNA polymerase I (pol I) (Smith et al., 
1989), RNA polymerase II (pol II) (Evers et al., 1989) and RNA polymerase III (pol 
III) (Kock et al., 1988; Smith et al., 1989) have been cloned, biochemically charac­
terised and classified according to their differential sensitivity to the fungal toxin 
a-amanitin (Clayton, 2002). The trypanosome pol II enzyme is structurally different 
form that of other eukaryotes (Evers et al„ 1989). Specifically, it lacks the heptapep- 
tide repeats in the C-terminal domain, which in higher eukaryotes is critical for the 
coupling of transcription, splicing and poly-adenylation.
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Most protein coding genes in trypanosomes are transcribed by pol II. However, pol II 
promoters have remained elusive, and the nature of the pol II complex remains to be 
characterised. Transfection experiments in T. cruzi, using episomal vectors suggest 
that pol II can initiate transcription in the absence of a specific promoter (Teixeira, 
1998; Teixeira et al., 1995). Transcription from chromosomes appears to be pre­
dominantly unidirectional, however, and it is thought that each contains just a few 
transcription initiation sites. Nuclear run-on experiments used to study transcription 
on L. major chromosomes I and III indicate that transcription initiation occurs in the 
strand switch region, between gene clusters (Martinez-Calvillo et al., 2004; 
Martinez-Calvillo et al., 2003). The complete sequence of a number of chromosomes 
with and without such strand switch regions are available (or will be shortly) as a 
result of the trypanosomatid genome sequencing projects. This provides ample mate­
rial to identify the nature of such transcription initiation sites.
Kinetoplastid ribosomal RNA genes, like those in other eukaryotes, are transcribed 
in the nucleolus by pol I. An unusual feature of trypanosome gene expression is the 
fact that pol I mediated transcription of protein coding genes can result in functional 
mRNA (Zomerdijk et al., 1991a). In T. brucei, the VSG and procyclin genes are 
transcribed by pol I. The respective promoters have been characterised in detail (Janz 
and Clayton, 1994; Zomerdijk et al., 1991a; Zomerdijk et al., 1991b; Zomerdijk et 
al., 1990), and they resemble other eukaryotic rRNA promoters. Even though they 
share little sequence similarity, the procyclin and rRNA promoter have been found to 
be functionally interchangeable (Janz and Clayton, 1994). The VSG and procyclin 
promoters represent the only promoters for protein coding genes of trypanosomes 
identified to date (Clayton, 2002; Vanhamme and Pays, 1995). Transfection ex­
periments in T. brucei have established that pol I mediated transcription can also 
drive the expression of reporter genes under the control of a rRNA promoter, and 
that the mRNA is correctly processed. Transcription of these reporter genes was 
shown to occur in the nucleolus (Rudenko et al., 1991). Interestingly, pol I mediated 
transcription of VSG occurs outside the nucleolus (Chaves et al., 1998; Navarro and 
Gull, 2001) in a distinct locus, termed the expression site body (ESB), which is 
present only in the bloodstream form of the parasite (Navarro and Gull, 2001). 
Recruitment of a single VSG gene to a privileged site such as the ESB could provide
45
a mechanism by which monoallelic expression from a large repertoire o f VSG genes 
is achieved (Borst, 2002).
The precursor RNA for the spliced leader sequence (SL, see below) is transcribed by 
pol II, and the SL genes represent the first instance where a pol II promoter has been 
characterised in trypanosomatids (Gilinger and Bellofatto, 2001; Gunzl et al., 1997; 
Nunes et al., 1997). Interestingly, recent evidence suggests that pol II mediated tran­
scription of the SL genes in T. cruzi also occurs in a distinct nuclear location, close to 
the nucleolus (Schenkman et al., 2004). Advances in imaging technology, has had a 
major impact on the perception of the eukaryotic nucleus. It has become clear that 
there are distinct compartments within the nucleus, despite the lack of internal mem­
brane boundaries (Dundr and Misteli, 2001; Spector, 2003). The question to what 
extent nuclear architecture contributes to the control of gene expression is an area of 
intense investigation (Misteli, 2000). It will therefore be of interest to identify the 
factors that direct specific genes to distinct subnuclear compartments in trypano­
somes, and to determine to what extent the positioning of genes within the nucleus 
affects their expression.
Small RNAs including tRNAs are transcribed by pol III, and a pol III promoter has 
been described (Fantoni et al., 1994). Small nucleolar RNAs are transcribed as part 
of polycistronic pol II transcription units (Clayton, 2002; Uliel et al., 2004).
There are still considerable gaps in our understanding of the steps from the poly­
cistronic pre-mRNA to the translated protein (D'Orso et al., 2003). While trypano­
somes share some of the mechanisms known from higher eukaryotes, there are 
clearly many interesting differences, as outlined below.
1.6.3 Trans-splicing and polyadenylation
The primary polycistronic transcript is processed to monocistronic mature mRNAs 
by RNA processing complexes (Figure 1.4). Unusually, in trypanosomes pol II- 
mediated transcription and mRNA capping are uncoupled. The 5’ end maturation of 
the mRNA occurs through addition of a common 39 nucleotide spliced leader (SL)
sequence derived from a separate transcript, in a trans-splicing reaction. Trans- 
splicing is mechanistically similar to cts-splicing in other eukaryotes (Davis, 1996; 
Nilsen, 1995). Branched intermediates are formed and utilise a 5-GpU dinucleotide 
splice donor and an ApG dinucleotide 3’ splice acceptor site. The SL is added to the 
5’ UTR sequence and does not affect the reading frame of the gene.
Originally discovered in trypanosomes (Sutton and Boothroyd, 1986), trans-splicing 
was later found to occur also in Euglena and in a number of metazoan phyla, in­
cluding nematodes (e.g. C. elegans and Ascaris), platyhelminthes (e.g. Schistosoma 
mansoni), cnidaria (Hydra) and chordata (Ciona intestinalis, a sea squirt) (Davis, 
1996; Stover and Steele, 2001; Vandenberghe et al., 2001). Unlike in trypanosomes, 
only a minority of mRNAs acquire a spliced leader sequence in these organisms. 
7rans-splicing has not been shown to occur in vertebrates. As gene expression has 
been analysed in only a very small proportion of lower eukaryotes, it is not clear how 
widespread trans-splicing is and what function it serves.
TRANSCRIPTION
GENE A G E IC B  GENE C GENE O
I  S P U C E O  LEADER
Figure 1.4: Polycisironic transcription in trypanosomes 
(from Taylor and Kelly, 2002)
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In a process coupled to the /raws-splicing reaction, a 3’-poly-A tail is added to the 
mRNA (poly-adenylation). In higher eukaryotes, the hexanucleotide sequence 
AAUAAA near the 3’ end of the RNA directs poly-adenylation. Trypanosomes, by 
contrast, contain no consensus polyadenylation signal. It occurs at a fixed distance 
upstream of the splice acceptor site and depends on the presence o f pyrimidine-rich 
sequence elements in the intergenic region. (Matthews et al., 1994; Schurch et al.,
1994) . A poly(A) binding protein has been characterised, which is thought to be 
involved in mRNA stability and translation (Batista et al., 1994; Hotchkiss et al., 
1999).
How the trypanosome mRNA is exported from the nucleus to the cytoplasm, and the 
degree of regulation involved, is presently unknown.
1.6.4 Differential gene regulation
The steady state levels of mRNA derived from different genes along the same 
transcription unit can differ radically (Abuin et al., 1999; Gibson et al., 1988; 
Teixeira et al., 1995). This implies that trypanosome gene expression must be 
controlled post-transcriptionally. The best-characterised polycistronic transcription 
units in trypanosomes are those that contain the genes for the T. brucei surface 
proteins VSG and procyclin. A combination of transcriptional and post- 
transcriptional controls determines the absolute stage-specificity o f these genes. This 
includes differential transcription elongation (Vanhamme et al., 1995), mRNA 
stability (Furger et al., 1997; Vanhamme et al., 1995) and translation efficiency 
(Schurch et al., 1997). Even though these genes differ from other protein coding 
genes in that they are transcribed by pol I and not pol II, their study has uncovered 
some general mechanisms of trypanosome gene regulation (Vanhamme and Pays,
1995) .
A central mechanism in the regulation of kinctoplastid gene expression is differential 
stability of mRNA molecules (D'Orso et al., 2003). Cis regulatory elements that 
determine the stability of mRNAs arc typically localised in the 3’ untranslated region 
(UTR) (Bcrberof et al., 1995; Blattner and Clayton, 1995; Furger ct al., 1997; Nozaki
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and Cross, 1995; Teixeira et al., 1995), or less commonly in the 5’ UTR (Pasion et 
al„ 1996). Treatment of trypanosomes with protein synthesis inhibitors such as 
cycloheximide can lead to an increase or decrease of specific transcripts (Abuin et 
al., 1999; Di Noia et al., 2000; Teixeira et al., 1995). This suggests that labile trans­
acting, protein factors play a role in selectively stabilising or destabilising certain 
transcripts, presumably by binding to the c/j-acting element.
Few of the cis regulatory elements and even fewer of the trans acting factors that 
regulate gene expression have been characterised. Given the importance of RNA 
processing in the control of trypanosome gene expression, surprisingly few protein 
factors that interact with RNA have been functionally characterised (D'Orso et al., 
2003). Since many RNA binding proteins can be easily recognised by the presence of 
conserved domains, that list is expected to grow as researchers continue to mine the 
trypanosomatid genome databases.
A small number of developmentally regulated RNA binding proteins have been 
studied in detail. These include the nuclear proteins p34/37 (Zhang et al., 1998; 
Zhang and Williams, 1997) and the nucleolar protein Nopp44/46 (Das et al., 1998), 
which have a role in ribosome biogenesis in T. brucei (Pitula et al., 2002a; Pitula et 
al., 2002b). Two RNA binding proteins from T. brucei called TbZFPl and TbZFP2 
have recently been demonstrated to play a direct role in regulating differentiation 
from bloodstream to procyclic forms (Hendriks et al., 2001). A knock down of 
TbZFP2 by RNAi inhibited differentiation to the procyclic form. Overexpression of 
TbZFP2 on the other hand resulted in a stage-specific remodelling of the cyto- 
skeleton, such as normally occurs during procyclic development (Hendriks et al., 
2001). Homologues of the ZFP! and ZFP2 genes have recently been cloned from T. 
cruzi (Morking et al., 2004), and it will be extremely interesting to determine their 
role in T. cruzi differentiation.
In T. cruzi, mechanistic insight into differential gene expression has been gained 
from analysis of stage-specific surface proteins.
Amastin/tuzin. Multiple copies of the amastin gene, which codes for an amastigote 
specific surface glycoprotein, are arranged in tandem repeats, alternating with genes 
of unknown function called tuzin. The amastin/tuzin gene cluster is equally tran­
scribed in all life-cycle stages, but the steady state RNA levels are differentially 
regulated. While amastin mRNA levels are at least 50 times higher in amastigotes 
than in other stages (Teixeira et al., 1994), the mRNA levels of the tuzin genes are 
not differentially regulated (Teixeira et al., 1995). Reporter gene assays demon­
strated a role for the amastin 3’ UTR in developmental regulation o f  mRNA levels 
(Nozaki and Cross, 1995; Teixeira et al., 1995). Further dissection of the 3’UTR 
sequence has shown that this process is mediated by a position and orientation de­
pendent element, which specifically binds a 36 kDa protein factor that is exclusively 
expressed in amastigotes (Coughlin et al., 2000; Teixeira et al., 1995).
Small mucin gene family. A multi-copy family of small mucin genes, called 
TcSMUG, exhibits stage-specific differences in mRNA levels. The highest levels are 
found in epimastigotes (Di Noia et al., 2000). Two functionally different c/s-acting 
elements were identified in the 3’ UTR of TcSMUG genes in reporter gene assays. A 
destabilising effect in metacyclics is mediated by a 44 nucleotide long AU-rich 
element (ARE), which also affects translation efficiency. Interestingly, this element 
is similar to ARE elements from higher eukaryotes (Di Noia et al., 2000). In addi­
tion, a novel G-rich element, termed GRE, selectively stabilises TcSMUG in epi­
mastigotes. There is evidence for a protein complex that recognises the GRE element 
(D'Orso and Frasch, 2001a). The RNA binding protein TcUBP-1, which specifically 
recognises AU-rich sequences, is involved in stage-regulated expression of TcSMUG 
genes (D'Orso and Frasch, 2001b). TcUBP-1 itself is developmentally regulated, and 
forms part of a large (~450k Da), ribonucleoprotein complex, suggesting the 
involvement of sophisticated processing machinery. This complex also contains the 
poly(A) binding protein and at least one other RNA binding protein (D'Orso and 
Frasch, 2002).
TcUBP-1 is part of a family of RNA binding proteins which contain the RRM type 
RNA binding domain (Burd and Dreyfuss, 1994). A query of the T. cruzi genome 
database using the RRM domain resulted in the identification and cloning of five
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other members of this family. These proteins show distinct stage-specific expression 
patterns, bind to RNA in vitro and are associated with different T. cruzi transcripts in 
vivo (De Gaudenzi et al., 2003). It will be interesting to determine the precise func­
tion of different RNP complexes in different life-cycle stages, and identify their 
specific RNA targets. A detailed characterisation of the mechanisms of TcSMUG 
regulation and further characterisation of these additional members is likely to add 
considerably to our understanding of the mechanisms by which stage-specific genes 
are regulated in T. cruzi.
Differential translation of mRNA transcripts and post-translational mechanisms add 
additional layers of control. For example, in T. cruzi the activity of the major cys­
teine proteinase cruzipain is upregulated in the insect stages, despite constant levels 
of mRNA throughout the life-cycle (Tomas and Kelly, 1996). In T. brucei stage- 
specific expression of the RNA-binding protein p37 is regulated both at the level of 
translation and post-translationally, by selective protein degradation (Li et al., 2003). 
A comparison of polysomal RNA fractions from epimastigotes and metacyclics 
identified a number of transcripts that showed stage-specific association with the 
polysomes (section 1.4.3). Differential mobilisation of transcripts to polysomes may 
be a mechanism by which stage-specific gene expression is regulated (Avila et al., 
2001). The //ww-acting factors that mediate differential mobilisation to polysomes 
and the factors that regulate translation have yet to be characterised.
Another level at which gene expression may be modulated as T. cruzi alternates 
between cell proliferation and cell differentiation is suggested by recent work com­
paring replicating and non-replicating forms of T. cruzi (Elias et al., 2001b). Global 
pol I and pol II transcription in non-replicating forms (metacyclics, cell-derived 
trypomastigotes, and epimastigotes in stationary phase) was significantly down 
regulated compared to replicating epimastigotes. Specifically, non-replicating try­
pomastigotes were found to incorporate 10 times less 3H-uridine than replicating 
cpimastigotes. Furthermore, total RNA extracted after in vitro incorporation of 32P- 
UTP in pcrmcabilised trypanosomes was hybridised with several pol II transcribed 
genes and satellite DNA. Signals with both types of probes were stronger in repli­
cating than in non-replicating cells, while the rate of RNA decay after addition of
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transcription inhibitor actinomycin D was shown to be similar in both forms. This 
down-regulation of transcriptional activity occurred in parallel with extensive 
remodelling of the nuclear structure (Elias et al., 2001b). The authors suggest two 
levels of control: (i) a global, non-specific down-regulation of transcription in non­
proliferating stages, and (ii) post-transcriptional control of stage-specific genes, 
which is expected to be directed by environmental signals (Elias et al., 2001a).
No link has yet been made from a membrane surface receptor to a factor that 
mediates RNA stability. Elucidation of the mechanisms of differential mRNA stabi­
lisation and translation is central to understanding how parasite development is con­
trolled and remains therefore an active area of research.
1.7 EXPERIMENTAL MANIPULATION OF T. CRUZI 
1.7.1 The genetic ‘toolbox’
The first report of successful transformation and expression of a reporter gene in a 
trypanosomatid (Bellofatto and Cross, 1989) initiated a new era of research. Rapid 
evolution of techniques that allowed stable transformation, and manipulation of gene 
expression led to important discoveries in many areas of trypanosome biology 
(Clayton, 1999; Taylor and Kelly, 2002). The current ‘genetic toolbox’ for kineto- 
plastid research is reviewed by Beverley (2003). Individual techniques, with empha­
sis on T. cruzi research are discussed below.
DNA is delivered into trypanosomes by electroporation. Selection o f transfected 
cells typically depends on the presence of a drug selectable marker gene which is 
flanked by processing signals, usually derived from a trypanosome housekeeping 
gene, such as glyceraldchyde-3 phosphate dehydrogenase (GAPDH). A list of com­
monly used marker genes for trypanosome transfections is presented in the review by 
Clayton (1999).
Episomal vectors. Several vectors have been devised for episomal expression of 
genes, including cosmid shuttle vectors that facilitated transfer of large (30-45 kb)
52
inserts (Kelly et al., 1994). The first shuttle vector that allowed expression of trans­
fected genes in T. cruzi was pTEX (Kelly et al., 1992), which contains the neomycin 
phosphotransferase (ArEO) gene flanked by GAPDH intergenic sequences, and a 
multicloning site for the insertion of the gene of interest. In the cell, pTEX is repli­
cated as an episome, usually in the form of concatemers, which segregate randomly 
at cell division and are not always stable. The mechanisms of replication and tran­
scription initiation have not been determined. In T. cruzi and Leishmania, no pro­
moter is necessary for the transcription of episomal genes (Kelly et al., 1992). pTEX 
is routinely used to express genes in T. cruzi, for a number of different applications. 
These include over-expression studies, expression of tagged proteins (e.g. expression 
of epitope-tagged proteins for localisation studies) or expression o f genes at a de­
velopmental stage when they would normally be suppressed. A derivative of pTEX, 
termed pRIBOTEX was constructed by inserting a ribosomal promoter (Martinez- 
Calvillo et al., 1997). This increased expression levels of a chloramphenicol acetyl 
transferase (CAT) reporter gene several thousand fold. In contrast to pTEX, which 
replicates episomally, pRIBOTEX was found to integrate into the rDNA locus.
Integrative transfection. Often it is desirable to stably integrate DNA into the 
genome. To achieve this, trypanosomes can be transfected with a piece of DNA, 
containing a selectable marker gene with 5' and 3' flanking sequences that facilitate 
transcript processing and a few hundred base pairs homologous to the target locus. 
Integration into the genome occurs by homologous recombination (Hariharan et al., 
1993). This method can be used to delete a gene from the genome (gene knockout). 
Null mutants are generated by deleting both allelic copies from the genome in two 
consecutive transfection steps, using two different marker genes. However, conven­
tional gene knockout has limited applications in T. cruzi for two reasons. This 
process is very slow, requiring six to nine months to generate a double knockout cell 
line (Taylor and Kelly, 2002). More significantly, many genes o f interest, such as 
cruzipain, adenylyl cyclase, and many interesting stage-specific surface proteins are 
present in multiple copies, which makes it impractical or impossible to delete them. 
This may explain why only a small number of T. cruzi null mutants have been 
reported in the literature (Caler et al., 1998; de Jesus et al., 1993; Manning-Cela et 
al., 2 0 0 1 ).
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Inducible expression. When a construct is integrated into a polycistronic tran­
scription unit, its expression depends on pol II run-through transcription. Often it is 
desirable to have conditional mutants with the gene of interest under the control of an 
inducible promoter. Based on the tetracycline (Tet) repressor system from E. coli, 
inducible systems have been developed for application in trypanosomes (Wirtz. and 
Clayton, 1995; Wirtz et al., 1998). Both the endogenous T. brucei pol I promoter 
from the procyclin locus (Wirtz and Clayton, 1995) or, more frequently, the bac­
teriophage T7 RNA polymerase and corresponding promoter have been used 
(DaRocha et al., 2004; Martin Taylor, unpublished; Wang et al„ 2000; Wirtz et al., 
1994; Wirtz et al., 1998). A vector for inducible expression o f genes in T. cruzi is 
shown in Figure 1.5. The Tet-inducible expression system can also be used for in 
vivo studies. When mice are infected with trypanosomes carrying a Tet-inducible 
gene, administration of the Tet-derivative doxycyclin via drinking water will induce 
transcription of that gene in the trypanosomes.
<1 MCS
rRNA upstream
OAH L
pTc INDEX
Figure 1.5: A vector for inducible protein expression in T. cruzi
Vector pTcINDEX was constructed by Martin Taylor (unpublished) for Tet-inducible expression o f  
proteins in T. cruzi. The gene o f interest is cloned into the multiple cloning site (MCS), flanked by the 
HXI splice acceptor site from the T. cruzi ribosomal protein P2f) H I.8 gene (hatched box; Vazquez 
and Levin, 1999) and actin intergenic sequence (green box). The gene o f interest and the hygromycin- 
selectable marker gene (HYC)  are under the control of T7 promoters (black arrows). The open circle 
represents the Tet- repressor binding site that allows transcription o f the gene of interest to be 
regulated by tetracycline. T: transcription terminator. The vector is linearised with Spe I, and 
transfected into cells that carry the genes for the Tet repressor protein and T7 RNA polymerase. 
Sequences corresponding to the upstream region of the I8S rRNA locus (I and II) target the vector for 
integration into the genome.
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RNAi. The discovery of RNA interference (RNAi) has added a powerful new method 
to the repertoire of genetic tools. This has had a major impact on T. brucei research 
(Ullu et al., 2004). It has also opened up a completely new field of research into the 
newly discovered role of small non-coding RNAs in gene silencing.
The initial impetus came from a landmark paper that demonstrated that expression of 
double-stranded RNA (dsRNA) in C. elegans causes rapid and sequence-specific 
degradation of mRNA transcripts, while leaving the endogenous genes unaltered 
(Fire et al., 1998). Soon it became apparent that this puzzling phenomenon functions 
in a wide variety o f organisms including T. brucei, where it was first used to inhibit 
tubulin gene expression (Ngo et al., 1998). Subsequent research into the mechanism 
and function of RNAi in a number of organisms clearly demonstrated that small 
RNA molecules play important regulatory roles in gene silencing phenomena, rang­
ing from viral defence mechanisms to developmental control. The hallmark of these 
processes is the generation of small (21-28 nt) RNAs from a number of different 
types of dsRNA precursors. These small RNAs are classified into three groups de­
pending on their origin and function: ‘siRNAs’ guide RNA degradation, ‘miRNAs’ 
guide translation inhibition (Meister and Tuschl, 2004) and ‘rasiRNAs’ direct 
heterochromatic modifications (Lippman and Martienssen, 2004).
Components of the RNAi pathways have been identified in a number of organisms, 
and their study has already provided considerable insight into the mechanisms in­
volved (Meister and Tuschl, 2004). Two proteins are central, and common to all 
organisms that are known to perform RNAi: DICER and argonaute (AGO). The 
aptly named DICER protein is a dsRNA specific RNase-III type endonuclease, 
which produces the small RNA duplexes (i.e. siRNAs) from dsRNA precursors. The 
protein consists o f an RNascIII domain, and a dsRNA binding domain. The siRNAs 
are subsequently incorporated into effector complexes. The so-called RNA-induced 
silencing complex (RISC) targets the sequence-specific degradation of target RNAs. 
The RISC complex always contains a member of the AGO family, which is thought 
to bind the siRNA directly. AGO proteins contain two conserved domains, PAZ and 
PIWI, which appear to function in protein-RNA and protein-protein interactions 
respectively.
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The mechanism of RNAi in T. brucei has been extensively studied (UUu et al., 
2004). A DICER-like enzyme, whose activity can be detected in cell free extracts 
processes dsRNA to siRNAs. The corresponding ‘DICER’ gene has not been identi­
fied, and the genome database contains no genes similar to the DICER consensus 
sequence. This could indicate that the T. brucei DICER is considerably divergent. 
The argonaute family member TbAGOl is the only component of the T. brucei 
RNAi machinery that has been characterised. It is thought to form part of the RISC 
complex where it binds the siRNA directly (Ullu et al., 2004). Generation of two 
independently derived AGOl knockouts has provided important clues as to the func­
tion of RNAi in T. brucei (Durand-Dubief and Bastin, 2003; Shi et al., 2004a). Both 
studies demonstrated that AGOl is essential for RNAi to occur in procyclic forms, 
but the gene (and the ability to perform RNAi) is not essential for the survival and 
proliferation of the cells. Mutational analysis of TbAGOl has subsequently identi­
fied a single arginine residue in the PIWI domain of the protein to be essential for 
RNAi (Shi et al., 2004b). Consistent with the proposal that RNAi has evolved as a 
mechanism for silencing retroposon transcripts (Tabara et al., 1999) and anti-viral 
defence, TbAGOl knockout cells were found to be defective in retrotransposon 
silencing (Shi et al., 2004a). The cells failed to accumulate siRNAs and the steady 
state levels of retroposon-transcripts increased fivefold in the T. brucei AGOl 
knockouts, an effect both of increased transcript stability and higher transcription 
rates (Shi et al., 2004a). As RNAi plays a central role in heterochromatic silencing in 
other organisms (Lippman and Martienssen, 2004; Volpe et al., 2002), the latter 
finding could indicate a similar function in T. brucei. The AGOl knockouts de­
scribed by Durand-Dubief and Bastin (2003), displayed a slow growing phenotype, 
and evidence of aberrant chromosome segregation. In the fission yeast S. pombe, the 
RNAi machinery is required for centromere cohesion and proper chromosome segre­
gation in mitosis and meiosis (Volpe et al., 2002). Future studies on T. brucei RNAi 
mutants will certainly determine to what extent similar mechanisms of RNA guided 
heterochromatic modifications operate in T. brucei. The interesting possibility that 
small RNAs could be involved in the regulation of specific genes opens up new 
avenues of research. These could add additional complexity to the mechanisms by 
which kinctoplastid genes are regulated. Investigation of RNAi thus promises to shed 
new light on the biology of T. brucei.
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The most immediate impact of the discovery of RNAi, however, was its immense 
usefulness as a tool to knock down genes. It is now the method of choice to down- 
regulate gene expression in T. brucei. Several labs have developed transfection vec­
tors for expression of dsRNA in T. brucei, using two principal methods to produce 
dsRNA: (i) insertion of the sequence of interest in between two opposing promoters. 
Transcription of the sense and antisense strand leads to formation of dsRNA which 
acts as a substrate for DICER (LaCount et al., 2000; Wang et al., 2000); (ii) insertion 
of inverted copies of the sequence of interest under the control of a single promoter. 
The transcript will then form a hairpin structure o f dsRNA (Bastin et al., 2000a). A 
major advantage o f RNAi technology is its suitability for large-scale high-throughput 
analysis, which could not easily be achieved by conventional gene knockout strate­
gies. For instance, simultaneous down-regulation of multiple genes can be achieved 
by targeting a sequence common to all these genes. This will no doubt greatly facili­
tate the study of functionally redundant genes. Genome-wide RNAi screens have 
been used to systematically knock down (almost) all annotated coding sequences in 
C. elegans, resulting in the identification of a large number of genes not previously 
associated with a phenotype (Kamath and Ahringer, 2003). An ongoing T. brucei 
functional genomics project aims to create a systematic collection of RNAi mutants 
(www.trypanofan.org).
RNAi was expected to prove especially useful to T. cruzi researchers, as it would 
circumvent the two major impediments to conventional gene knockout. An RNAi 
approach significantly reduces the time to generate knockdown mutants, and mul­
tiple gene copies can be targeted simultaneously. Attempts were therefore made to 
knock down genes by RNAi using the strategies that have been successful in 
T. brucei. For example in this lab, a vector was constructed for Tet-inducible RNAi 
(Martin Taylor, unpublished) which allows cloning of the sequence of interest be­
tween two opposing inducible T7 promoters, and integration into the 18S rRNA 
spacer region in the T. cruzi genome. Thorough attempts knock down genes by 
RNAi in T. cruzi (DaRocha et al., 2004, Taylor, unpublished) and in Leishmania 
(Robinson and Beverley, 2003), have all yielded negative results. Attempts to knock 
down trypanothione reductase in T. cruzi by expressing antisense RNA from an 
cpisomal vector equally failed to down regulate this gene (Tovar and Fairlamb,
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1996). Thus, T. cruzi researchers are left with limited options for generating gene 
knockdown mutants.
A likely explanation for the inability of these organisms to perform RNAi is this: no 
AGOl homologue or any other gene involved in RNAi has been identified in the 
T. cruzi or Leishmania genomes (Martin Taylor, personal communication Ullu et al., 
2004). Thus, at least the genome sequencing strains lack the genes for essential 
components of the RNAi machinery. Whether this is true for all T. cruzi strains and 
Leishmania species remains to be determined. How T. cruzi, whose genome is rich in 
retroposon-like elements keeps these in check is a matter of speculation. Unlike 
T. hrucei and T. cruzi, the Leishmania genome is largely deficient in transposable 
elements, and may therefore not require this defence mechanism.
1.7.2 Functional genomics approaches
Whole genome sequence information allows to ask completely new questions 
(Lander, 1996). Novel high throughput methods (below) make it possible to monitor 
gene expression patterns or the levels and modification state of proteins in response 
to a stimulus on a genome wide level. Bioinformatic analysis already plays a pivotal 
role in molecular biology research, and computational power will become even more 
essential in the future to process the vast amount of data generated by these studies.
Microarray expression profiling. Microarrays are an increasingly popular method to 
monitor changing mRNA levels in response to experimental conditions or to com­
pare gene expression between different cell types. It is thus a potentially very 
powerful method to identify developmentally regulated genes, despite the technical 
difficulties associated with it, and the advanced analysis skills required to detect 
meaningful patterns in the data produced. Microarray technology has for example 
been extremely successful in identifying novel stage-regulated transcripts in the 
malaria parasite Plasmodium. Random shotgun DNA microarrays were probed with 
RNA from blood stage trophozoites and sexual stage gametocytes and a large 
number differentially expressed transcripts were identified. This approach also iden­
tified previously non-annotated genes (Hayward et al., 2000). A similar approach has
58
been used to compare transcripts of T. brucei insect and bloodstream forms (Diehl et 
al., 2002) or L. major promastigotes, metacyclics and amastigotes (Beverley et al., 
2002). Both studies successfully identified a number of known stage-specific tran­
scripts, as well as a number of novel stage-regulated genes. However, the proportion 
of genes that showed more than two-fold difference in expression levels was very 
small. In contrast to Plasmodium, where genes are transcriptionally regulated, try- 
panosomatids control gene expression mainly post-transcriptionally (section 1 .6 ). 
Monitoring their gene expression by microarray technology is therefore expected to 
provide only limited information.
Proteomics. High-throughput proteomics approaches (Pandey and Mann, 2000) on 
the other hand may prove more useful to dissect developmental regulation in kineto- 
plastids. Protein extracts from cells cultured under different conditions can be 
separated by 2D-gel electrophoresis, and protein spots which reproducibly cor­
respond to proteins that are up- or down-regulated or modified in response to 
experimental stimuli, or in different stages of the life-cycle, can be excised and 
analysed by mass spectrometry. The genes corresponding to the selected peptide 
spots can easily be identified if the sequence database is sufficiently complete.
For example, proteomic methods have been successfully used to study gene expres­
sion and changes in protein phosphorylation in response to a stimulus in fibroblasts: 
Newly synthesised proteins were monitored by using pulsed [35S] methionine label­
ling followed by autoradiography for spot detection on 2D-gels, and protein identifi­
cation by high-sensitivity MALDI mass spectrometry (Predic et al., 2002). To detect 
changes in phosphorylation patterns, protein extracts separated by 2D-gel electro­
phoresis were electro-blotted, and phosphorylated proteins detected with anti- 
phosphotyrosine and anti-phosphoserine antibodies and identified by MALDI-TOF 
mass fingerprinting and ESI peptide sequencing. Analysis of peptide fragments by 
tandem mass spectrometry identified the precise site of phosphorylation (Soskic et 
al., 1999).
One difficulty associated with 2D gel electrophoresis is that the results have not 
always been reproducible. The isolation procedure of the protein sample also affects
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the results significantly. Improved equipment and commercially available reagents 
have allowed for better standardisation. A detailed protocol for the analysis o f try­
panosome proteins by 2D gel electrophoresis and mass spectrometry has recently 
been made available (van Deursen et al., 2003). Using this method, around 1000 
protein spots could be resolved. An initial comparison of the soluble proteins of two 
distinct life-cycle-stages of T. brucei, bloodstream and procyclic forms revealed a 
remarkably similar profile for both stages (van Deursen et al., 2003).
The tools for genetic manipulation of trypanosomes make it feasible to generate 
specific mutants for interesting genes discovered by high-throughput technologies, 
and eventually determine their function.
1.8 THE AIM OF THIS STUDY
In response to stress conditions, T. cruzi epimastigotes differentiate to metacyclics, 
which are pre-adapted for transmission to a mammalian host. The process o f  meta­
cyclogenesis is poorly understood. In order to get a handle on the molecular mecha­
nisms that control metacyclogenesis, it was necessary to establish an in vitro 
differentiation system suitable for experimental manipulation. The main part of the 
work then focused on the functional characterisation of two novel genes, MET2 and 
MET3, which were identified in a screen for transcripts that are upregulated during 
metacyclogenesis in the Dm28c strain of T. cruzi (Yamada-Ogatta et al., 2004).
The specific objectives of the project were to:
• Determine the conditions for in vitro differentiation of our CL Brener laboratory 
stock and develop a system suited for experimental manipulation
• Identify molecular markers associated with metacyclogenesis in CL Brener
• Identify the CL Brener homologues of the MET2 and MET3 genes
• Determine the stage-specificity of these genes in the CL Brener strain
• Determine the subcellular localisation of the MET2 and MET3 proteins
• Functionally characterise MET2 and MET3 by generating knockout mutants
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2. MATERIALS AND METHODS
2.1 MATERIALS
General chemicals were from Sigma, restriction enzymes from Promega, and oligo­
nucleotides were synthesised by Sigma Genosys.
Commonly used buffers were phosphate buffered saline (PBS): 10 mM phosphate 
buffer, 2.7 mM KC1 and 137 mM NaCl, pH 7.4; Tris buffered saline (TBS): 100 mM 
Tris, 150 mM NaCl, pH 7.4; 20X SSC: 3 M NaCl, 0.3 M sodium citrate.
2.2 CELL CULTURE
2.2.1 Trypanosoma cruzi strain
T. cruzi CL Brener (Zingales, 1997a) was used for all experiments. Epimastigotes 
were grown at 27°C in RPMI-1640 medium (Sigma) supplemented with 10% (v/v) 
heat-inactivated foetal calf serum (Sigma), 0.5% (w/v) trypticase, 0.5% (w/v) 
HEPES, 0.03 M haemin, 2 mM sodium glutamate, 2 mM sodium pyruvate, 2.5U ml' 1 
penicillin, 2.5 pg ml' 1 streptomycin (referred to in the text as ‘RPMI-1640’).
2.2.2 Induction of metacyclogenesis
Triatomine Artificial Urine (TAU). The method of Contreras, (1985b) was used. 
Briefly, late log phase epimastigotes were pre-incubated for 2 hours at a density of 
1-5x10® cells ml' 1 in TAU (190 mM NaCl, 17 mM KC1, 2 mM MgCl2, 8 mM phos­
phate buffer pH 6.0), followed by dilution to 3-5xl06 cells ml' 1 into 10 ml of TAU 
supplemented with 10 mM L-proline or 2 mM D-glucose, or as required, and the 
cells incubated at 27°C.
Grace's Insect Medium. Late log phase epimastigote cultures (between 5xl06 and 
lxlO7 cells ml'1, containing less than 1% metacyclics) were collected by centri­
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fugation at 1,640 g for 5 min. The old RPMI-1640 medium was removed and 
replaced with an equal volume of 80% RPMI-1640/20% Grace's Insect Medium 
(Gibco BRL) (v/v) and the cells were incubated at 27°C.
Giemsa staining. To determine the proportion of metacyclics, cells were collected by 
centrifugation and fixed in 2% paraformaldehyde for at least 20 min at r/t. The fixed 
cells were washed in PBS and suspended in PBS. 20 pi of appropriate dilutions were 
spotted onto glass slides and air-dried. The slides were submerged for a few seconds 
in methanol and stained with Giemsa for 10 min. Slides were washed with H20  and 
air-dried. The percentage of metacyclics (as assessed by the location of the kineto- 
plast posterior to the nucleus) was determined from at least 2 0 0  cells, using a light 
microscope at l,0 0 0x magnification.
2.2.3 Infection of macrophages with T. cruzi
Mouse macrophages (Raw 264 cell line) were used as host cells for the mammalian 
stages o f the T. cruzi life-cycle. Macrophages were grown in RPMI-1640 medium 
(supplemented as for T. cruzi epimastigotes, but without haemin) at 33°C in a hu­
midified atmosphere containing 5% C 0 2 in tissue culture flasks or 24 well microtiter 
plates. To obtain T. cruzi amastigotes for microscopic examination, macrophages 
were placed on sterile glass cover slips in 24 well microtiter plates with 0.5-1 ml 
medium per well. Macrophages were left to adhere for at least 2 hours before infec­
tion with 10 pi of a stationary T. cruzi culture (protocol adapted from Allaoui et al., 
1999). Cell-derived trypomastigotes were obtained by infecting 10 ml cultures of 
approximately 50% confluent macrophage monolayers in tissue culture flasks with a 
100 pi inoculum of a stationary T. cruzi culture. After overnight incubation, the 
infected macrophages were washed twice with medium to remove any residual epi­
mastigotes. Cover slips were processed for immuno-staining 24 hours after infection. 
The culture medium in the flasks was replenished every 2 to 3 days. The first trypo­
mastigotes emerged from macrophages 6  days after infection.
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2.2.4 Bacteria strains and culture
E. coli XLl-blue and E. coli BL21 were grown at 37°C in NZCYM medium (Sigma) 
with agitation or on NZCYM-agarose plates with appropriate antibiotics. For 
blue/white selection, 0.4% X-Gal and 6 mM IPTG were added to each plate.
2.3 PREPARATION, MANIPULATION AND ANALYSIS 
OF NUCLEIC ACIDS
2.3.1 Nucleic acid preparation from cells
Preparation o f plasmid DNA. Plasmid DNA was prepared from E. coli using the 
standard alkaline lysis procedure (Sambrook et al., 1989), or the QIAprep® Miniprep 
or HiSpeed™ Plasmid Midi Kits (Qiagen), according to the manufacturer’s instruc­
tions.
Isolation o f genomic DNA from T. cruzi. DNA was prepared according to Kelly 
(1993). Parasite cells were pelleted by centrifugation at 1,640 g for 5 min, and 
washed once in PBS. The cells were re-suspended in TEN cell lysis buffer (50 mM 
NaCl, 50 mM EDTA, 1% SDS, 50 mM Tris-HCl, pH 8.0) and 100 pg ml'1 Pro­
teinase K (Roche) was added. The mixture was incubated at 37°C overnight. The 
DNA was then purified by extraction with equal volumes of phenolxhloroform, and 
precipitated by addition of 1 volume of isopropanol. The DNA aggregate was trans­
ferred to a new tube, and RNA was degraded by addition of 10 pg ml'1 heat-treated 
RNase A (Sigma).
Isolation o f T. cruzi chromosomes for Clamped Homogenous Electric Fields 
Electrophoresis (CHEFE). Parasites from late log phase cultures (107 cells ml'1) 
were collected by centrifugation at 1,640 g for 5 minutes at r/t. The resulting pellet 
was washed once in PBS and re-suspended in PBS at approximately 3x10* parasites 
ml'1. This suspension was mixed 1:1 with 1.5% low melting point agarose (Bio Rad) 
maintained at 42°C, and immediately pipetted into a block/plug mould (Bio Rad) and 
left on ice to solidify for 20 min. The blocks were removed from the casts and incu-
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bated in digestive buffer (0.5M EDTA, pH 8.0; 3% sarcosyl, 2 mg ml'1 of Proteinase 
K) for 48 hours at 50°C. Blocks were washed several times with L-buffer (100 mM 
EDTA, 10 mM Tris pH 8.0, 20 mM NaCl) and stored in L-buffer at 4°C.
Isolation o f RNA from T. cruzi. RNA was prepared according to Kelly (1993). 
Parasite cells were pelleted by centrifugation, washed once in PBS, and re-suspended 
in 4 M guanidinium thiocyanate solution (GTC) to disrupt cells and inactivate 
RNases. After shearing DNA by passage of the lysates through a narrow gauge 
syringe needle, the lysates were layered onto a 1.5 ml 5.7 M caesium chloride 
cushion and centrifuged at 36,000 rpm at 20°C for 20 hours in a Beckman L8/80 
Ultracentrifuge using a SW55 rotor. The RNA pellet was washed in 70% ethanol and 
suspended in 400 pi RNA suspension buffer (0.3 M sodium acetate pH 5.5, 0.1 mM 
EDTA). The RNA was precipitated by addition of 1 ml ice-cold 70% and incubation 
at -20°C for 2 hours. The RNA pellet was dissolved in sterile ddH20, and RNA 
concentration was determined by measuring the absorbance at 260 nm (an A26o of 1.0 
corresponds to 40 pg RNA ml'1). Alternatively, the RNeasy kit (Qiagen) was used, 
according to the manufacturer’s instructions.
2.3.2 Polymerase chain reaction (PCR)
General PCR conditions. PCR was used to generate DNA fragments for the con­
struction of expression vectors, knockout targeting constructs and probes for hybridi­
sation experiments. Reaction mixes contained approximately 100 ng of plasmid or 
genomic template DNA, 20 pmol of each relevant primer (listed in appendix), 
2 mmol dNTP mix, lx PCR buffer (Bioline), 1-5 mM MgCl2 (optimal concentration 
determined for each primer pair), and 1 unit Taq polymerase (Bioline) or TaqPlus 
Precision Polymerase mixture (Stratagene) in a total volume of 50 pi. Reactions were 
run on a Hybaid Omni-Gene thermal cycler, and typical cycling conditions were 30 
cycles of 30 seconds denaturing at 94°C/30 seconds annealing at 50°C/1 minute 
elongation at 72°C. The annealing temperature and elongation time were adjusted 
according to the primer pair used.
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P C R  P r im e rs .  R estr ic tio n  s ite s  introduced to facilitate  c lo n in g  are un derlined .
S L - P R IM E R : dGGGGGATCCACAGTTTCTGTACTAoh
m e t 2 - l c l r : pCTCCATAGCGTTGACGAACAoh
m e t 2 - l c l r : pATGATGGGAACGACAATTCAoh
T R C M E T 2F : oAGAGGATCCCCTGCCGCTCCAACCAAoh
T R C M ET 2R : dAGAAAGCTTCCGACTGCGTATGCTCATCoh
T R C M E T 3 F : oAGAGGATCCGCAAGGATAACAAATCCCACoh
T R C M E T 3R : dCACAAGTCCGGCGCAGAAACTGCTAoh
m e t 2 0 R F - I f  : oCCCACTAGTATGATTCCCTGCCGCTCCAACCoh
m e t 2 0 R F - l r : □CCCGCCGGCCTTAGATGAATCATCTATAATCCTGCoh
m e t 3 0 R F - 1 f : dCCCACTAGTATGTCGCGACGCAAAGATAACoh
m e t 3 0 R F - l b r : oAAAGCCGGCGGGCCCACCTGTCCTCoh
M E T 3 - G F P f ( 2 ) : dCCCGATATCATGTCGCGACGCAAAGATAACoh
M E T 3 - G F P f ( 5 ) : oCCCGAATTCATGCGTCGCCACCGTGACGoh
M E T 3 - G F P f ( 7 ) : dCCCGAATTCATGGGCCGTCAGGGAACGCCTCoh
M E T 3 - G F P f ( 1 1 ) : dCCCGAATTCATGTCTACGGAAAGCGACCoh
M E T 3 - G F P f ( 1 4 ) : oCCCGAATTCATGACAGGGAGCCGAGCAAGoh
M E T 3 - G F P r ( 3 ) : □CCCGGATCCTGATCGCGAAGTCGACGoh
M E T 3 - G F P r ( 4 ) : dCCCGGATCCTGATGCTCCCGTCCTTGAToh
M E T 3 - G F P r ( 6 ) : oAAAGGATCCGGCCCACCTGTCCTCGoh
M E T 3 - G F P r ( 9 ) : oCCCGGATCCCCTTCACCCGTGCGTGCoh
M E T 3 - G F P r ( 1 0 ) dCCCGGATCCGAGCGTGGGAGATAGGoh
M E T 3 - G F P r ( 1 2 ) □CCCGGATCCCCTATTACACGTCCCGoh
M E T 3 - G F P r ( 1 3 ) dCCCGGATCCGATGTGGACGGGAGGAoh
M E T 3 - 9 E 1 0 f ( 7 ) dAAAACTAGTATGGGCCGTCAGGGAACGCCTCoh
M E T 3 - 9 E 1 0 r ( 8 ) □GGGAAGCTTACAAGTCCTCTTCAGoh
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M E T 2 - 5 F L - F
M E T 2 - 5 F L - R  
M E T 2 - 3 F L - F  
M E T 2 - 3 F L - R  
M E T 3 - 5 F L - F  
M E T 3 - 5 F L - R  
M E T 3 - 3 F L - F  
M E T 3 - 3 F L - R
pCCCGAGCTCTGTGCATGTATCCTTCoH
pCCCGATATCAACGCACCAGAGACAATCqh
pCCGCTCGAGAAGCTTTTAAAGGACATTGoH
pCCCGGTACCTC TTC TTC TC G C A TG C qh
pCCCGAGCTCTATGTGAGACTTGAACGqh
pCCCGATATCTATTATTGTGTGACGCAGCqh
pCCCGGTACCGAGTGCAATATATACACqh
pCCCCTCGAGTTTCTGCGCCA ATTG AG qh
2.3.3 RT-PCR amplification of MET2 and MET3 cDNA
Reverse transcriptase PCR (RT-PCR) was used to identify the splice acceptor site the 
5’UTR of the MET2 and MET3 genes. The Access RT-PCR system (Promega) was 
used according to the manufacturer’s recommendations. For first strand cDNA syn­
thesis, 1 pg of OHgo(dT)is primer and 1 pg total RNA from T. cruzi stationary cells 
were used. Reverse transcription reactions were carried out in 50 pi, at 37°C for 60 
min, followed by 2 min at 94°C. For the second strand cDNA synthesis and PCR 
amplification a forward primer was used that recognised the spliced leader sequence 
(SL-PRIMER), and the reverse primer was specific to the coding sequence of MET2 
(primer met2-lclr) or MET3 (primer met3-lclr). Cycling conditions were 30 seconds 
dénaturation at 94°C/30 seconds annealing at 55°C/1 minute elongation at 72°C (30 
cycles). The PCR fragments were cloned in pGEM-T (Promega) and sequenced.
2.3.4 Cloning techniques and vector construction
DNA cloning techniques. Standard techniques were employed for restriction enzyme 
digestion of DNA, ligation reactions and propagation of plasmids in E. coli.
Isolation o f DNA fragments from agarose gels. For purification of DNA from aga­
rose gels the QIAquick® Gel Extraction Kit (Qiagen) was used according to the 
manufacturer's instructions.
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Vectors for expression of MET2 and MET3 in E. coli. For in-frame cloning into the 
expression vector pTrcHis C (Invitrogen), the respective coding sequences were 
PCR-amplified from T. cruzi CL Brener genomic DNA as follows: fragment met2C 
was amplified with the primers TRCMET2F and TRCMET2R, and fragment met3C 
was amplified with the primers TRCMET3F and TRCMET3R. pTrcHis-met2 and 
pTrcHis-met3 were generated by digesting the pTrcHis C vector and the met2C and 
met3C fragments with Bam HI and Hind III, and subsequent ligation of the relevant 
PCR fragment with the vector. This resulted in fusion genes encoding proteins with 
an N-terminal 6x histidine tag for protein purification, and an epitope tag for detec­
tion with the anti Xpress antibody. Plasmid clones were identified by restriction 
digest analysis, and the sequences were verified by sequencing both strands of the 
inserts.
Vectors for expression o f c-myc tagged protein in T. cruzi. Episomal expression 
vectors pTEX-MET2-9E10 and pTEX-MET3-9E10 (Figure 2.1) were constructed by 
replacing the APX coding sequence in pTEX-APX-9E10 (Wilkinson et al., 2002) 
with the gene of interest. The resulting proteins carried at their C-terminus the amino 
acid sequence of the c-myc(9E10) epitope (EQKLISEEDL). The fragments corre­
sponding to the MET2 and MET3 coding sequences were amplified by PCR from 
T. cruzi CL Brener genomic DNA as follows. The MET2 coding sequence was 
amplified using primers met20RF-lf and met20RF-lr. The MET3 coding sequence 
was amplified using primers met30RF-lf and met30RF-lbr. The resulting PCR 
fragments were cloned in pGEM-T (Promega) and sequenced. The vector pTEX- 
APX-9E10 was digested with Spe I / Eco RV to remove the 1 kb APX fragment. The 
linearised vector fragment was ligated with the MET2 or MET3 coding sequence, 
which had been excised from the relevant pGEM-T construct with Spe I / Nae I. The 
resulting plasmids pTEX-MET2-9E10 and pTEX-MET3-9E10 were sequenced, and 
the correct in-frame fusion of the c-myc sequence with the 3’ end of the coding 
sequence was confirmed.
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Figure 2.1: pTEX-M ET2-9EI0 andpTEX-MET3-9EI()
Episomal vectors for expression o f MET2 and MET3 proteins with a C-terminal c-myc epitope tag. 
Strong black lines indicate OAPDH intergenic sequences that facilitate transcript processing.
Vectors for expression o f GFP-fusion proteins in T. cruzi. pTEXeGFP was con­
structed by Martin Taylor. The eGFP gene was excised from pEGFP (Clontech) 
using Eco RI (overhang blunted) and Hin dill and ligated into pTEX (Kelly et al., 
1992) digested with Xho I (overhang blunted) and Hind III. Vectors to express 
MET3-GFP fusion proteins were constructed by replacing the BPP-l-N fragment in 
pTEXeGFP-N (Bromley et al., 2004) with fragments of the MET3 coding sequence. 
The MET3 fragments were generated by PCR, using the vector pTEX-MET3-9E10 
as DNA template. Forward primers were MET3-GFPf(2), -(5), -(7), -(11) and -(14). 
Reverse primers were MET3-GFPr(3), -(4), -(6), -(8), -(9), -(10), -(12) and -(13). 
The resulting PCR fragments were digested either with Eco Rl / Bam HI or Eco RV / 
Bam HI, depending on which site was engineered into the primer. pTEXeGFP-N was
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cut with Eco RI / Bam HI to remove the BPP-l-N fragment, and then ligated with the 
Eco RI / Bam HI digested PCR fragments. For ligation with the Eco RV / Bam HI 
digested PCR fragments, pTEXeGFP-N was linearised with Eco RI and the ends 
made blunt. The BPP-l-N fragment was then excised by digesting with Bam HI, and 
the vector fragment ligated with the relevant PCR fragment. To build fusion 
construct 7/8 (encoding N-terminally truncated MET3 with a C-terminal c-myc tag) 
primers MET3-9E10f(7) and MET3-9E10r(8) were used to amplify the relevant 
fragment from pTEX-MET3-9E10. This PCR fragment was Spe I / Hin dill digested 
and cloned into Spe I / Hin dill digested pTEX. The MET3-GFP and MET3-9E10 
fusion constructs were sequenced. A schematic diagram of the constructs is shown in 
Figure 4.27. The names of the constructs indicate the primer pairs used for the 
amplification of the MET3 fragments.
MET2 and MET3 knockout targeting constructs. Fragments corresponding to the 
sequences flanking the MET2 and MET3 coding sequences were amplified by PCR 
from T. cruzi CL Brener genomic DNA as follows. The MET2 5’ flanks were ampli­
fied using primers MET2-5FL-F and MET2-5FL-R. The resulting fragment derived 
from allele 39p3 is 921 bp and contains a diagnostic Xho I restriction site. The frag­
ment derived from allele lol7 is 639 bp. The MET2 3’ flanks (2.3 kb fragments) 
were amplified using primers MET2-3FL-F and MET2-3FL-R. The MET3 5’ flank 
(416 bp fragment) was amplified using primers MET3-5FL-F and MET3-5FL-R. 
The MET3 3’ flank (1.3 kb fragment) was amplified using primers MET3-3FL-F and 
MET3-3FL-R. The PCR fragments were cloned in vector pGEM-T (Promega). The 
resulting plasmids pGEM-T-5’MET2(lol7), pGEM-T-5’MET2(39p3), pGEM-T- 
3’MET2(lol7), pGEM-T-5’MET3 and pGEM-T-3’MET3 were sequenced.
Construction o f pko-MET2(39p3)-NEO. The 5’ A/£T2(39p3) Xho I / Kpn I fragment 
excised from pGEM-T-5’MET2(39p3) was ligated into pko2-MPX-NEO (Shane 
Wilkinson, unpublished) from which the 5’ MPX fragment had been excised with 
Sac I / Spe I. The resulting plasmid pko-5’MET2-NEO was digested with Hin dill / 
Kpn I to remove the 3 'MPX fragment. The 3’MET2(39p3) Hin dill / Kpn I fragment 
excised from pGEM-T-3’MET2(39p3) was ligated into the linearised pko-5’MET2- 
NEO vector, resulting in plasmid pko-MET2-NEO (Figure 2.2A).
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Construction o f pko-MET2(lol7)-HYG. The 5’ MET2(\o\l) Sac I / Spe I fragment 
excised from pGEM-T-5’MET2(lol7) was ligated into pSHYGK (courtesy of 
Martin Taylor) which had been linearised with Sac 1 / Spe I. The resulting plasmid 
pko-5’MET2-HYG was linearised with Hin dill / Kpn I. The 3’MET2(lol7) Hin dill 
/ Kpn I fragment excised from pGEM-T-3’MET2(lol7) was ligated into linearised 
pko-5’MET2-HYG resulting in plasmid pko-MET2(lol7)HYG (Figure 2.2B).
Construction o f pko-MET2(lol7)-PAC. The HYG gene in pko-MET2(lol7)HYG 
was replaced with the PAC gene as follows. pko-MET2(lol7)HYG was digested 
with Eco RI / Sac I and the pko-MET2(lol7) vector fragment was isolated from an 
agarose gel (thereby removing the HYG ORF and the 5’ GAPDH flank). Digestion of 
pko-MPX-PAC (Shane Wilkinson, unpublished) with Eco RI / Sac I, allowed isola­
tion of a Eco RI / Sac I fragment containing the PAC ORF, and an Eco RI fragment 
containing the 5’ GAPDH flank. First, the PAC ORF was ligated into the pko- 
MET2(lol7) vector fragment, resulting in pko-MET2-PACl. Then the 5’ GAPDH 
flank was ligated into pko-MET2-PACl, linearised with Eco RI, resulting in plasmid 
pko-MET2(lol7)-PAC (Figure 2.2C). The correct orientation of the 5’ GAPDH 
flank was verified by a diagnostic Sac II digest.
Construction o f pko-MET3-HYG. The 5 'MET3 Sac I / Spe I fragment excised from 
pGEM-T-5’MET3 was ligated into pSHYGK (Martin Taylor, unpublished) which 
had been linearised with Sac I / Spe I. The resulting plasmid pko-5’MET3-HYG was 
first linearised with Hin dill, the ends blunted, and then digested with Kpn I. pGEM- 
T-3’MET3 was digested with Xho I and the end made blunt. Then the plasmid was 
digested with Kpn I to excise the 3’MET3 Xho I / Kpn I fragment, which was ligated 
into linearised pko-5’MET3-HYG, resulting in plasmid pko-MET3-HYG (Figure 
2.3A).
Construction o f pko-MET3-PAC. The HYG gene in pko-MET3-HYG was replaced 
with the PAC gene as follows. pko-MET3-HYG was digested with Spe I / Sal I to 
obtain vector fragment pko-MET3, containing the MET3 flanks and the 3’ GAPDH 
flank. A fragment containing the 5’ GAPDH flank and the PAC ORF was excised
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from pko-MET2(lol7)PAC (see above) and ligated into pko-MET3, resulting in 
pko-MET3-PAC (Figure 2.3B).
The integrity o f all knockout constructs was checked by analysis of restriction pat­
terns. For transfection of T. cruzi, the fragments containing the MET2 or MET3 
flanks and drug selectable marker gene were excised from the relevant vector with 
Sac I / Kpn I.
Figure 2.2: Targeting constructs for  MET2 knockouts
Linear targeting fragment from (A) pko-MET2(39p3)-NEO, (B) pko-MF.T2(lol7)-HYG and (C) pko- 
MET2(lol7)-PAC. These fragments were used to replace the M ET2  gene with the neomycin phos­
photransferase gene (NEO), the hygromycin phosphotransferase gene (//KG') or the puromycin acetyl 
transferase gene (PAC). Strong black lines indicate GAPDH intergenic sequences that facilitate 
transcript processing. Blue lines indicate sequences flanking the MET2 gene, used to target homolo­
gous recombination.
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Figure 2.3: Targeting constructs fo r  MET3 knockouts
Linear targeting fragment from (A) pko-MET3-HYG and (B) pko-MET3-PAC. Strong black lines 
indicate GAPDH  intergenic sequences that facilitate transcript processing. Red lines indicate 
sequences flanking the MET3 gene.
The Rediprime” II Random Prime Labelling System (Amersham Pharmacia Bio­
tech) was used according to the manufacturer's instructions to label DNA fragments 
with [32P] dCTP for use in hybridisation protocols.
Southern blotting. Genomic DNA was incubated with the appropriate restriction 
enzymes for >4h at 37°C and size-fractionated on 0.8% agarose gels in lx TAE 
buffer (40 mM Tris-acetate, 1 mM EDTA, pH 8.0), at 20 V over-night. DNA was 
transferred to Nylon membranes (Osmonics) in lOx SSC by standard Southern blot 
procedures, using capillary transfer over-night. After transfer, the DNA was cross- 
linked to the membrane in a UV Stratalinker (Stratagcne).
2.3.5 Radio-labelling of DNA fragments
2.3.6 Electrophoresis and blotting of nucleic acids
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Separation o f T. cruzi chromosomes. 1% agarose gels for Clamped Homogenous 
Electric Fields Electrophoresis (CHEFE) were made with 0.5 x TBE buffer (0.89M 
Tris, 0.89M sodium borate, 0.02M EDTA) and low-melt agarose (Bio Rad). T. cruzi 
chromosomes embedded in agarose blocks (section 2.3.1) were inserted into the 
wells of the gel and sealed with agarose. Saccharomyces cerevisiae chromosomal 
DNA (Bio Rad) was used as size markers. Gels were run in the CHEF Mapper® XA 
System (Bio Rad), at 14°C, using the auto-algorithm settings. A separation range of 
0.2 Mb to 1 Mb was chosen for MET2 analysis, and 0.5 Mb to 2 Mb for MET3 
analysis. To visualise chromosomes the gel was stained after the run with ethidium 
bromide, and de-stained in distilled water. The DNA transferred to nylon membranes 
by Southern blotting.
Agarose electrophoresis o f  RNA. To denature, 10 pg RNA in 5.4 pi ddH20 were 
mixed with 5.4 pi 6 M glyoxal, 16 pi DMSO, 3 pi lx TAE buffer, and incubated for 
1 hour at 50°C. Denatured RNA was size-fractionated on 1.2% agarose gels, run in 
lx TAE buffer at 100 V. RNA was visualised by staining the gel with ethidium 
bromide after fractionation.
Northern blotting. RNA was transferred to Nylon membranes in 20x SSC by capil­
lary transfer overnight, using the same setup as for Southern bots.
Hybridisation o f membranes. Non-specific binding sites on the membranes were 
blocked by pre-hybridisation for >1 hour at 65°C in hybridisation solution (lx Den- 
hardt's solution, 6x SSC, 0.5% SDS, 0.2 mg ml'1 sheared and denatured herring 
sperm DNA). Labelled DNA probes were denatured by boiling for 5 min, chilled on 
ice and added to the hybridisation. Hybridisation was overnight at 65°C. To remove 
non-specific bound probe, membranes were washed in 2x SSC for 5 min at r/t, 20 
min in 0.5x SSC / 0.1% SDS at 65°C, and 20 min in O.lx SSC / 0.1% SDS at 65°C 
with agitation. [12P]-labelled probes were detected by exposing the membrane to 
X-ray film (Kodak XAR-5) and intensifying screens at -80°C for the required time.
73
2.3.7 DNA sequencing
DNA sequencing was performed by a dideoxynucleotide chain termination method 
using a DNA Sequencing Kit (Applied Biosystems). Briefly, DNA was mixed with 
1.6 pmol of oligo-nucleotide primer and the BigDyeIM Terminator Cycle Sequencing 
Ready reaction mix, in a total volume of 10 pi. Cycling conditions were 25 cycles of 
30 sec at 96°C / 15 sec at 50°C / 4 min at 60°C in a Hybaid OmniGene thermal 
cycler. Unincorporated nucleotides were removed by passing the sample through a 
Sephadex G-50 column before loading onto an ABI PRISM 377 automated 
sequencer.
2.3.8 Transfection of T. cruzi
Electroporation. DNA was introduced into T. cruzi by electroporation. Briefly, epi- 
mastigotes from a logarithmically growing culture were collected by centrifugation 
and washed once in cytomix (2 mM EGTA, 120 mM KC1, 0.15 mM CaCl2, 10 mM 
K2HP04/KH2P04, 25 mM HEPES, 5 mM MgCl2.6H20, 0.5% glucose, 100 pg ml’1 
BSA, ImM hypoxanthine; pH 7.6). The cells were then suspended in lx cytomix at 
approximately 108 cells ml'1. 0.5 ml of this cell suspension was mixed with 
approximately 10 pg DNA (in 50 pi) in a Bio Rad Gene Pulser Cuvette. Cells were 
electroporated in a Bio Rad Gene Pulser apparatus set at 1.5 kV, using two pulses.
Selection o f episomes. Electroporated cells were transferred to 10 ml RPMI-1640 
medium. After 48 hours incubation at 27°C, the culture was split in three aliquots. 
Fresh RPMI-1640 was added to each aliquot to a final volume of 10 ml, and drug 
was added as required. After one week, these cultures were diluted 1:10 into fresh 
selection medium.
Selection o f integration events. To obtain clonal lines, electroporated cells were 
transferred to 12 ml supplemented RPMI-1640 medium, and transferred to a 24 well 
microtiter plate (0.5 ml per well). After 48 hours incubation at 27°C / 5% C 02, 
0.5 ml of fresh medium was added, containing twice the required drug concentration. 
Plates were monitored at weekly intervals. If the cell density in the wells was too
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high, 0.25 ml aliquots were transferred to a fresh plate, and fresh selection medium 
added to 1 ml.
Drugs. To select for resistant epimastigotes, Hygromycin B (Life Technologies) and 
G418 were added to final concentrations of 80-100 pg ml'1. Puromycin was added to 
a final concentration of 3-5 pg ml*1. Drug resistant populations typically started to 
grow out 4-6 weeks after transfection.
2.4 PREPARATION AND ANALYSIS OF PROTEIN
2.4.1 Preparation of protein extracts
Preparation o f T. cruzi protein. To obtain whole cell lysates, 2 x 101 T. cruzi cells 
were lysed with 200 pi of protein sample buffer (0.4 M Glycine, 2% (w/v) SDS, 
5% (w/v) 2-mercaptoethanol, 0.1% bromphenol blue), vortexed and boiled for 5 min. 
Samples were stored at -20°C. Alternatively, T. cruzi cells were lysed in protein lysis 
buffer N (1% (v/v) Nonidet P-40, 50 mM Tris pH 8.0, 150 mM NaCl, Roche Mini- 
Complete™ protease inhibitors), 30 min on ice. Lysates were centrifuged in a micro- 
fuge at 13,000 rpm for 5 min to separate the soluble and insoluble fractions. To 
assess the effect of salt concentration on MET3 protein solubility, the NaCl concen­
tration in protein lysis buffer N was adjusted as required.
Preparation o f extracts for detection of phosphorylated proteins (adapted from 
Mynott et al., 1999). 1.5xl08 T. cruzi cells were collected by centrifugation at 1640 g 
for 5 min. The cell pellet was washed once in PBS, suspended in 700 pi protein lysis 
buffer T, containing phosphatase inhibitors and protease inhibitors (25 mM Tris 
pH 7.4, 75 mM NaCl, 0.4 mM EDTA, 0.5% Triton X-100, 0.4 mM sodium ortho­
vanadate, 10 mM Na F, 10 pg ml"1 leupeptin, 740 pm PMSF, 0.7 pg ml'1 pepstatin 
A, 1 pg ml'1 E64, 100 pM TLCK) and incubated on ice for 30 min until lysis was 
complete. The suspension was centrifuged in a microfugc at 13,000 rpm for 20 min 
at 4°C. The resulting supernatant (soluble fraction) was rapidly frozen in liquid 
nitrogen and stored at -80°C. The pellets (insoluble fraction) were stored at -20°C.
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Preparation of protein extracts for detection o f cruzipain activity. Parasites were 
collected by centrifugation at 1640 g at 4°C for 10 min. The cell pellet was washed 
once in PBS, solubilised at lx 108 cells ml'1 in TBS/ 1% (v/v) Nonidet P-40 and 
vortexed rapidly for 15 sec. The suspension was centrifuged in a microfuge at 13,000 
rpm for 3 min at r/t and the resulting supernatant was rapidly frozen in liquid nitro­
gen and stored at -20°C (Greig and Ashall, 1990).
Determination o f protein concentration. The protein content of parasite extracts was 
estimated using the BCA protein assay system (Pierce), using bovine serum albumin 
(BSA) as a standard and performed according to the manufacturer's instructions.
2.4.2 Expression of recombinant MET2 and MET3 in E. coli
100 ml of an overnight culture of E. coli BL21 pTrcHis-met2 or E. coli BL21 
pTrcHis-met3 in NZCYM containing 100 pg ml"1 ampicillin (NZCYM-amp) was 
diluted 1:10 into 1 litre NZCYM-amp, and incubated at 37°C with shaking for 1-3 
hours. Expression was induced by adding IPTG to a final concentration of 1 mM and 
the culture was incubated for an additional 2 hours (for MET2 expression) or over­
night (for MET3 expression). The cells were collected by centrifugation in a Beck­
man J2-21 centrifuge at 4,000 rpm for 20 min. The cell pellets were frozen at -80°C 
for at least 30 min prior to lysis.
2.4.3 Purification of recombinant MET2 and MET3 from E. coli
For preparation of cleared lysates under native conditions, cell pellets were lysed for 
30 min on ice in lysis buffer (50 mM NaHjP04  pH 8.0, 300 mM NaCl, 10 mM imi­
dazole, 1 pg ml'1 lysozyme, 1% Triton X-100, Roche Mini Complete™ protease 
inhibitors, EDTA-free), before sonication on ice for six 10-second bursts, with a 10- 
second cooling period between each burst. The lysate was centrifuged in a Beckman 
J2-21 centrifuge at 12,000 rpm for 20 min at 4°C. 2 ml of 50% Ni-NTA slurry 
(Qiagen) was added to the cleared lysate and mixed by shaking at 4°C for at least 
one hour. The lysatc-Ni-NTA mixture was loaded into a column and the flow­
7 6
through collected. The column was washed with 4x 5 ml wash buffer (50 mM 
NaH:P0 4 , pH 8.0, 300 mM NaCl, 10 mM imidazole, Mini Complete™). The protein 
was eluted by increasing the amounts of imidazole in the buffer to 20 mM, 50 mM, 
100 mM, 200 mM and 500 mM, and using 4 ml of each elution buffer. All fractions 
were stored at 4°C until use. 20 pi samples of each fraction were analysed by SDS- 
PAGE and Western blotting.
2.4.4 Generation of antiserum
Purified 6xHIS-MET3 or 6xHIS-MET2 protein was excised from an SDS-PAGE gel, 
placed in a pestle and mortar and pulverised in the presence of liquid nitrogen. 1 ml 
Freund’s complete adjuvant was added and the sample homogenised by passage 
through a syringe needle. Immediately before use, the sample was sonicated for five 
5-second blasts. Approximately 150 pi of this suspension was injected intra- 
peritoneally into each of three Balb/c mice, which had previously been pre-bled from 
a tail vein. This was done by Michael Miles at LSHTM. After 2 weeks, another 
protein sample was prepared in the same way, except that Freund’s incomplete adju­
vant was used, and administered to the mice. This was repeated twice more at two 
week intervals. Blood samples were left to clot at 4°C overnight, then centrifuged for 
10 min at 13,000 rpm in a microfuge. The serum supernatant was stored in 50% 
glycerol, 0.02% sodium azide at -20°C.
2.4.5 Electrophoresis and blotting of proteins
SDS-PAGE. Parasite extracts were separated by discontinuous SDS-polyacrylamide 
gel electrophoresis (SDS-PAGE) in a Mini-PROTEAN 3 electrophoresis cell (Bio 
Rad) according to standard procedures. 10% or 12% polyacrylamide Ready Gels 
(Bio Rad) were used as required. Samples were mixed with sample buffer (0.4 M 
Glycine, 2% (w/v) SDS, 5% (w/v) 2-mercaptoethanol, 0.1% bromphenol blue) and 
boiled for 5 min prior to loading. Protein from 2 x 10h cells was loaded per lane. 
Precision protein standardsIM (Bio Rad) were loaded in parallel. Electrophoresis was 
performed at 100 V in lx running buffer (25 mM Tris/ 0.25 M glycine/ 0.1% (v/v) 
SDS). Gels were stained in 0.25% (w/v) Coomassie Brilliant Blue R 250/ 45% (v/v)
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methanol/ 45% (v/v) ddH20/ 10% glacial acetic acid and destained in 5% (v/v) 
methanol/ 7.5% (v/v) glacial acetic acid or by boiling in ddH20.
Western Blotting. Proteins separated by SDS-PAGE were transferred to Protran*- 
nitrocellulose membranes (Schleicher and Schuell), in a Trans-Blot Semi-Dry Elec­
trophoretic Transfer Cell (Bio Rad) according to the manufacturer's instructions, 
using Bjerrum and Schaefer-Nielsen transfer buffer (48 mM Tris, 39 mM glycine, 
20% (v/v) methanol). Blotting was carried out at 15 V for 1 hour. Membranes were 
blocked in TBS/ 5% (w/v) milk powder for 30 min. Antibodies were diluted in TBS/ 
5% milk powder and incubated at r/t for one hour. Unbound antibody was washed 
off with three changes of TBS. Primary antibodies were anti Xpress™ (Invitrogen), 
diluted 1:5,000; mouse anti c-myc (9E10) (Santa Cruz Biotechnology), diluted 
1:1,000; mouse antiserum to MET3 (section 2.4.4), diluted 1:500; P-tubulin antibody 
KMX1 (a gift from K. Gull), diluted 1:500. Secondary antibodies were goat anti­
mouse IgG horseradish peroxidase conjugate (Bio Rad), diluted 1:3,000. The blot 
was incubated with ECL Plus chemiluminescence substrate (Amersham Pharmacia 
Biotech) for 5 min prior to exposure to X-ray film for 1-5 min.
For detection of phosphoproteins, free binding sites on the membrane were blocked 
with Blotto B (TBS/ 1% (w/v) BSA/ 1% (w/v) milk powder) at r/t for at least 1 hour 
or at 4°C overnight. The following antibodies were used: Rabbit anti-Phosphoserine 
(PS) and Rabbit anti-Phosphothreonine (PT), polyclonal, 0.2 mg ml'1 (Zymed Labo­
ratories Inc.), and Mouse Anti-Phosphotyrosine (4G10), monoclonal, 1 mg ml'1 
(Upstate Biotechnology UK). The relevant antibody was diluted 1:500 in TBS/ 1% 
BSA and added to the membranes. Membranes were incubated either at r/t for one 
hour, or at 4°C overnight, with gentle agitation. Unbound antibody was washed off 
with three changes of TBS. The blots were then incubated as required with goat anti­
rabbit or goat anti-mouse IgG horseradish peroxidase conjugate (Bio Rad) diluted 
1:3,000 in Blotto B for 1 hour at room temperature, and washed as above prior to 
chemiluminescence detection.
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2.4.6 Immunofluorescence and confocal microscopy
T. cruzi cells were fixed in suspension with 2% paraformaldehyde (PFA) in PBS for 
20 min at r/t. Fixed cells were pelleted and washed twice with PBS and re-suspended 
in PBS. 20 pi cell suspensions were spotted onto multitest glass slides (ICN Bio­
medicals Incorporated) and dried at r/t. To fix T. cruzz-infected macrophages grown 
on glass cover slips, fixative was added to the culture medium to a final concentra­
tion of 2% PFA. After 20 min, cover slips were washed several times with PBS and 
left to dry. For immuno-staining, the slides or cover slips were placed in a humid 
chamber at r/t. Unreacted aldehyde groups were blocked with 50 mM N H4CI (in 
PBS), 5 min. After a rinse in PBS, non-specific protein binding sites were blocked 
with 50% horse serum in wash buffer (PBS/ 0.1% (w/v) saponin), 20 min. Anti­
bodies were diluted in wash buffer/ 2% horse serum. Slides were incubated with the 
primary antibody for 45 min, and with the secondary antibody for 30 min, and rinsed 
in three changes of wash buffer. Primary antibodies were mouse anti c-myc (9E10) 
(Santa Cruz Biotechnology), diluted 1:200; mouse antiserum to MET3 (section 
2.4.4), diluted 1:400; L1C6 monoclonal antibody (K. Gull, unpublished), diluted 
1:200. Secondary antibodies were AlexaFluor 488- and 546-conjugated anti-mouse 
or anti-rabbit antibodies (as appropriate), all diluted 1:400. DNA was stained with 
1 pM TOTO-3 (Molecular Probes) in PBS/ 0.1% saponin/ 10 mg ml'1 RNase A, for 
20 min. Slides were washed twice in PBS and mounted in PBS/ 50% glycerol and 
viewed under a Zeiss LSM 510 axioplan confocal laser scanning microscope.
2.4.7 Protease assay
Detection o f cruzipain activity in gelatin gels. For detection of protease activity, 10% 
polyacrylamide gels were prepared according to standard procedures, but 0.2% (w/v) 
gelatin was co-polymerised with the resolving gel (Greig and Ashall, 1990). Samples 
were diluted in sample buffer (0.4 M glycine, 2% (w/v) SDS, 0.1% bromphenol 
blue) without 2 -mercaptoethanol (2-Me) and were not boiled. Electrophoresis was at 
100 V for 2 to 3 hours. After electrophoresis, gels were shaken in 200 ml o f  2% (v/v) 
Triton X-100 for 1 hour for SDS removal. For protease detection, gels were 
incubated in digestion buffer (50 mM sodium citrate, 50 mM HEPES, 50 mM
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sodium phosphate, 50 mM sodium Borate (Borax); pH 5.6) with 26 nM 2-Me for 18 
hours at 37°C. Coomassie Blue staining was carried out as described in section 2.4.5 
except that for destaining 10% (v/v) glacial acteic acid was used. Gels were 
photographed on a light box.
2.5 BIOINFORMATIC SEQUENCE ANALYSIS
Preliminary genomic data were accessed via http://www.genedb.org/. Most of the 
genomic data were provided by the Wellcome Trust Sanger Institute and The Insti­
tute for Genomic Research (TIGR), which are supported by the Wellcome Trust and 
the National Institutes of Health, USA (grant AI043062), respectively. Searches of 
GenBank were performed using the BLAST server at http://www.ncbi.nlm.nih.gov. 
Web-based analysis tools for protein sequence analysis were accessed via 
http://www.expasy.ch. In addition, for secondary structure predictions the programs 
PSIPRED (McGuffin et al„ 2000), SSPR02 (Pollastri et al., 2002), PROF (Ouali and 
King, 2000) were used. For 3D structure predictions, programs ESyPred3D (Lambert 
et al., 2002), 3D-PSSM (Kelley et al., 2000) and FUGUE (Shi et al., 2001) were 
used. The default parameters were used unless otherwise indicated.
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3. I N  V ITR O  METACYCLOGENESIS
The study of metacyclogenesis has been complicated by conflicting reports on the 
factors that trigger it (section 1.4.2), and a paucity of molecular data (section 1.4.3). 
Advances in genetic manipulation techniques in conjunction with the information 
available from the genome sequencing project provide new opportunities to address 
longstanding questions regarding the differentiation from replicating non-infective 
epimastigotes to non-replicating infective metacyclics. However, the design of 
informative experiments and the interpretation of results obtained with genetically 
altered parasites, rely on a model system for metacyclogenesis. This requires de­
velopment of a robust in vitro metacyclogenesis assay, and a description o f  morpho­
logical and molecular correlates of differentiation.
The work reported in the first part of this chapter (section 3.1) therefore aimed to 
establish culturing conditions that promote metacyclogenesis in our laboratory stock 
of the genome sequencing strain T. cruzi CL Brener. The second part of this chapter 
describes morphological (section 3.2) and molecular changes (section 3.3) that are 
associated with metacyclogenesis in this strain. Specifically, the upregulation of 
protease activity was demonstrated using a qualitative method, and changes in phos­
phorylation patterns were investigated using antibodies against phosphorylated 
residues. The results of an in-depth characterisation of two novel genes that are 
upregulated during metacyclogenesis are presented in chapters 4 and 5.
3.1 IN VITRO METACYCLOGENESIS
To dissect the molecular mechanisms of differentiation in vitro, we require a system 
in which differentiation occurs at a high and reproducible rate. Early experiments 
with cultured T. cruzi epimastigotes established that the development of metacyclics 
is favoured in old cultures (Brener, 1973). Over the years, various culture conditions 
have been reported to enhance metacyclogencsis (section 1.4.2), but what works 
consistently well in one parasite strain in one laboratory has often been found not to 
work in another strain or laboratory. This could be a consequence of the genetic
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diversity o f  T. cruzi. Moreover, the rate of metacyclogenesis not only differs between 
different T. cruzi strains, but it is negatively affected by the length of time that a 
strain has been maintained in culture (Brener, 1973; Zingales et al., 1997b). Because 
of this variability, it was first necessary to establish conditions under which epi- 
mastigotes of our CL Brener laboratory stock would differentiate to metacyclics, and 
to set up a system suitable for experimental manipulation.
3.1.1 Spontaneous differentiation in RPMI-1640 medium
Initially we observed the development of metacyclics in supplemented RPMI-1640 
medium, which is the medium used for routine culture of epimastigotes. The de­
velopment of different forms was quantified by taking samples at various time 
points, and counting Giemsa stained cells under the microscope as described in 
Materials and Methods, section 2.2.2. For a more detailed description of the mor­
phological criteria by which cells were scored see also section 3.2 below.
Spontaneous differentiation in RPMI-1640 occurred as follows: During exponential 
growth the rapidly dividing epimastigotes are uniform in size and shape and less than 
1% (typically none) of the cells are metacyclics or intermediate forms (i.e. forms 
with a kinetoplast in an intermediate position as described in section 3.2). In mid to 
late log phase, at a density of 4-5 x 107 cells m l1, epimastigotes become elongated 
and concomitantly metacyclics begin to appear. At the beginning o f stationary phase 
(at 6-8 x 107 cells ml'1), the average percentage of fully developed metacyclics is 5% 
(± 2%). Five independent cultures were left to incubate well into the stationary 
phase, and after 3 weeks yielded 4.5%, 19%, 27%, 33% and 41% metacyclics, re­
spectively. After this prolonged incubation, however, accurate quantification 
becomes difficult, as cells start to show signs of degradation (such as missing kineto- 
plasts or nuclei, detached flagella, accumulating debris). The high variability in the 
proportion of metacyclics that are produced makes this an unsatisfactory system for 
experimental manipulation. Other conditions were therefore investigated.
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3.1.2 Grace's insect medium supports rapid metacyclogenesis
Grace's Insect medium has previously been reported to enhance metacyclogenesis 
when added to CL Brener epimastigotes grown in liver infusion tryptone (LIT) 
medium (Zingales et al., 1997b). We found that transfer of epimastigotes at the 
beginning of exponential growth into a medium consisting of 80% RPM1-1640 and 
20% Grace's Insect Medium (20% Grace's, section 2.2.2) led to rapid development of 
metacyclics (Figure 3.1 A). On day six after transfer 24% (± 8.5) metacyclics were 
found in 20% Grace's, compared to 5% (± 2) metacyclics in cultures incubated in 
parallel in RPMI-1640 (mean value from 6 experiments ± standard deviation). No 
difference in growth rate was observed (Figure 3.IB).
The time-point when the maximal number of metacyclics in 20% Grace's was 
reached coincided with the end of the exponential growth phase. Longer incubation 
in 20% Grace's did not lead to a higher proportion of metacyclics (data not shown). 
Increasing the proportion of Grace's medium to 50% did not enhance the proportion 
of metacyclics, while culturing the cells in 100% Grace's without RPMI-1640 re­
duced the yield of metacyclics to 2.5%.
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time after transfer (days)
B
16
hinure J. I: Timecour.se o f  differentiation in 20% Grace's and RP Ml- / 640
T. cruzi Cl. Brener epimastigotes were grown in RPMI-1640 medium to a density of Ix l07 cells m l'1 
before transfer to fresh RPMI-1640 medium, with or without 20% Grace's. Samples were taken at the 
indicated time points. (A) The bars show the average proportion of metacyclics in each culture as 
determined from six experiments. Krror bars indicate standard deviation. (B) Cell density vs. time in 
culture as measured in one representative experiment. 'Itte arrow indicates the timepoint of transfer to 
different media.
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3.1.3 Triatomine Artificial Urine (TAU) does not induce 
metacyclogenesis in CL Brener
The minimal medium TAU is routinely used to trigger metacyclogenesis in the 
T. cruzi strain Dm28c, typically yielding 30-80% metacyclics (Contreras et al., 
1985a; Contreras et al., 1985b; Homsy et al., 1989; Krassner et al., 1990, see also 
section 1.4.2). However, this method does not to work for all T. cruzi strains 
(Krassner et al., 1990; Sanchez et al., 1990). To assess whether TAU would promote 
metacyclogenesis in the CL Brener strain, cells were incubated according to the 
procedure of Contreras, (Contreras et al., 1985b , section 2.2.2) and observed over a 
period of up to three weeks.
Within the first 24 hours in TAU epimastigotes became long and thin compared to 
control cells in RPM1-1640, and firmly attached to the culture flask. This is consis­
tent with the model proposed by Tyler and Engman (2000), that reduced levels of 
glucose trigger attachment of epimastigotes to a hydrophobic surface (section 1.4.2). 
However, very few unattached metacyclics developed in our experiments. The per­
centage of metacyclics in the cultures was determined after 10 days, and the follow­
ing values were obtained. 5% in TAU supplemented with 10 mM L-proline; 1% in 
TAU supplemented with 2 mM D-glucose; < 1% in TAU supplemented with 0.035% 
NaHCOj. Over a period of three weeks the attached epimastigotes became even 
longer and thinner. Cells remained motile, but no increase in cell number was 
observed. When these epimastigotes were diluted back into RPM1-1640 after three 
weeks in TAU, the epimastigotes resumed normal growth. Culturing CL Brener 
epimastigotes in TAU thus resulted in the elongated morphology typical for starved 
cells, and the cells ceased to proliferate, but did not differentiate.
3.1.4 cAMP analogues do not enhance the rate of metacyclogenesis
Several studies suggest that an increase in intracellular cAMP is involved in the 
differentiation of trypanosomes (Fraidenraich et al., 1993; Gonzales-Perdomo et al„ 
1988). Specifically, addition of cAMP analogues to T. cruzi cpimastigotc cultures 
has been reported to enhance metacyclogenesis (Gonzales-Perdomo et al., 1988). We
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attempted to replicate these findings. Epimastigotes were grown in supplemented 
RPM1-1640 medium as usual. Membrane permeable cAMP analogues (100 pM 
8-Br-cAMP or 100 pM dibutyryl-cAMP) were added to mid log phase cultures. 
After continued incubation for six days, the proportion metacyclics was 5% in every 
culture. Exactly the same proportion of metacyclics developed in control cells grown 
in RPMI-1640 medium without the addition of cAMP analogues. Thus in our hands, 
the addition of exogenous cAMP to early log phase epimastigote cultures had no 
discernible effect on metacyclogenesis.
In summary, of the different conditions tested, only Grace's Insect Medium enhanced 
development of metacyclics in the CL Brener strain, consistent with previously 
published observations (Zingales et al., 1997b). Incubation in 20% Grace’s medium 
was therefore used in all subsequent experiments to induce metacyclogenesis. 
Because neither TAU nor cAMP analogues enhanced differentiation above the level 
observed in RPMI-1640 in these preliminary experiments, these methods were not 
further investigated.
3.2 MORPHOLOGICAL MARKERS
Giemsa staining of trypanosomes (section 2.2.2) allows the visualisation of its over­
all cell shape, and determination of the relative positions of kinetoplast, nucleus and 
flagellum. This easy method is traditionally used to distinguish different life-cycle 
stages, and was used routinely to determine the relative proportions of different cell 
types in cultures in this study. However, it is important to note here that the study of 
metacyclogenesis in the insect vector has always been complicated by the occurrence 
of various morphologically intermediate cell types of uncertain relationship, as de­
tailed in the introduction (section 1.4.1). For example, Schaub (1989) described 18 
morphologically distinct T. cruzi forms in the insect vector. Microscopic examination 
of CL Brener stationary phase in vitro cultures in 20% Grace’s medium immediately 
revealed a similar situation: stationary phase cultures are mixed populations of vari­
ous types of morphologically distinct cells.
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F igure 3.2: Epimastigotes and melacyclics in Giemsa stained preparations
T. cruzi epimastigotes and metacyclics are morphologically distinct cells. They can easily be distin­
guished in (jjemsa stained preparations, as shown in the image. The epimastigote nucleus (N) is round 
and the kinetoplast (K) is located at the anterior end of the cell adjacent to the nucleus. The metacyclic 
nucleus is elongated, and the kinetoplast is located at the posterior end of the cell, away from the 
nucleus. The flagellum (F) is at the anterior end o f the cell.
The key distinguishing criterion between epimastigotes and fully developed meta- 
cyclics is the position of the kinetoplast relative to the nucleus (Figure 3.2). In epi­
mastigotes the kinetoplast is at the anterior end of the cell, in close proximity to the 
nucleus. In metacyclics the kinetoplast is at the posterior end of the cell with a gap 
between nucleus and the kinetoplast. Epimastigotes and metacyclics also differ in the 
shape of the nucleus (round in epimastigotes, elongated in metacyclics), the shape of 
the kinetoplast (disc shaped in epimastigotes and spherical in metacyclics) and the 
general shape o f the cell body. Epimastigotes in stationary phase are more elongated 
than epimastigotes in log phase, but otherwise they are morphologically similar. A 
subset of cells in stationary cultures has an intermediate morphology. Based on two 
criteria, the position of the kinetoplast, and the shape of the nucleus, we established a 
simplified matrix that contains four intermediate types (Table 3.1) in addition to the 
classic epimastigote and metacyclic forms. We found this to be sufficient to describe 
all cells found in stationary cultures in 20% (¡race's. Cells that did not fit into this 
matrix were encountered only very rarely. At present, the relationship between these 
forms, their replicative potential and commitment to differentiation is unclear.
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Table 3.1: Morphologically distinct cell types in stationary T. cruzi cultures
T. cruzi CL Brener stationary cultures in 20% Grace's medium are mixed populations of morpho­
logically distinct cell types. Based on the shape of the nucleus and the position of the kinetoplast, six 
types can be distinguished: epimastigotes, metacyclics (see also Figure 3.2) and four intermediate 
types. The intermediates are assumed to be in the process of differentiation, but the relationship 
between them is uncertain.
round nucleus elongated nucleus
anterior kinetoplast epimastigote intermediate 3
interm ediate k ine top last intermediate 1 intermediate 4
posterior kinetoplast intermediate 2 metacyclic
3.3 MOLECULAR MARKERS ASSOCIATED WITH METACYCLOGENESIS
3.3.1 Up-regulation of cruzipain activity in 20% Grace's medium
An increase in the activity of cruzipain, the major cysteine proteinase of T. cruzi, 
during the growth of epimastigotes, and a link between cruzipain activity and meta­
cyclogenesis has previously been shown in the strain Silvio X10/6 (Tomas et al., 
1997). We asked whether cruzipain activity also increased in the CL Brener strain 
during metacyclogenesis in Grace's medium. To test this, epimastigotes induced to 
differentiate in 20% Grace's medium were observed for nine days. The proteolytic 
activity associated with protein extracts taken at different time points during differ­
entiation was detected in a qualitative assay, using the conditions optimised for 
detection of cruzipain activity (section 2.4.7). Detailed previous studies had assayed 
proteolytic activities in T. cruzi extracts at a range of pH values, and with different 
classes of protease inhibitors. These studies established that under the conditions 
employed here, the main proteolytic activity is derived from cruzipain. A weaker, 
higher molecular weight band corresponds to a developmentally regulated métallo­
protéase, which is optimally active at pH 9.0 (Tomas, 1995).
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Figure 3.3: Detection o f  proteolytic activity in T. cruzi extracts
T. cruzi CL Brener epimastigotes were incubated in RPMI-1640 medium without (-) or with 20% 
Grace's (+). Cultures were incubated at 27°C/5% C 0 2 for nine days. Samples were taken at the time 
points indicated above each lane. 4 pg o f soluble protein was separated on a 10% SDS-PAGK gel, 
containing 0.1% gelatin. The gel in (A) was incubated in digestion buffer for 18 hours followed by 
staining of the gel with Coomassie. White bands appear where proteolytic activity has degraded the 
gelatin. (B) Kqual loading in all lanes was confirmed by Coomassie staining of duplicate samples in a 
standard SDS-PAGF. gel. Numbers on the left show molecular sizes in kilo Daltons.
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Table 3.2: Cruzipain assay: cell density and proportion of metacyclics in samples
DAY 0 2 2 4 4 7 7 9 9
20% Grace's - • + - + - + - +
cells m i1 (x 107) 1.0 3.5 4.5 5.5 5.5 8.0 6.5 6.0 7.5
% m etacyclics < 1% < 1% 2% 3% 5% 3.5% 18.5% 5% 15%
As the CL Brener cells reached stationary phase, increased proteolytic activity was 
clearly observed (Figure 3.3). Cruzipain activity increased over time in both cultures, 
with and without Grace’s medium, with an apparent peak on day 7. However, cells in 
20% Grace’s medium, which produce more metacyclics, also showed a more pro­
nounced up-regulation of cruzipain activity. The proportion of metacyclics rose from 
<1% to 5% over nine days in RPMI-1640. In 20% Grace's the proportion of meta­
cyclics reached a peak o f 18.5% on day 7, dropping slightly to 15% on day 9 
(summarised in Table 3.2). This confirms that up-regulation of cruzipain activity 
correlates with an increased rate of metacyclogenesis. The greatest difference be­
tween the cells in RPMI-1640 and 20% Grace’s medium is seen on day 4, when the 
difference in the number o f  metacyclics is still small. Up-regulation of cruzipain 
activity is thus an early marker for metacyclogenesis.
3.3.2 Changes in protein phosphorylation
Reversible protein phosphorylation is an important regulatory mechanism in many 
signal transduction pathways (section 1.5.1). The kinase activities and phosphoryla­
tion profiles associated with T. cruzi metacyclogencsis have not yet been studied. 
The initial objective of this project was to dissect the cAMP signalling pathway of 
T. cruzi and its role during metacyclogenesis. However, there are now considerable 
doubts regarding the results that suggested a role for cAMP in T. cruzi differentiation 
(section 1.5.2). Our own attempts to reproduce the finding that membrane permeable 
cAMP analogues induce metacyclogencsis yielded negative results (see above).
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To begin a dissection of T. cruzi signalling pathways that might regulate meta­
cyclogenesis, we sought to identify stage-specific protein phosphorylation. First, the 
pattern of protein phosphorylation in epimastigotes was analysed, and then it was 
compared with the pattern observed during metacyclogenesis.
In order to do this, commercially available anti-phosphoserine (PS) anti-phos- 
phothreonine (PT) and anti-phosphotyrosine (PY 4G10) antibodies were used to 
detect phosphorylated residues on ID Western blots of T. cruzi protein extracts as 
described in sections 2.4.1 and 2.4.5. We optimised conditions for immunochemical 
detection of phosphorylated T. cruzi proteins, and established the pattern of phos­
phorylation in wild type CL Brener epimastigotes and stationary cultures that contain 
metacyclics.
3.3.3 Phosphorylated proteins in T. cruzi CL Brener epimastigotes
Threonine phosphorylation. Numerous protein bands between 37 and 250 kDa were 
detected in both the insoluble and soluble of parasite lysates (Figure 3.4A). In the 
soluble fraction a band of about 37 kDa, several bands between 60 and 100 kDa and 
a band of about 150 kDa gave the strongest signals. Between experiments the overall 
pattern remained unchanged but the relative signal intensities of the different bands 
did vary. In particular the 37 kDa band gave a very strong signal in some but only a 
weak signal in other blots.
Serine phosphorylation. Two strong bands of about 75 and 30 kDa and a weak band 
of about 60 kDa were detected in the soluble fraction of epimastigote extracts. No 
bands are detected in the insoluble fraction (Figure 3.4B).
Tyrosine phosphorylation. A strong band of about 250 kDa was invariably detected 
in the insoluble fraction. In most blots, no bands were detected in the soluble fraction 
(Figure 3.4C). Occasionally, two weak bands (30 kDa and 40 kDa) were detected in 
the soluble fraction (not shown).
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Figure 3.4: Western Blot analysis o f  phosphorylated epimasligote proteins
Western blots of protein from log phase epimastigotes were probed with antibodies against phospho- 
rylated residues. (A) anti phospho-threonine (PT); (B) anti phospho-serine (PS); (C) anti phospho- 
tyrosine (PY). Lane I: insoluble protein; Lane 2: soluble protein (20 pg per lane). Numbers on the left 
indicate molecular sizes in kilo Daltons.
3.3.4 Phosphorylation of low molecular weight proteins 
during metacyclogenesis
To obtain a first overview o f  changes in protein phosphorylation that occur during 
metacyclogenesis, protein extracts from cultures containing different proportions of 
metacyclics were compared to pure epimastigote extracts, using the same method as 
in the experiments described above.
No changes in the pattern o f serine and tyrosine phosphorylation were detected in 
extracts from differentiating populations in Western blots of protein extracts sepa­
rated on 1D SDS-PAGE gels (not shown). However, distinct changes in the pattern 
of threonine phosphorylation were observed. Several strongly phosphorylated low 
molecular weight bands (between 20 and 30 kDa) appeared in the soluble protein 
fraction from populations with >20% metacyclics. These bands were absent in epi­
mastigote cultures, and appeared only weakly in an extract from a population con­
taining 6% metacyclics (Figures 3.5A). In the insoluble fraction a signal of around 
20 kDa was detected in an extract from a population containing 23% metacyclics but
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not in extracts from populations with 14% or less metacyclics (Figure 3.5B). The 
identity of these proteins remains to be determined.
Unfortunately, it was not possible to analyse pure metacyclic preparations for techni­
cal reasons. Complement mediated lysis is a commonly used method to eliminate 
epimastigotes from mixed populations in other T. cruzi strains (Nogueira et al., 
1975). This works because in those strains resistance to complement mediated lysis 
is developmentally regulated. This method could not be used here because CL 
Brener epimastigotes are resistant. Attempts to purify the CL Brener metacyclics 
from 20% Grace's medium by anion exchange chromatography (Alvarenga and 
Brener, 1979; Orr et al., 2000) yielded unsatisfactory results. Only a slight enrich­
ment of metacyclics was achieved, and a large proportion of cells was lost in the 
procedure.
A <1% 6% 24% <1% 40% B 10% 14% 23%
Figure 3.5: Western Blot analysis o f phosphory luted proteins in differentiating populations 
Protein extracts from T. cruzi Cl. Brener populations with different proportions of mctacyclics were 
analysed on Western blots using the anti phospho-threonine antibody PT. (A) soluble protein (20 pg 
per lane) (B) insoluble protein fraction. The percentage of metacyclics in the sample is indicated 
above each lane. Phosphorylated proteins o f approximately 20 kl)a are detected only in extracts 
containing a high percentage of mctacyclics (arrows). Numbers on the left indicate molecular sizes in 
kilo Daltons.
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In summary, we have found that in epimastigote extracts numerous proteins are 
phosphorylated on threonine residues, but only few are phosphorylated on serine or 
tyrosine. Several, as yet unidentified low molecular weight proteins become phos­
phorylated on threonine during metacyclogenesis. These results indicate that a pro- 
teomics approach is likely to identify novel stage regulated proteins or protein 
modifications.
3.4 DISCUSSION
There are many conflicting reports in the literature as to the conditions that induce 
metacyclogenesis in T. cruzi (Bonaldo et al., 1988; Contreras et al., 1985b; de Isola 
et al., 1981; Homsy et al., 1989; Sullivan, 1982; Ucros et al., 1983). Several factors 
have been found to enhance the process, including starvation conditions (Contreras et 
al., 1985b; Krassner et al., 1990; Miles, 1993), transfer of epimastigotes to Grace's 
Insect medium (Heath et al., 1990; Sullivan, 1982; Zingales et al., 1997b) and the 
addition of cAMP analogues (Gonzales-Perdomo et al., 1988). Results obtained with 
one T. cruzi strain however, are often not generally applicable (Krassner et al., 1990; 
Sanchez et al., 1990), and the molecular mechanisms and signal transduction path­
ways that control the differentiation process are poorly understood (Parsons and 
Ruben, 2000).
Different methods were tested to study the conditions under which T. cruzi CL 
Brener, the genome reference strain, would differentiate reproducibly in vitro. Only 
two conditions supported the development of metacyclics. The best in vitro differen­
tiation rates were obtained with Grace's Insect medium. Transfer of epimastigotes in 
the mid-log phase of growth from RPMI-1640 to a medium containing 20% Grace's 
Insect medium enhanced metacyclogenesis considerably. Up to 25% metacyclics 
were routinely obtained within six to eight days, while only 5% metacyclics devel­
oped in RPMI-1640 medium over the same time. The second method that typically 
resulted in a relatively high proportion of metacyclic cells is simply to let stationary 
phase cultures in RPMI-1640 medium incubate for several weeks. However, this 
method has two disadvantages. First, the significant number of dead cells, which 
accumulate in old stationary phase cultures, complicate analysis of any experiment.
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Second, the time course of development of metacyclics cannot be predicted with the 
accuracy required to design experiments. The proportion of metacyclics produced 
varies enormously (between 4 and 40%), and it takes several weeks for development 
to occur.
It is important to note that Grace's medium did not increase the maximal number of 
metacyclics that could be obtained. The advantage of using 20% Grace’s medium to 
induce metacyclogenesis in CL Brener is that development occurs much faster and 
that the cells follow a predictable time course of development. Six to eight days after 
addition of Grace’s medium the maximum number of metacyclics will have accu­
mulated. These cultures contain epimastigotes, metacyclics, and a number of inter­
mediate forms of defined morphologies (Figure 3.2 and Table 3.1), without the 
decaying or dead cells that are observed in older stationary phase cultures. Using 
20% Grace’s medium is therefore the best method currently available for the purpose 
of comparing the effect of experimental manipulation on the rate of metacyclo­
genesis in CL Brener.
Still, this system is not ideal, as a yield of 25% metacyclics is too low to obtain clean 
results when doing comparative biochemistry, for example. The rationale behind 
using the CL Brener strain for this study was to work with the same model strain that 
was used for sequencing the genome. However, if higher rates of metacyclogenesis 
cannot be achieved using the CL Brener strain, then one must consider using a dif­
ferent strain for future work in this area. Ideally, a strain should be sought that differ­
entiates well in the defined minimal medium TAU. That system is likely to be more 
reproducible and better suited for biochemical analysis than complex and undefined 
media. Strain Dm28c should be considered, as this strain consistently yields high 
proportions of metacyclics in TAU medium (Contreras et al., 1985b). The strain 
Silvio X I0/6 should also be tested, because a cell line stably transfected with the 
genes for T7 polymerase and Tet repressor gene has already been generated in this 
laboratory . This cell line can be used for inducible gene expression (Martin Taylor, 
unpublished, see also section 1.7.1), which will be an invaluable tool for genetic 
research.
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To dissect metacyclogenesis further, it will be important to untangle the relationship 
between the different morphological forms. This is still unclear, despite a number of 
detailed studies that have addressed this question (Brack, 1968; Schaub, 1989). 
Specifically, it is not clear in which order the observed morphological changes occur, 
whether each of the intermediate forms gives rise to a fully developed metacyclics, 
and which forms are infective to mammalian cells. Molecular markers should help to 
clarify the relationship between these morphologically distinct forms.
Cysteine protease activity has been implicated in the process of metacyclogenesis in 
the Dm28c strain (Bonaldo et al., 1991) and the Silvio X10/6 strain (Tomas et al., 
1997). There are strain-specific differences in the proteolytic activities of epimas- 
tigotes (Greig and Ashall, 1990), but that study did not include the CL strain. We 
therefore investigated the proteolytic activity in CL Brener epimastigotes and sta­
tionary cultures. The results obtained confirm that cruzipain activity increases when 
CL Brener epimastigotes enter stationary phase, similar to the results obtained with 
the XI0/6 strain (Tomas et al., 1997). Interestingly, purified metacyclics of the 
Dm28c strain showed very low cysteine protease activity (Bonaldo et al., 1991). Up- 
regulation of cruzipain activity thus appears to occur transiently during metacyclo­
genesis, but is not a marker for fully developed metacyclics.
The analysis of phosphoproteins in whole parasite extracts using antibodies against 
phosphorylated residues suggests that threonine-phosphorylation of several low 
molecular weight proteins is associated with metacyclogenesis. Using proteomics 
technology (section 1.7.2), there are two directions in which this potentially very 
fruitful area can be followed up: (i) a comprehensive analysis of the phosphorylation 
patterns associated with different T. cruzi life-cycle stages, and (ii) identification of 
the phosphorylated low molecular weight proteins associated with metacyclogenesis.
There are a number of techniques that allow a more detailed analysis of the phos­
phorylation profiles of log phase epimastigotes and metacyclics. A common 
approach used to study global protein phosphorylation is to grow the cells in medium 
containing inorganic 12P. Lysates from these cells can then be separated on 2D gels 
and analysed by autoradiography to compare phosphorylation patterns from different
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cell types. A protocol for the separation of trypanosome proteins by 2D gel electro­
phoresis has recently been published (van Deursen et al., 2003), which may be used 
as a basis to initiate such a large scale proteomics analysis in T. cmzi. To increase the 
sensitivity and detect proteins that are not abundant, it may be necessary to prepare 
samples that are enriched in phosphoproteins (Oda et al., 2001; Zhou et al., 2001).
Using mass spectrometry approaches it should be feasible to identify the nature of 
the low molecular weight phosphoproteins detected in the present experiments, and 
determine the precise site of phosphorylation (Ficarro et al., 2002; Soskic et al., 
1999). The identification of these proteins would no doubt shed some light on the 
signal transduction pathways active in stationary T. cruzi cells. To pin down compo­
nents that regulate metacyclogenesis, it will be particularly important to subsequently 
identify the corresponding protein kinase(s) by biochemical methods.
A global analysis of changes in phosphorylation patterns during metacyclogenesis 
may also help to clarify the role of cAMP signalling. The involvement of the cAMP 
signalling pathway in development of metacyclics is frequently cited as fact (Tyler 
and Engman, 2001). However, a closer scrutiny of the literature on T. cruzi metacy­
clogenesis reveals that the evidence for an involvement of cAMP is rather scarce 
(sections 1.4.2). Previous studies often based their conclusions on the effect of sub­
stances that activate or inhibit enzymes of the mammalian cAMP signalling pathway, 
such as the adenylyl cyclase activator forskolin, or the phosphodiesterase inhibitor 
IBMX. None of theses studies provide any supporting molecular data. Recently, 
cloning and analysis of the relevant genes from trypanosomes revealed important 
biochemical differences between the trypanosomatid enzymes and their mammalian 
counterparts (Bieger and Essen, 2001; Taylor et al., 1999; Zoraghi et al., 2001, see 
also section 1.5.3). The older data thus clearly needs to be reassessed.
Gonzales-Perdomo (1988) also reported that the simple addition of cAMP analogues 
enhanced the development of metacyclics directly. Our attempts to replicate these 
findings failed to confirm this. The addition of membrane permeable cAMP ana­
logues to cpimastigotcs in RPMI-1640 or TAU did not enhance metacyclogencsis 
above the level observed in RPMI-1640 medium alone. These preliminary experi­
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ments thus provided no support for the notion that cAMP is a trigger for metacyclo­
genesis.
Metacyclogenesis occurs under conditions of stress and starvation. It is conceivable 
that cAMP signalling plays a role in these processes. How a starvation response is 
linked to differentiation is currently unknown. Clearly, there is scope for much inter­
esting work in this area. The demonstration of developmentally regulated protein 
phosphorylation could be a first step towards dissecting the signal transduction 
pathways involved.
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4. THE M E T 3 GENE
A first step in dissecting the molecular mechanisms that control development of 
T. cruzi is to identify genes that are differentially expressed in different life-cycle 
stages. Goldenberg and co-workers have identified several genes that are upregulated 
during in vitro metacyclogenesis of T. cruzi strain Dm28c, using a method of selec­
tive amplification of RNA transcripts (Krieger et al., 1999; Krieger and Goldenberg, 
1998). Initial characterisation of a small number of transcripts has confirmed that the 
corresponding proteins are expressed during metacyclogenesis in the Dm28c strain 
(Avila et al., 2001; Dallagiovanna et al., 2001; Fragoso et al., 2003). The specific 
function of these gene products has not been elucidated. Development of genetic 
tools for T. cruzi has progressed significantly in recent years and provides scope for 
experimental manipulation of T. cruzi genes (Taylor and Kelly, 2002). We have used 
transfection-based approaches to characterise in detail two of these stage-regulated 
genes, MET2 and MET3. These genes show no apparent relatedness to previously 
characterised genes, and may therefore shed light on novel aspects of metacyclo­
genesis in T. cruzi.
This chapter is divided into three sections. Section 4.1 describes the identification 
and detailed sequence analysis of the MET3 gene from the genome sequencing strain 
CL Brener. Section 4.2 reports the results of confocal microscopy studies to deter­
mine expression and localisation of the MET3 protein. Stage-regulated nuclear 
localisation of native MET3 was observed. MET3 associates with the nucleolus, and 
we identified MET3 sequence elements that can direct the protein to the nucleolus. 
Section 4.3 describes the generation and analysis of MET3 null mutants. The results 
from their analysis show that MET3 is not essential for T. cruzi metacyclogenesis.
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4.1 CHARACTERISATION OF MET3 FROM T. CRUZI CL BRENER
4.1.1 Identification of two MET3 alleles from CL Brener
We identified the CL Brener homologues of MET3 by using the cDNA sequence 
from the Dm28c strain (metaciclina III, GenBank AC:AF312553) to screen DNA 
sequence databases. A search of GenBank initially identified a single open reading 
frame (ORF) on a 21 kb genomic contig from CL Brener (GenBank AC:090078). 
This ORF was named MET3-CL1. Subsequent searches of the T. cruzi CL Brener 
genome shotgun sequences (section 2.5) with the MET3 sequence identified a second 
allele that we called MET3-CL2. The names for the CL Brener genes were chosen 
according to the recommended nomenclature for trypanosome genes (Clayton et al., 
1998). The MET3 gene from strain Dm28c is referred to in the literature alternatively 
as Met-I (Avila et al., 2003), metacyclin-111 /  Met-III (Yamada-Ogatta et al., 2004) or 
metaciclina III (GenBank AF312553). For consistency, and to clearly distinguish it 
from the CL Brener genes, we refer to it in this text as MET3-Dm28c.
A comparison of the three sequences reveals considerable sequence variation (Figure 
4.1). Sequence identity between the two CL Brener alleles is only 97%, and between 
the CL Brener alleles and MET3-Dm28c, the sequence identity is 97% and 96%, 
respectively. A similar degree of sequence divergence between CL Brener alleles has 
been described for other genes (Bromley et al., 2004; Tran et al., 2003) and is likely 
to be a consequence of the hybrid nature of this strain (Machado and Ayala, 2001; 
Pedroso et al., 2003; Sturm et al., 2003). Surprisingly, the length of the MET3 coding 
sequence is different in the two T. cruzi strains. This difference is caused by a single 
nucleotide insertion at position 570 in the coding sequence of both CL Brener alleles 
(Figure 4.1), which causes a frameshift relative to the MET3-Dm28c coding se­
quence. MET3-CL1 and MET3-CL2 extend over 576 bp, terminating at the stop 
codon TAA at position 574-6. MET3-Dm28c extends over 600 bp, terminating at 
stop codon TAG at position 598-600. To exclude the possibility that this frameshift 
was due to a sequencing error in the CL Brener contig, we compared all available 
shotgun sequences (from different sequencing centres) and found that the frameshift 
relative to MET3-Dm28c is present in all the relevant CL Brener sequences.
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The CL Brener sequences were also confirmed experimentally, by sequencing PCR 
fragments derived from genomic DNA, and RT-PCR fragments, derived from cDNA 
templates (section 2.3.2 and 2.3.3). Sequencing cloned cDNA also identified the 
5’ splice-acceptor site in MET3-CL1: the spliced leader sequence (SL) is added to the 
RNA at an AG dinucleotide, 59 bases upstream of the start codon. The cDNA se­
quence of MET3-Dm28c deposited in GenBank also contains the SL, and it is spliced 
at the same position as MET3-CL1. As yet we have not identified the splice acceptor 
site for MET3-CL2.
Figure 4 .1 (overleaf): Alignment o/MET3 DNA sequences
The sequences designated MET3-CLI and MET3-CL2  correspond to the genomic sequence of the two 
M ET3  alleles from T cruzi CL Brener. The sequences were identified in searches of GenBank and 
GeneDB, using MET3-Dm28c as query. M ET3-CLI is contained on cosmid AC090078. MET3- 
Dm28c  corresponds to the metaciclina III cDNA sequence (GenBank AC:AF312553). The spliced 
leader sequence is not shown. The splice acceptor site (underlined) is at the same position in MET3- 
CLI  and MET3-Dm28c. Start and stop codons are marked with bold letters. One nucleotide insertion 
at position 570 in the CL Brener sequences (highlighted) causes the reading frame to shift relative to 
MET3-Dm28c. This could be due to a sequencing error in MET3-Dm28c. Note how the poly-A stretch 
tail at the 5’ end of the MET3-Dm28c sequence (putative poly A-tail) aligns with an A rich stretch in 
the genomic sequences of CL Brener.
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CLl -119 CATTCGGTGCGTTTATTTATTTTTTCTTCTTCTTGTTTCTCCGCTGCGTCACACAATAAT
CL2 -116 .............. G .........CT................................. ...
Dm28c
CLl -59 AGACATTGAGGAAAGAAGCCACGGGGGGTGGCTCCAAAGGCATAAGAGGTGGCGGAAGTA 1
CL2 -59  A 1
Dm28c -57 ...........G ................................................A 1
CLl TGTCGCGACGCAAAGATAACAAATCCCACCTGAAAGAATTCCTCCGTCGACTTCGCGATC 61
CL2 TO ......................................... G ................... 61
Dm2 Sc TO..............................................................  61
CLl AGGGCCGTCAGGGAACGCCTCAGGCATCGGCCGGGCGGGGGAGAGCACGCACGGGTGAAG 121
CL2 ................................................ G .............  121
Dm2 Sc ................................................ G .............  121
CLl GCAGCGGACGGTACGCTCTCTCCTTTTCAGGGCGTTCCGTGGTGGCAACCGCCCCCACAC 181
CL2 ___ A ..........................................................  181
Dm28c ...................... T ........................ G .............  181
CLl GTGGCCGCTCCTATCTCCCACGCTCGCGCAAGGATAACGAAGATGACAGCATGCCTCTTG 241
CL2 ......................................C ....................... A 241
Dm28c ....................................C ......................... A 241
CLl CTGTTGCCAATGCCGCCTTGTCGTCAACGGATGACGCGCGGGATCAAGGACGGGAGCATC 301
CL2 ........G .......T .......................... G .................. 301
Dm2 8 c ...C.A....G................................ GA................. 301
CLl AGCGTCGCCACCGTGACGAGGAGACAAGGACGTCAGAGGAGAGTTCACGGAGGCGCCCTT 361
CL2 ..........T ........................ G ........C ................. 361
Dm28c ............................................. C ................. 361
CLl CTCGCTCTACGGAAAGCGACCCACATGAGGTCGTGTTGTCAGAGAGCCGCGCGTCTGTCC 4 21
CL2 .............................C..T.............................. 421
Dm2 8 c .................... A ....................C ....................  421
CLl TCCCGTCCACATCGACAGGGAGCCGAGCAAGCGGCAGCACTGATCCCGTTTCCGAACACG 4 81
CL2 ....T..................... A ...................................  481
Dm2 8 c .......................................... C .....T .............  481
CLl CTGCAAGGCGGGCGGACGCGGGACGTGTAATAGGCAGAAGGAGAGGCGGGGACAGTGAGA 541
CL2 ............T....A..A..... G ... G ..............................  541
Dm2Bc ............T ..............O ................................... 541
CLl AGAGTCTAAAGCGCCCGAGGACAGGTGGGCCCTAACGTGAATTGTCGTTCCCATCATTAG 601
CL2 .............................G...TAA..........................  601
Dm28c .............................-.............C ............... TAG 600
CLl CAGTTTCTGCGCCAATTGAGGGCAAATAATGAGAGGGAGTAAACGGCAGCAAAGAAACAA 661
CL2 .....................................A ..........  647
Dm28c ................................................................ 660
CLl GAAAAAAGATTCAAATAGCAACGAGTGTGGAAAACGCAAATAAATTATTTCGCGTGTCGA 721
CL2
Dm2 8 c ................................................................ 720
CLl GGGCTCCAAAACCTCATTGCTGCATCTGATTCTTTTTTTTGTGTCTG- -TGCATAATTGG 779
CL2
Dm2 8 c .............................................. G..TG...........  780
C L l CAAAGAGGGGGGAACCAGTAAAAAAGAAACAAAA 813
CL2
Dm2 8 c ..... A .......A ..........A...A.... 814
Figure 4. /
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4.1.2 Genomic organisation of MET3
A contiguous 54 kb fragment of genomic DNA from T. cruzi CL Brener, spanning 
the MET3 locus was assembled using two contigs from the genome sequencing 
project (TSKTSC_8550 and AC090078). Analysis of the sequence, using the 
Artemis software (Rutherford et al., 2000), showed that MET3 is a single copy gene, 
in an area of high gene density. A BLAST search of GenBank and GeneDB, identi­
fied 22 putative coding sequences (CDS) within this contig -  one for every 2.5 kb. 
All genes are encoded on the same strand of DNA. The average GC content is 
47.6%. MET3 is flanked by two CDS with predicted functions (Figure 4.2). A CDS 
that shows high similarity to delta-1-pyroline-5-carboxylate dehydrogenases 
(P5CDH; enzyme that catalyses the second step in conversion of proline to 
glutamate) ends 522 nucleotides upstream of MET3. A putative protein kinase gene 
(similar to MAP kinases) is located 2.8 kb downstream of MET3. The intergenic 
sequences up- and downstream of MET3 contain long runs of single nucleotides 
(mainly T) and dinucleotide repeats.
Gene order in kinetoplastids is highly conserved (Bringaud et al., 1998; Ghedin et 
al., 2004). A comparison of the T. cruzi genomic contig with sequences from other 
kinetoplastids identified regions on T. hrucei chromosome 10 and L. major chromo­
some 3 that show a high level of synteny in the genes flanking MET3. They do not 
encode any gene similar to MET3 itself (Figure 4.2). No similarity between the 
nucleotide sequences of T. cruzi, T. brucei and L. major were found in pair-wise 
comparisons using the sequence in between P5CDH and MAPK of T. cruzi (3.8 kb, 
including MET3), T. brucei (4.5 kb) and L. major (1.9 kb). More significantly, 
BLASTX searches that translate the T. hrucei and L. major nucleotide sequences in 
all six reading frames found no amino acid sequences similar to any part of MET3.
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T. cruzi
MET3
m — D
L. major o — m — D
U2AF P5CDH MAPK UP CoAS UP L38 UP
Figure 4.2: Genomic organisation o/MF.T3 and comparison o f  syntenic loci
The diagram shows a schematic alignment (not drawn to scale) o f — 17 kb surrounding the MET3 locus 
with syntenic loci from L. major chromosome 3, and T hrucei chromosome 10. MET3 is unique to 
T. cruzi, while the genes flanking M ET3  are preserved in al three species. The predicted genes 
(arrows) code for the following. U2AF: U2 snRNP auxiliary factor small subunit; P5CDH: delta-1- 
pyroline-5-carboxylate dehydrogenase; MAPK'. protein kinase; U P:  hypothetical protein; Co AS: fatty 
acyl CoA synthetase; L3H: ribosomal protein.
In silico analysis suggests that MET3 is a ‘single copy’ gene, with two allelic 
variants present in the genome of T. cruzi CL Brener. This was confirmed experi­
mentally by Southern blot analysis of genomic DNA (Figure 4.3A). DNA was di­
gested with ten different restriction enzymes and probed with the MET3 CDS. Each 
digest results in either a single band or a doublet, where both bands are o f equal 
intensity. This suggests that restriction site polymorphisms are present that cause 
small variations in the size of restriction fragments derived from each locus. Fur­
thermore it suggests that only two allelic copies of MET3 are present, despite the 
partially trisomic nature of the CL Brener genome (unpublished observations). The 
hybridisation pattern obtained with a fragment from the upstream gene P5CDH is 
consistent with this interpretation. P5CDH is also a single copy gene with two allelic 
variants, and the restriction site polymorphisms are consistent with the pattern 
obtained when hybridising with MET3. The information derived from Southern blot 
analysis, and from the genomic sequences, was used to draw a detailed restriction 
map of an 18 kb region surrounding the MET3 gene (Figure 4.3B). This facilitated 
the gene deletion experiments outlined in section 2.3. The MET3 locus was mapped 
to a 2 Mb chromosome by pulse field gel electrophoresis (Figure 4.4).
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Figure -4. 3: Restriction map o f the M  ET3 locus
( A )  (icnomic DNA from T. cruziCL Brener was digested with restriction enzymes as indicated above 
each lane. The banding pattern on a Southern blot probed with MET3 or a fragment of P5CDH (the 
gene upstream of MET3) is consistent with single copy genes. Two bands are seen in most lanes 
because of restriction site polymorphisms between allelic loci. Numbers on the left indicate size in kb.
(B) A restriction map o f the MET3-CLI locus, drawn based on information from the genome sequence 
and experimentally confirmed by the Southern blot. Numbers indicate nucleotide positions. The first 
nucleotide in the MF.T3 start codon was designated position T .  Black lines show location of probes 
used for hybridisation.
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Figure 4.4: MET3 is localised on a 2 Mb chromosome
Chromosomes of T. cruzi CL Brener were separated by CHEFE (lane 1). A blot o f  the gel probed with 
the MET3 coding sequence shows that it is localised on a chromosome of approximately 2 Mb (lane 
2). Saccharomyces cerevisiae chromosomes were run as size markers (lane M).
4.1.3 MET3 is found only in T. cruzi
Extensive searches of all available kinetoplastid databases and o f  GenBank (section
2.5) failed to identify any MET3 homologues. Nor were any partially similar se­
quences identified that could be used to assign a biochemical function to the MET3 
protein. Only sequences with spurious similarities were identified in a BLAST search 
of kinetoplastid sequences in GeneDB (version 2.1 ¡section 2.5). Equally, none of the 
‘hits’ in BLAST searches of other sequence databases is likely to be related to 
MET3, based on sequence alignment scores. The most recent search of the EMBL 
data yielded no hits better than an expect value E = 3.0. Interestingly, however, these 
weak hits contain a linker histone protein (HMG-I/Y) from Arabidopsis thaliana 
(40% identity over 40 amino acids). This may be significant in light of our 
experimental results, which show that the MET3 protein localises to the nucleus 
(section 4.2). These results and the comparative analysis of the MET3 locus (Figure 
4.2) show that MET3 is clearly absent from T. brucei and L. major, and appears to 
have no homologues in any other organism sequenced to date.
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4.1.4 MET3 protein sequence analysis predicts nuclear localisation 
and possible nucleic-acid binding capacity
In order to extract as much information as possible from the predicted protein 
sequence of MET3, we utilised a wide range of bioinformatic analysis tools (section
2.5). MET3 codes for a protein with a calculated molecular weight of 21 kDa and a 
pi of 11.4. The protein contains a high number of serine residues, and charged amino 
acids (Table 4.1). An alignment of the derived amino acid sequences for MET3-CL1, 
MET3-CL2, and MET3-Dm28c is shown in Figure 4.5. MET3-CL1 and MET3-CL2 
are eight amino acids shorter than MET3-Dm28c, due to the frameshift in the MET3- 
Dm28c gene. Non-synonymous nucleotide substitutions cause an additional eight to 
twelve (depending on the allele) amino acid substitutions throughout the protein 
(Figure 4.5). All three sequences were subjected to bioinformatic analysis as de­
scribed in materials and methods. Despite small differences in primary sequence, the 
three sequences are the same with respect to the features described below.
Table 4.1: Properties o f  MET3 amino acid sequence
Properties of the deduced amino acid sequences of MET3-CL1, MET3-CL2 and MET3-Dm28c. 
These proteins contain high numbers of serine residues and charged amino acids (mainly arginine). 
The difference in molecular weight is due to a frameshift in the sequence of the MET3-Dm28c gene.
MET3-CL1 MET3-CL2 MET3-Dm28c
number of amino acids 191 191 199
molecular weight 21 kDa 21 kDa 22 kDa
theoretical pi 11.35 11.46 11.41
negatively charged 26 26 25
amino acids (D+E) (13.6%) (13.6%) (12.6%)
positively charged 41 42 43
amino acids (R+K) (21.5%) (22%) (21.6%)
arginines (R) 35 36 36
(18.3%) (18.8%) (18.1%)
serines (S) 29 29 30
(15.2%) (15.2%) (15.1%)
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MET3 - CL1 MSRRKDNKSHLKEFLRRLRDQGRQGTPQASAGRGRARTGEGSGRYALSFSGRSWATAPT 6 0
MET3-CL2 .............. V ................................................  60
MET3 -Dm28c ................................................................  60
MET3 -CL1 RGRSYLPRSRKDNEDDSMPLAVANAALSSTDDARDQGREHQRRHRDEETRTSEESSRRRP 120
MET3-CL2 ............T .......T. .D..........G ..........................  120
MET3 -Dm28c .....................TATK..........G ..........................  120
MET3 -CL1 SRSTESDPHEWLSESRASVLPSTSTGSRASGSTDPVSEHAARRADAGRVIGRRRGGDSE 180
MET3-CL2 .........D ....................T .............. V.TR.GM.........  180
MET3 -Dm28c ...... T ...................................... V --- G ..........  180
MET3-CL1 KSLKRPRTGGP* 191
MET3-CL2 ........... * 191
MET3 -Dm28c ...........NVNCRSHH* 199
Figure 4.5: Alignment o f  MET3 protein sequences
The alignment compares the deduced MET3 amino acid sequences of the two alleles from T. cruzi CL 
Brener with the T. cruzi Dm28c protein (GenBank AAK37449). A dot (.) denotes amino acids iden­
tical to the MET3-CL1 sequence. A star (*) denotes a stop codon. Note that the predicted MET3- 
Dm28c protein is longer, due to a frameshift in the DNA sequence.
MET 3
PKC
CK2
ASN
MYR
MSRRKDNKSHLKEFLRRLRDQGRQGTPQASAGRGRARTGEGSGRYALSFSGRSWATAPTRGRSYLPRSRKDNEDDSMPL
<~> < - > < - >  <->
<  -  -  >
<---->
MET3
PKC
CK2
CAMP
MYR
AVANAALSSTDDARDQGREHQRRHRDEETRTSEESSRRRPSRSTESDPHEWLSESRASVLPSTSTGSRASGSTDPVSEH
< - >
< ~ ~ >
<---->
MET3 AARRADAGRVIGRRRGGDSEKSLKRPRTGGP
PKC < - > < - >
AMI < - - >
Figure 4.6: Distribution o f potential modification sites in the MET3 protein
Arrows indicate the positions of potential modification sites in the MET3 protein sequence. A Prosite 
scan identified potential phosphorylation sites for protein kinase C (PKC), casein kinase II (CK2) and 
cAMP- and cGMP-depcndent protein kinase (CAMP). Putative glycosylation (ASN), N-myristoy- 
lation (MYR) and amidation sites (AMI) were also identified.
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Figure 4.7: Sum m ary o f  MET3 sequence features
( A )  A schematic representation of the MET3 protein sequence shows potential nuclear localisation 
signals (NLS) dispersed throughout the sequence. The filled red box indicates a bipartite NLS, The 
open boxes represent monopartite NLS. (B) Vertical black lines indicate SR/RS dipeptides that are 
found scattered throughout the sequence. (C) The grey box indicates a region which corresponds to 
the consensus core sequence o f the RNA-binding motif RNP-I (see also Figure 4.8). (D) MET3 is 
predicted to fold into a mix of a  helices (orange boxes) and p sheets (yellow boxes). Numbers on top 
indicate amino acid positions.
Figure 4. ft: M ET3 contains a putative RNA recognition m otif
Sequence alignment of amino acid positions 42-69 of MET3 and the RNP-I motif of T. hrucei RNA- 
binding protein p34/37 (/.hang and Williams, 1997). These sequences conform to the consensus 
structural core sequence o f the RNP-I motif (RNP-ICSC; Bimey et al., 1993). Conserved amino acids 
are shown in red, and conservative substitutions in orange. X any residue; U uncharged residue; Z 
“  U + S, T. The sequence similarity between MET3 and p34/37 docs not extend beyond this motif.
TcMET3 SGRYA SFSGRSVVATAPTRGRSYLPRS 
T b p 3 4 / 3 7  RRYAI FFENAAAVRKAIDLFNEKEVLG 
RNP-1 CSC x U x V x F x x x x x Z x x A
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MET3 contains a number of potential post-translational modification sites (Figure
4.6). Several putative phosphorylation sites for casein kinase 11 (CK2), and cAMP- 
and cGMP-dependent protein kinase are found in the central part of the sequence. 
Putative PKC phosphorylation sites are dispersed throughout MET3. Putative ASN 
glycosylation site, and two N-myristoylation sites and one amidation site were also 
detected in a motif scan of Prosite patterns and profiles (Hulo et al., 2004). In addi­
tion, we found at least ten potential arginine methylation sites (not shown on Figure): 
arginine residues in the contexts RGG, RXR, GRG or RG may be targets of arginine 
methylation (McBride and Silver, 2001).
MET3 is predicted to localise to the cell nucleus [PSORTII (Nakai and Kanehisa, 
1992), 74% probability]. A scan of Prosite profiles, and PSORT II predictions iden­
tified a bipartite nuclear localisation signal (NLS) at the N-terminus, and four mono- 
partite NLS distributed throughout the sequence (Figure 4.7A). The program DBS- 
Pred (Ahmad et al., 2004) predicts that MET3 binds to DNA (91.7% probability), 
based on amino acid composition. MET3 has several other features characteristic of 
nucleic-acid binding proteins: the protein is classified as arginine-rich by Prosite 
profile scan, and nine RS or SR dipeptides are found dispersed throughout the 
sequence (Figure 4.7B). Furthermore, a sequence reminiscent of RNP-1 is present in 
the N-terminal half of MET3 (amino acid positions 44-58) (Figures 4.7C and 4.8). 
RNP-1 is one of two submotifs of the RNA recognition motif RRM (Burd and 
Dreyfuss, 1994), a region of around 80 amino acids found in many RNA binding 
proteins (of prokaryotes and eukaryotes). MET3 corresponds to the conserved struc­
tural core sequence of RNP-1 (Figure 4.8) (Bimey et al., 1993), but the second sub­
motif, RNP-2, is absent from MET3. MET3 is clearly distinct from the recently 
discovered family of T. cruzi RNA-binding proteins which contain the canonical 
RRM domain (De Gaudenzi et al., 2003). There is however similarity between 
MET3 and the RNP-1 domain of the developmentally regulated nuclear RNA bind­
ing proteins p34/37 of T. brucei (Zhang and Williams, 1997) (Figure 4.8). None of 
these features alone is a definitive indicator of a particular function. Taken together 
however, they suggest that MET3 may bind to nucleic acids.
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We extended sequence analysis of MET3 to structure, to gain maximal insight into 
its potential function. Since accurate ab initio protein structure prediction has re­
mained beyond the limits of current bioinformatic analysis, and since there are no 
homologous sequences available on which MET3 structure could be modelled, our 
analysis was limited to the prediction of likely secondary structures, and the search 
for conserved protein folds. The latter can identify more distant evolutionary rela­
tionships that are not detected by standard sequence alignment, and give important 
clues to a putative function. MET3 is predicted to fold into a mixture of a  helices 
and P strands (Figure 4.7D), as determined from the consensus output from four 
different prediction programs (section 2.5). We also used 3D structure prediction 
programs (section 2.5) to calculate if MET3 could adopt any protein fold represented 
in the Protein Data Bank PDB, but found no known conserved folds. This suggests 
that MET3 represents a novel structure.
In summary,
• MET3 is a T. cruzi specific gene with no apparent homologues in other organisms.
• MET3 is a single copy gene, in a gene-rich region on a 2 Mb chromosome.
• The MET3 protein sequence contains a high proportion of basic residues and 
several putative nuclear localisation signals.
• Sequence analysis suggest that MET3 is a nuclear protein that may interact with 
DNA or RNA.
4.2 MET3 IS A STAGE-SPECIFIC NUCLEAR PROTEIN
4.2.1 MET3 RNA is upregulated during metacyclogenesis
MET3 was initially identified in a screen for RNA transcripts that are enriched in 
metacyclics of T. cruzi strain Dm28c (Yamada-Ogatta et al., 2004). We established 
by Northern blot analysis that MET3 expression is also upregulatcd in CL Brener 
during metacyclogenesis (Figure 4.9A). RNA was extracted from cultures containing 
0%, 6% and 24% metacyclics, respectively. A double band migrating at about 
3.5/3.9 kb hybridises with a probe derived from the MET3 CDS in all samples. The
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signal is much stronger in the sample from the culture with 24% metacyclics com­
pared to the ones with fewer metacyclics. The abundance of MET3 transcripts thus 
correlates with development of metacyclics in CL Brener. This pattern of upregu- 
lation is similar to that found for MET3-Dm2Xc. As an internal control, the same 
RNA was hybridised with a probe for the metacyclic-spccific gene gpX2. A probe 
corresponding to the 5' end of the coding sequence of gpN2 (Fragment J18b coding 
for amino acids 224-516, (Araya et al., 1994)) hybridised to a single 2.2 kb band in 
all RNAs tested (Figure 4.9B). The signal was much stronger in RNA from a popu­
lation containing 24% metacyclics than in a pure epimastigote culture, consistent 
with the reported up-regulation of steady-state levels of gpX 2 RNA in metacyclics.
Figure 4.V: Northern blot shows upreguiation o f  MKT3 transcripts in stationary phase cultures 
Total RNA was extracted from cultures containing different proportions of mctacyclics and analysed 
on Northern blots. I.anc I: log-phase cpimastigotes; lane 2: 6% mctacyclics; lane .3: 24% metacyclics. 
( A )  Two transcripts are detected with a MKT3 probe (calculated si/e: 3.9 and .3.5 kb, respectively). 
MF.Ti transcripts are strongly upregulated in cultures containing 24% metacyclics. ( B )gp82 ,  a gene 
known to be uprcgulatcd in mctacyclics. (C) RNA loading was controlled by cthidium bromide 
staining o f the ribosomal RNA bands (I8S, 24S<t and 24SJI) prior to blotting. lOpg RNA was loaded 
per lane. Numbers on the right indicate si/e in bases.
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4.2.2 MET3 protein expression is stage-specific
To determine whether MET3 is a marker specifically for metacyclics, or whether 
MET3 is expressed in all cells of a stationary phase population, we raised antisera 
against recombinant MET3 protein as described in sections 2.4.2 to 2.4.4. The full- 
length MET3 gene was cloned in expression vector pTrcHis C (section 2.3.4). The 
resulting vector pTrcHis-met3 was transformed into E. coli BL21, and expression of 
the recombinant 6xHis-MET3 protein was induced with IPTG. Western blots of 
E. coli lysates were screened, using the anti-Xpress antibody. 6xHis-MET3 is 
expressed at low levels in E. coli, and is predominantly found in the insoluble 
fraction. Expression of the protein at 18°C or 4°C instead of 37°C did not yield 
higher proportions of soluble protein. Addition of 1% Triton X-100 to the lysis 
buffer, increased the amount of soluble protein and allowed purification of soluble 
6xHis-MET3 under native conditions on a Ni-NTA agarose column (Figure 4.10A).
The purified recombinant protein was used to raise antisera in mice. Antisera that 
detect recombinant MET3 (Figure 4.1 OB), as well as native MET3 from T. cruzi 
lysates (Figure 4 .IOC) were obtained from two mice. No protein was detected with 
the pre-immune sera (Figure 4.IOC), confirming that the antisera specifically recog­
nise MET3. Western blot analysis using these antisera shows that a protein of 
approximately 21 kDa (calculated molecular weight for MET3) is expressed at high 
levels in cells from stationary phase cultures, but not detectable in lysates from log- 
phase epimastigotes (Figure 4.11).
We noticed that MET3 is solubilised at high salt concentrations. At NaCl concentra­
tions lower than 0.3 M, MET3 is present in the soluble as well as insoluble fraction 
of T. cruzi protein extracts (Figure 4.11). At higher concentrations (0.5 M to 1.2 M) 
MET3 was detected exclusively in the soluble fraction (data not shown).
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Figure 4.10: Generation o f  MET3 antiserum
(A) Purification of recombinant MET3 from E. coli. Full-length MET3, with an N-terminal 6xHis tag 
and an Xpress epitope tag (6xHis-MET3) was expressed in E. coli BL2I, and purified under native 
conditions using a Ni-NTA agarose column (section 2.4.3). The image shows detection of 6xHis- 
MF.T3 with the anti-Xpress antibody in a Western blot o f the E. coli lysate (L). and protein fractions 
eluted from the column using increasing concentrations of imidazole (indicated above each lane).
(B) Purified 6xHis-MET3 was used to raise antiserum in mice (section 2.4.4). l-ane I: Purified 6xHis- 
MF.T3 (24 kl)a) in a Coomassie stained SDS-PAGE gel. I.anes 2 and 3: Antisera from two mice 
delect the purified 6xHis-MET3 on a Western blot. (C) l.ane I: Detection of native MET3 (21 klla) 
on a Western blot of T. cruzi stationary phase cell lysates, using the antiserum from mouse I. l.ane 2: 
Pre-immune scrum from mouse I docs not detect any protein in the if. cruzi lysate. Numbers on the 
left indicate molecular sizes in kilo Daltons.
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Figure 4.11: Western blot shows stage-specificity o f MET3 expression
Protein lysates from T. cruzi log phase epimastigotes (lanes I and 2) and stationary phase cells (lanes 
3 and 4) were analysed on a Western blot, using the MET3 antiserum. Prior to fractionation on SDS- 
PAGE, the lysates were separated in a soluble fraction (lanes I and 3) and an insoluble fraction (lanes 
2 and 4) by centrifugation (section 2.4.1). (A) High levels o f  MET3 are detected in the stationary 
phase cell lysates, both in the soluble (lane 3) and insoluble fraction (lane 4). In epimastigote lysates 
no MET3 protein is detected (lanes I and 2). (B) Loading control: Coomassie stained protein gel. 
Numbers on the left indicate molecular sizes in kilo Daltons.
4.2.3 MET3 is a nuclear protein that associates with the nucleolus
To determine at which stage during the T. cruzi life-cycle the MET3 protein is ex­
pressed. we used the MET3 antiserum to visualise the protein in individual cells by 
immuno-fluorescence confocal microscopy (Figures 4.12 - 4.17). We found that 
MET3 expression is specific to a subset of cells in stationary phase culture: MET3 is 
strongly expressed in fully developed metacyclics where it localises to the nucleus 
(Figures 4.12 and 4.13). It is also detected in the nucleus of cells that arc morpho­
logical intermediates between epimastigotes and mctacyclics, as defined by the 
position of the kinetoplast (Figures 4.12 and 4.14). Cells with cpimastigotc mor­
phology arc negative for MET3 staining, both in stationary phase cultures (Figures 
4.12 and 4.14), and in log phase cultures (Figure 4.15), consistent with Western blot
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results (Figure 4.11). As negative controls, prc-immune mouse sera, and secondary 
antibodies alone were tested and found not to stain T. cruzi (not shown). Metacyclics 
frequently exhibit a striking pattern of MET3 distribution. Four to six spherical 
clusters of MET3 staining are spread in regular order along the anterior-posterior 
axis o f the elongated nucleus (Figure 4.13A-C). Some cells show punctate MET3 
staining throughout the nucleus which appears less regular (Figure 4.13D-E), while 
in others just one or two clusters of stronger staining persist with most of the signal 
dispersed diffusely throughout the nucleus, (Figure 4.13F). Areas of strong MET3 
staining tend to stain weakly with the DNA stain TOTO-3. This pattern of staining 
suggested a possible nucleolar localisation.
Distribution of MET3 in the nucleus of intermediate forms also appears punctate, 
with one area staining strongly for MET3 and patches of weaker staining arranged 
along the edge of the nucleus (Figure 4.14). MET3 was also detected in the nucleus 
of a subset of amastigotes at early stages of macrophage infections where it localises 
to the nucleolus (Figure 4.16A-B). Amastigotes at later stages o f macrophage infec­
tions (Figure 4.17A), or trypomastigotes released from infected macrophages six 
days after infection (Figure 4.17B-C) were negative for MET3 staining. Thus, MET3 
expression is a specific marker for cells that go through metacyclogenesis: MET3 
expression is first seen in intermediate forms in stationary phase, and is maintained 
in fully developed metacyclics. MET3 expression ceases at an early time point after 
development of the amastigotc form.
DNA MET3 merged
Figure 4 12: MFT3 is expressed in metacyclics and intermediate forms
Cells from a stationary phase culture were fixed and immuno-labelled with MET3 antiserum (MET3). 
Staining is seen in the nucleus of metacyclics (m. panels A-C) and intermediate forms (i, panels C and 
I)). hut not in the nucleus of epimastigotes (e. panels A-D). Kinetoplast <K) and nuclear DNA (N) is 
stained with TOTO-3. Scale bar 2 pm.
Figure 4.13 (overleaf): Localisation o f MET3 in the metacydic nucleus
A detailed examination o f  the metacyclics in stationary cultures (see Figure 4.12) revealed that MET3 
is found dispersed in the elongated nucleus of these cells. Most metacyclics show a punctate pattern, 
which appears structured into segments in some cells (A-C). and dispersed in other cells (D-F.). A few 
cells show diffuse MET.3 staining throughout most of the nucleus (F). Scale bar 2 pm.
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Figure •> 1-4 Subnuclear distribution o f  MET3 in intermediate forms
Cells from a stationary phase culture were fixed and immune-labelled with MET3 antiserum (MET3). 
Kinetoplast (K) and nuclear DNA (N) is stained with TOTO-3. In epimastigotes the kinetoplast is 
positioned at the anterior end of the nucleus. In intermediate forms the kinetoplast has moved to the 
side o f  the nucleus. MET3 is detected in the nucleus of intermediate forms (A and B). MET3 appears 
to be concentrated in patches. No MET3 is delected in the nucleus of epimastigotes (panel A. cell on 
the left). Scale bar = 2 pm.
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Figure 4.15: MET3 is not expressed in proliferating epimasligotes
Kpimastigotes in log phase of growth were fixed and immuno-lahelled with MET3 antiserum (MET3). 
No MET3 is detected in these cells. Kinetoplast and nuclear DNA is stained with TOTO-3. Scale har 
-  2 |im.
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Figure V. 16: MET} in the nucleolus o f  early amasligoles
T. cruzi-infected macrophages were fixed 24 h post infection. Cells were immuno-labelled with 
MET3 antiserum, and kinetoplast (K) and nuclear DNA (N) is stained with TOTO-3. (A) An enlarged 
image of one amastigote shows that MET3 staining is concentrated in the nucleolus, which stains 
weakly with TOTO-3. (B) Amastigotes inside a macrophage. MET3 is detected in the nucleus of three 
amastigotcs. Two amastigotes are negative for MET3 staining. Scale bar = 2 pm.
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Finure 4.17: Replica!inf; amasligoles and Irypomasligotes express no MET3
T. crazi-infected macrophages and cells from the supernatant of infected cultures were fixed and 
immuno-labelled with MET3 antiserum. Kinetoplast (K) and nuclear DNA <N) were stained with 
TOTO-3. (A) Six days post infection amastigotes have replicated inside macrophages. The antiserum 
fails to detect any MET3 in these amastigotes. (B) A trypomastigote that has emerged from the in­
fected macrophages on day six is also negative for MET3 staining. (C) Two weeks post infection, 
try pomastigotes and amastigotes are abundant in the supernatant of infected macrophage cultures. The 
MET3 antiserum fails to detect any MET3 in the nucleus of these cells. Scale bar 2 pm.
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4 .2 .4  T h e  n u cleo lu s
Earlier studies have documented extensive nuclear reorganisation that takes place 
during T. cruzi differentiation. Heterochromatin becomes widespread and nucleolar 
antigens disperse in the nucleus of trypomastigote forms (Elias et al., 2001b). The 
nucleolus is a morphologically defined, yet highly dynamic structure. Its primary 
function is ribosome biogenesis, which involves transcription of rDNA, processing 
of pre-rRNA and assembly of rRNA with ribosomal proteins into ribonucleoprotein 
complexes (Melese and Xue, 1995). How the functional architecture of the nucleolus 
is regulated is only partially understood and remains a focus o f ongoing investigation 
(Scheer and Hock, 1999). Interestingly, in recent years it has emerged that in addi­
tion to its role in ribosome biogenesis, the nucleolus also plays regulatory roles in the 
control of cell proliferation, through sequestration of regulatory molecules (Carmo- 
Fonscca et al.. 2000; Scheer and Hock, 1999).
In trypanosome nuclei stained with TOTO-3, the nucleolus is visible s a single acen­
tric spherical region from which the DNA dye is excluded. T. brucei bloodstream 
forms are shown in Figure 4.18, and replicating T. cruzi cells in Figures 4.18 and 
4.19. In the nucleus of non-replicating T. cruzi cells, a nucleolus is not readily dis­
cernible. In these cells, DNA-staining is non-homogenous with a number of patches 
that stain weakly for DNA (Figure 4.20). Since the distribution of MET3 resembled 
closely the reported distribution of nucleolar antigens in metacyclics (Elias et al., 
2001b), and since MET3 clearly localises to the nucleolus in early amastigotes 
(Figure 4.16), we examined in more detail the dynamics of nucleolar antigens. To 
compare the localisation of MET3 and nucleolar antigens directly we used antibodies 
against nucleolar antigens, and expressed tagged versions of MET3.
4.2.5 Distribution of nucleolar antigen L1C6 throughout the life-cycle of T. cruzi
To follow the distribution of nucleolar antigens in the T. cruzi nucleus, we tested two 
antibodies: The rabbit NOG1 antiserum, raised against a well-characterised highly 
conserved T. brucei nucleolar G-protein with a role in ribosome biogenesis (Jensen 
et al., 2003; Park et al., 2001) and the L1C6 antibody, raised against an uncharacter-
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ised nucleolar T. brucei antigen (K. Gull, unpublished). To determine with certainty 
that L1C6 detects a nucleolar antigen we stained T. brucei cells with NOG1 and 
L1C6. The results clearly demonstrate co-localisation of NOG1 and L1C6 in the area 
of the nucleus that stains weakly with TOTO-3 (Figure 4.18A-B). When T. cruzi 
epimastigotes were stained with these antibodies, identical results were obtained with 
L1C6 (Figure 4.18C), but the NOG1 antiserum gives extensive background staining 
in most T. cruzi cells (Figure 4.18C).
In replicating cells, i.e. epimastigotes taken from log phase of growth, and in amas- 
tigotes, the nucleolus is visible as a distinct dot in a round nucleus as determined by 
weak TOTO-3- and strong L1C6 staining (Figure 4.19). In dividing cells, each o f the 
two daughter nuclei has a well-defined nucleolus. Occasionally the L1C6 signal 
appears slightly dispersed, but remains restricted to a small area of the nucleus 
(Figure 4.19B). This pattern is maintained in epimastigotes until the end of log phase 
growth.
In non-replicating cells taken from stationary phase cultures, the nucleolar antigen 
disperses (Figure 4.20). L1C6 staining is visible as a punctate pattern distributed 
throughout the nucleus of these non-dividing epimastigotes. In some cells a small 
number of discrete dots are observed (Figure 4.20A-B), which coincide with areas of 
weak DNA staining, whereas others show large patches of diffuse staining through­
out the nucleus (Figure 4.20C). Cells that are intermediate forms between epimas­
tigotes and metacyclics show a dispersed L1C6 staining pattern (Figure 4.21 A), 
similar to that in stationary phase epimastigotes (Figure 4.20). In fully developed 
metacyclics, L1C6 detects a small number of discreet dots along the anterior-poste­
rior axis of the elongated nucleus (Figure 4.21 B-D), which again coincide, with areas 
of weak DNA staining.
The distribution of the L1C6 nucleolar antigen in intermediate forms, metacyclics 
and early amastigotes follows essentially the same pattern as the distribution of 
MET3. Of particular note is the segmented pattern in some metacyclics that is seen 
with both antibodies (compare Figures 4.13 and 4.21).
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DNA NOG1 L1C6 merged DIC
Figure 4. IS: Markers fo r  the trypanosome nucleolus
(A) and (B) T. hrucei bloodstream forms were fixed and double labelled with rabbit antiserum against 
nucleolar G-protein NCXil and mouse monoclonal antibody LIC6. Kinetoplast (K) and nuclear ON A 
(N) is stained with TOTO-3. The nucleolus stains weakly with TOTO-3 (panel B. arrow). The merged 
images show that the LIC6 antigen co-localises with NOGI. (C) T cruzi epimastigotes were fixed 
and double labelled with the anti-NOGI and LIC6 antibodies. The LIC6 antigen is localised to the 
nucleolus, which stains weakly with TOTO-3 (arrow). Antiserum against NOGI (upper panel) does 
not specifically stain the T. cruzi nucleolus in this cell. Scale bar 2 pm.
Technical difficulties have prevented us from proving co-localisation directly by 
double staining. Because both the MET3 antiserum and the L1C6 antibody were 
raised in mice, they would have to be directly labelled with a fluorescent substance 
in order to distinguish the signals. The rabbit NOGI serum which could be used in 
double labelling experiments gives extensive background staining in most T. cruzi 
cells and was therefore considered unsuitable to analyse the dispersed pattern in 
metacyclics.
DNA L1C6 merged
Figure 4 IV: The nucleolar antigen LIC6 in replicating T. cruzi cells
Cells were fixed and labelled with monoclonal antibody LIC6. kinctoplast (K) and nuclear DNA (N) 
is stained with TOTO-3. The nucleolus is visible as area of weak TOTO-3 staining. A single dot of 
L1C6 staining is visible in the nucleolus in log phase epimastigotes (A-C), and in amastigotes (D-E). 
Scale bar = 2 pm.
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Figure 4.20: Dispersal o f the nucleolar antigen LIC6 in non-replicating T. cru/i epimastigotes 
T. cruzi stationary phase cells were fixed and labelled with monoclonal antibody LIC6. Kinetoplast 
(K> and nuclear DNA (N) is stained with TOTO-3. In stationary phase epimastigotes. LIC6 staining 
appears as a dispersed punctate pattern. The LIC6 nucleolar antigen clusters in distinct foci on a 
background of diffuse staining. Scale bar 2 pm.
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DNA L1C6 merged DIC
Figure 4.21: Distinct clusters o f  nucleolar antigen LIC6 in the nucleus o f metacyclics 
T. cruzi stationary phase cells were fixed and labelled with monoclonal antibody LIC6. Kinetoplast 
(K) and nuclear DNA (N) is stained with TOTO-3. In intermediate forms (A), and in stationary 
cpimastigotes (B. C) a dispersed I.IC6 staining pattern is observed. In metacyclics (B-l>) the 1.IC6 
antigen clusters in distinct foci along the axis o f the elongated nucleus. Scale bar 2 pm.
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4.2.6 Episome-encoded MET3 localises to the nucleolus 
of replicating epimastigotes
In wild-type T. cruzi, MET3 is not expressed in replicating epimastigotes. Episomal 
expression vectors were therefore constructed (section 2.3.4) to constitutively 
express tagged versions of MET3 in epimastigotes. These were used to test whether 
the recombinant protein localises to the nucleolus and to determine if inappropriate 
expression of MET3 enhances metacyclic development. Vector pTEX-MET3-9E10 
was designed for expression of MET3 with a C-terminal c-myc tag (MET3-9E10). 
Vector pTEX-MET3-GFP was designed for expression of MET3 fused at the C- 
terminus to green fluorescent protein (GFP). Transfectants for both constructs were 
readily obtained, and used for localisation of the recombinant proteins by immuno- 
staining, or direct visualisation of GFP fluorescence.
In epimastigotes, MET3-GFP localises to the nucleolus. Double-labelling shows co­
localisation of MET3-GFP with the L1C6 nucleolar antigen (Figure 4.22). MET3- 
9E10 also localises to the nucleolus in most cells (Figure 4.23A-B). In a few cells, 
MET3-9E10 is found along the nuclear periphery with only weak staining of the 
nucleolus (Figure 4.23C). Identical staining patterns were observed with the antibody 
against the c-myc tag (not shown).
Importantly, we did not observe dispersal of the nucleolar antigens as a consequence 
of constitutive MET3-GFP expression. Epimastigotes that express tagged versions of 
MET3 appear morphologically no different from wild-type epimastigotes, which do 
not express any form of MET3.
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Figure 4.22: Co-localisation o f  MET3-CFP and LIC6 in the epimastigote nucleolus 
T cruzi epimastigotes transfected with pTEX-MET3-GFP were fixed and stained with monoclonal 
antibody 1.IC6. MET3-GFP was localised by directly visualising GFP fluorescence. Kinetoplast <K) 
and nuclear DNA (N) were stained with TOTO-.V the merged image shows that MET3-GFP and 
LIC6 co-localise in the nucleolus.
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DNA MET3 merged DIC
Figure -I.2J: Suhnuclear localisation o f MET3-9EIO in log phase epimasligoles
T. cruzi epimasligoles transfected with pTEX-MET3-9EI0 w ere fixed and labelled with M10T3 
antiserum. Kinetoplast (K) and nuclear DNA (N) is stained with TOTO-3. (A-B) In most cells, strong 
MET3 staining is observed in the nucleolus, where DNA staining is weak. (C) In some cells MliT3 
staining is observed at the nuclear periphery, with no signal in the nucleolus. Scale bar 2 pm.
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Western blot analysis shows that transfected epimastigote populations express high 
levels of MET3-9E10 (Figure 4.24). Additional bands recognised by the antiserum, 
above the 21 kDa MET3, are possibly modified forms of the MET3 protein. The 
proportion of cells that express MET3-9E10 is very high, and high expression levels 
are maintained after continuous passage (>1 year) with no apparent deleterious ef­
fects. We observed a rapid decrease in the proportion of cells that express MET3- 
GFP over time. This is consistent with a toxic effect of GFP expression in T. cruzi 
that was noted in other contexts (unpublished observations).
A
7 8  
80 
37
25
20
15
50
Figure 4.24: Detection o f  MET3-VEI0 in Western blots
(A) Western blot of whole cell extracts from non-transfected T. cruzi stationary phase cells (lane I ). 
non-transfected epimastigotes (lane 2) and pTEX-MET3-9EI0 transfected epimastigotes (lane 3). 
Antiserum against MET3 detects native MET3 in non-transfected stationary phase cells (lane I), and 
recombinant MET3-9EIO in transfected epimastigotes (lane 3). Non-transfected epimastigotes express 
no MET3 (lane 2). The same blot was probed with anti-fl-tubulin antibody (TUB) as a loading control.
(B) Western blot of the soluble protein fraction from non-transfected T. cruzi stationary phase cells 
(lane 4) and from pTEX-MET3-9EI0 transfected epimastigotes (lane 5). MET3 antiserum detects the 
native MET3 (lane 4) in non-transfected cells, and recomhinant MET3-9EI0 in transfected cells (lane 
5). An antibody against the c-myc tag (9F.I0) detects the recomhinant MET3-9EI0 (lane 5). Numbers 
on the left indicate molecular weight in kilo Daltons.
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In non-replicating cells, the tagged MET3 protein becomes dispersed. MET3-9E10 is 
found in a dispersed punctate pattern in stationary' phase epimastigotes (Figure 4.25). 
differentiating cells (Figure 4.26A) and metacyclics (Figure 4.26B-D). Regions ol 
strong MF.T3-9E10 signal tend to stain weakly for DNA. This pattern resembles 
closely the dispersal of the L1C6 nucleolar antigen we found in wild-type cells.
DNA MET3-9E10 merged DIC
Figure 4.25: Dispersal o f  M ET3-9EI0 in the nucleus o f stationary phase epimastigotes 
Stationary phase epimastigotes expressing MET3-9EI0 were fixed and labelled with MET3 anti­
serum. Kinctoplast (K> and nuclear DNA (N) is stained with TOTO-3. MET3 staining is visible as 
dispersed pattern. Strong MF.T3 staining coincides with areas where DNA staining is weak. Scale har
“  2 pm.
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DNA MET3 merged DIC
Figure 4.26: Clusters o f MFT3-VEI0 in the metacyclic nucleus
Stationary cells expressing MET3-9EIO were fixed and labelled with MET3 antiserum. Kinetoplast 
and nuclear DNA is stained with TOTO-3. In metacyclics (A-C) and intermediate forms (D). MET3- 
9EI0 clusters in distinct foci, particularly in areas where DNA staining is weak. Scale bar 2 pm.
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In summary,
• MET3 RNA levels are upregulated during metacyclogenesis
• MET3-specific antiserum was generated using recombinant MET3, expressed in 
E. coli.
• MET3 protein expression is stage-specific. The protein was only detected in inter­
mediate forms, metacyclics and early amastigotes.
• MET3 is a nuclear protein.
• The subnuclear localisation of native MET3, and tagged versions of MET3 
suggests association with nucleolar components.
• Dispersal of nucleolar antigens was observed in all non-replicating T. cruzi cells.
• Overexpression of MET3 in epimastigotes had no apparent effect on the cells.
4.3 IDENTIFICATION OF TWO SEQUENCE ELEMENTS THAT CAN 
MEDIATE NUCLEOLAR LOCALISATION
A commonly used method to locate targeting sequences in a protein is to fuse frag­
ments of the protein to green fluorescent protein (GFP) (Chalfie et al., 1994), or to an 
epitope tag (such as c-myc), and determine the subcellular localisation by fluores­
cence microscopy. Both approaches have been used successfully in trypanosomes. 
With regard to nuclear targeting, GFP-fusion experiments demonstrated that a 
monopartite NLS in the La protein homologue, and a bipartite NLS in histone H2B 
mediate nuclear import in T. brucei (Marchetti et al., 2000). Nuclear import in try­
panosomes has been found to rely on signals and machinery similar to that in higher 
eukaryotes (Marchetti et al., 2000).
Whereas NLS can be predicted with some confidence (Cokol et al., 2000), nucleolar 
targeting signals are much more diverse. Very few sequence motifs have been char­
acterised in detail that can mediate nucleolar targeting in trypanosomes (Das et al., 
1998; Hoek et al., 2000; Marchetti et al., 2000).
Bioinformatic analysis of the MET3 amino acid sequence detected one bipartite and 
four monopartite NLS in MET3 (Figure 4.7A). The experiments presented here
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aimed to determine which elements in the MET3 sequence are critical for the spe­
cific subnuclear localisation of MET3. Ten expression constructs were designed for 
this purpose (overview in Figure 4.27). Each construct contains a fragment of the 
MET3 coding sequence, fused in-frame with the full length sequence of GFP, or with 
the c-myc (9E10) epitope (section 2.3.4). Every construct was expressed in epi- 
mastigotes. Localisation of the fusion proteins was analysed in epimastigotes and in 
metacyclics by direct observation of GFP fluorescence, or where applicable, by 
observation o f  immuno-stained cells using the anti-c-myc antibody.
Figure 4.27 (overleaf): Summary o f  MET3 fusion  constructs
(A) Schematic diagram of expression vector pTEXeGFP (section 2.3.4). Fragments of the MET3 gene 
were cloned into the multiple cloning site (MCS) of this vector to generate in-frame fusions with the 
green fluorescent protein (GFP) coding sequence. Fusion proteins were expressed in T. cruzi epimas­
tigotes and their localisation determined by microscopic examination. (B) Schematic representation of 
the MET3 protein. (C) Fragments of MET3 that localise to the T cruzi nucleolus when fused to c-myc 
(construct 7/8) o r GFP (all other constructs). (D) Fragments of MET3 that do not specifically localise 
to the nucleolus when fused to GFP. These fusion-proteins are found throughout the cytoplasm and 
nucleus. Numbers on top identify two sequence elements that are critical for targeting of the proteins 
to the T cruzi nucleolus. Element 1 consists of a bipartite NLS (filled red box) and a sequence with 
similarity to the RNA-binding motif RNP-1 (grey box). Element 2 consists of two NLS at the C- 
lerminus (filled red boxes). Elements 1 and 2 can mediate nucleolar localisation independently. The 
open boxes represent predicted NLS sequences that were found not to target GFP to a specific loca­
tion.
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The fusion proteins fall into two classes. The first class localises exclusively to the 
nucleolus in epimastigotes (Figure 4.28 A-D, I-J, M-O), and disperses in the nucleus 
of metacyclics (Figure 4.28 E-H, K-L, P). These fusion proteins show the same 
localisation as full-length MET3 (Figure 4.22). The second class is dispersed 
throughout the whole of the cell cytoplasm, including the flagellum, and the nucleus, 
but excluding the kinetoplast (Figure 4.29). These fusion proteins show the same 
localisation as GFP on its own (Figure 4.31). We noted that expression levels of GFP 
and GFP-fusion proteins differ markedly between individual cells in a population 
(Figures 4.29F and L and data not shown).
Detailed analysis shows that at least two independent elements within the MET3 
sequences can mediate nucleolar targeting. Non-overlapping fragments of the N- 
terminal half (2/4; Figure 4.28 A-B, E-F) and the C-terminal half (5/6; Figure 4.28 
C-D, G-H) of the MET3 fused to GFP both localise to the nucleolus. Further trunca­
tion of these fragments show that elements responsible for nucleolar localisation are 
near the N- and C-terminus, respectively.
An N-terminal fragment containing the predicted bipartite NLS and the adjacent 
putative RNA binding domain is sufficient to restrict localisation of the fusion pro­
tein to the nucleolus (2/10; Figure 4.28 1-L). This exclusive nucleolar localisation is 
completely abolished when the two domains are separated: constructs that contain 
only the predicted bipartite NLS (2/3, 2/9; Figure 4.29 A-I) or only the putative RNA 
binding domain (7/4; Figure 4.29 J-O) are all dispersed throughout the cytoplasm 
and nucleus. Those MET3 fusion proteins that did not specifically accumulate in the 
nucleolus were not excluded from the nucleus, presumably because they are small 
enough to enter the nucleus freely by diffusion.
A second clement at the extreme C-terminus can target the fusion protein to the 
nucleolus independently o f the N-terminal sequence. Fusion proteins 5/6 (Figure 
4.28 C-D, G-H), 14/6 (Figure 4.28 M-P) and 7/8 (Figure 4.30A) all show exclusive 
nucleolar localisation. Fusion proteins 5/13 (Figure 4.29 P-S) and 11/12 (Figure 4.29 
T-Y), which lack the extreme C-terminus as well as the entire N-terminal half of 
MET3, are completely dispersed. This indicates that the last 19 amino acids (the only
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sequence element present in 14/6 but absent from 11/12) are important in determin­
ing localisation.
The smallest fragment that conferred nucleolar localisation is 46 amino acids long. 
This fragment contains two closely spaced NLS. At the N-terminus, a sequence that 
conforms to the consensus for a bipartite NLS is critical for nucleolar accumulation, 
but it only confers specificity when it is present jointly with the sequence that resem­
bles a RNA binding motif. We found no evidence of a role in protein localisation for 
the clusters of positively charged amino acids in the central part of MET3. Fusion 
proteins that contain these elements, but neither of the N- or C-terminal sequences 
described above (i.e. constructs 7/4 and 5/13), are dispersed throughout the cell. 
Fusing the c-myc tag instead of GFP to MET3 (7/8; Figure 4.30A) demonstrates that 
nucleolar localisation is not an artefact of fusing GFP to fragments of MET3.
139
A B
MET3
2/4
Figure -I.2N MET3-GFP fusion constructs that localise to the nucleolus
(A-P) Images of cells that show nucleolar localisation of the fusion protein in epimastigotes. In meta- 
cyclics (F.-G. H-K. L. P). these fusion proteins disperse in the nucleus, similar to wild-type MET3. 
The diagram below each set of images shows schematically the full length MET3 sequence (MET3) 
and underneath it the fragment of MET3 that was fused to GFP. Critical for targeting of GFP to the 
nucleolus are the nuclear localisation signals (NLS) at the N- and C- terminus (filled red boxes) and a 
sequence with similarity to the RNA-binding m otif RNP-I (grey box). Predicted NLS in the central 
part of MET3 (open boxes) were found not to target GKP to a specific location.
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Figure 4.29: MET3 fusion constructs that J o  not specifically localise to the nucleolus 
(A-O) Images of cells that show no specific localisation of the fusion proteins. In epimastigotes and 
metacyclic trypomastigotes. these non-localised proteins are found throughout the cell, including the 
nucleus and along the flagellum They are excluded from the kinetolpast. A diagram below each set of 
images shows schematically the full length the MET3 sequence (MET.!) and underneath it the 
fragment o f  MET3 that was fused to GFP. The N-terminal NLS (filled red box) on its own (A-I)or the 
putative RNA-binding motif (grey box) on its own (J-O) are both insufficient for targeting GKP to the 
nucleolus. The non-localised fusion proteins also lack the C-terminal NLS (red box). Open boxes 
indicate predicted NLS sequences that were found not to target GPP to a specific location.
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Figure 4.30: Nucleolar localisation o f  a control construct: truncated MET3 with a c-myc tag 
The fusion protein 7/8 consists of an N-terminally truncated fragment of MFT3, with a C-terminal 
c-myc epitope tag. The fusion protein was detected in fixed cells using an anti-c-myc antibody 
(c-myc). This fusion protein also localises to the nucleolus in epimastigotes. Nucleolar localisation 
thus occurs independently of a GFP-fusion.
Figure 4.31: Epimastigote expressing CJFP
When (iFP is expressed on its own. it is found dispersed throughout the cell, including the nucleus 
and along the flagellum (image courtesy of Liz Bromley, (Bromley et al„ 2004)). Scale bar 5 pm.
In summary-.
• Expression of MET3-GFP fusion proteins in epimastigotes identified two
sequence elements that can direct the protein to the nucleolus.
• These elements can direct nucleolar localisation independently.
• Nuclear and nucleolar localisation could not be uncoupled.
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4.4 GENERATION OF KNOCKOUT MUTANTS DEMONSTRATES 
THAT MET3 IS NOT AN ESSENTIAL GENE
4.4.1 Deletion of the METS gene by homologous recombination
We hypothesised that the metacyclic stage-specific protein MET3 would not be 
essential for parasite survival in the cpimastigote stage, and therefore proceeded to 
delete both alleles by homologous recombination. The METS gene was deleted from 
the genome of T. cruzi CL Brener by successive replacement of both alleles with 
drug selectable marker genes. Targeting constructs contained the hygromycin phos­
photransferase gene (pkoMET3-HYG) or the puromycin acetyl transferase gene 
(pkoMET3-PAC) flanked by GAPDH processing signals, and with 5’ and 3’ un­
translated sequences from the METS locus to target homologous recombination 
(Figure 4.32A-B). For transfection, linear targeting fragments were delivered to 
epimastigote cells by electroporation (section 2.3.8).
In the first round of transfection, a number of drug resistant clones were obtained 
with both constructs. Deletion o f one copy of MET3 occurred in three clones trans­
fected with the HYG construct, and in one clone transfected with the PAC construct. 
Based on restriction analysis, it was established that the same allele was deleted in all 
four single knockout clones (data not shown). The size of the restriction fragments 
suggest that the deleted allele corresponds to the one designated CL-1 (Figure 4.1). 
The three MET3/HYG single knockout clones (sko) were used for the second round 
of transfection, using construct pkoMET3-PAC. One double knockout clone (dko) 
was obtained from each single knockout clone, and Southern blot analysis demon­
strated that the MET3 gene was no longer present in these clones (Figure 4.32C; data 
for the third clone not shown). Southern blot analysis also confirmed single inser­
tions of the HYG and PAC gene, respectively, as well as linkage of the insertions to 
the P5CDH gene upstream of METS (Figure 4.32C). Southern blot analysis therefore 
suggests correct integration of the targeting constructs into the MET3 locus, resulting 
in MET3 null mutant cell lines.
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Figure 4.32 (overleaf): Generation ofT. cruzi MET3 null mutants
(A) Targeting fragments pkoMET3-HYG and pkoMET3-PAC, and the MET3 genomic locus. The 
targeting fragments contain the drug selectable marker genes IIYG  or FAC, flanked by T. cruzi 
GAPDH intergenic sequences (black lines) and MET3 intcrgenic sequences (grey lines). H, Hin dill 
restriction site. (B) T cruzi HYG and FAC genomic loci generated by integration of the targeting 
fragments. (C) Genomic Southern blot of Hin dill digested genomic DNA from wild-type (wt), two 
single knockout clones (sko 1 and 2), and two double knockout clones (dko 1 and 2). A MET3 probe 
detects two bands in wt DNA, corresponding to the two alleles. In the sko clones, only one MET3 
allele remains. The MET3 probe fails to hybridise to DNA from dko clones indicating that both alleles 
have been deleted. Hybridising fragments detected with HYG, PAC and DPCDH probes are of the 
expected size. Numbers on the left indicate size in kb.
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4 .4 .2  O ne o f  the tw o  M E T 3  a lle le s  from CL B rener is  a p scu d o g en e
The single knockout cells were used to determine whether the two MET3 transcripts 
detected in wild-type RNA (Figures 4.9 and 4.33) are derived from the same or 
separate alleles. Total RNA was extracted from early stationary phase cultures of 
single knockout and wild-type cells, and compared in Northern blots probed with the 
MET3 coding sequence. Only one of the two transcripts is present in RNA from the 
single knockout, whereas two transcripts (with equal signal intensities) are detected 
in wild-type RNA (Figure 4.33A). This is consistent with the hypothesis that the two 
transcripts in the wild-type are derived from different alleles. The size difference 
between the two transcripts (estimated to be around 380 bp) could be due to alterna­
tive splicing of the two transcripts.
Western blot analysis was performed to compare the levels of MET3 protein in the 
wild-type and single knockout clones, and to confirm the null mutants no longer 
express any MET3. As expected, a strong band of 21 kDa was detected by the MET3 
antiserum in wild-type lysates of stationary phase cells, but not in lysates from null 
mutants (Figure 4.33B). Surprisingly, no MET3 protein was detected in the single 
knockout lysate (Figure 4.33B). Northern blot analysis shows that these cells lack the 
longer MET3 transcript. The levels of the shorter MET3 RNA transcript are the same 
in single knockout and wild-type cells (Figure 4.33A). These results suggest that the 
smaller transcript is not translated into protein, and that the MET3 protein in the 
wild-type is derived from only the larger transcript. One of the MET3 alleles thus 
appears to be a pseudogene, and the single knockout cells are functional MET3 null 
mutants.
154
A B
wt sko wt dko sko
Figure -4.33: The MET3-CL2 allele appears to he a pseudogene
(A) Total RNA from wild-type (wt) and MET3 single knockouts (sko) was analysed on Northern 
blots. A MF.T3 probe detects two transcripts in the wild-type, but only one in the single knockout. 
T his suggests that the two transcripts are derived from different alleles of MET3. (B) Western blot 
analysis of whole cell lysates from stationary cultures o f  wild-type (wt), double knockouts (dko) and 
single knockouts (sko) were analysed with the MET3 antiserum. MET3 protein is detected in wild- 
type, but is absent from the single- and the double knockouts. All lysates contained 4% metacyclic 
trypomastigotes. The blot was subsequently probed with an anti-P-tubulin antibody (TUB) to control 
for loading. Numbers on the left indicate molecular weight in kilo Daltons.
4.4.3 MET3 is not essential for metacyclogenesis
Since the MET3 protein is expressed only during metacyclogenesis, deletion of the 
MET3 gene was expected to have no effect on epimastigotes. Examination of epi- 
mastigote morphology by light microscopy revealed no differences between wild- 
type and MET3 knockout cells. MET3 dkol epimastigotes grew at the same rate and 
to the same density as wild-type epimastigotes (Figure 4.35B). MET3 dko2 cells 
grew marginally slower than the MET3 dkol and wild-type cells (not shown).
The MET3 double knockout cells were used to determine whether the MET3 gene, 
which is upregulated during metacyclogenesis in wild-type cells, is essential for
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development of metacyclics. To examine the effect of MET3 gene deletion on the 
ability of cells to produce metacyclics, wild-type and MET3 dkol and dko2 cells 
were induced to differentiate in vitro, using Grace’s insect medium (section 2.2.2). 
Initial analysis of the cell lines revealed that metacyclics were present in wild-type 
controls and in both the MET3 knockout cultures (Figure 4.34A). MET3 is therefore 
not essential for development of metacyclics. However, a quantitative comparison 
showed that the MET3 knockout cell lines produced significantly fewer metacyclics 
than the wild-type (Figure 4.34B). Wild-type cultures contained four times more 
metacyclics on average than MET3 dkol cells (11.1% in wild-type, compared to 
2.8% in dkol, t-test: p<0.001). Conversely, the number of intermediate forms in 
MET3 dkol cultures was more than twice that in wild-type cultures (Figure 29B; 
23.5% in dkol compared to 10.5% in wild-type, t-test: p<0.001). Interestingly, one 
in four dkol intermediates had an elongated nucleus and an anterior kinetoplast (type 
3 in Figure 4.34A; see also section 3.2). In the wild-type, less that one in ten inter­
mediates is of this morphological type. The number of epimastigotes was not signifi­
cantly different (78.3% in wild-type compared to 73.6% in dkol, t-test: p>0.2). This 
indicated that the same proportion of cells initiated differentiation, but the dkol cells 
progressed more slowly to the fully developed metacyclic form. The MET3 dko2 
cells also produced significantly fewer metacyclics than wild-type controls (Figure 
4.34B); 0.3% in dko2 compared to 11.1% in wild-type, t-test: p<0.001). Contrary to 
the results obtained with MET3 dkol cells, however, the MET3 dko2 cells did not 
show a significant accumulation of intermediate forms. These initial experiments 
thus showed that MET3 is not essential for the development of metacyclics, but 
revealed a difference in the rate of metacyclogenesis between wild-type and MET3 
knockouts. They also revealed slight differences between the two knockout cell lines.
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Figure 4.34: Differentiation o f  T. cruzi wild-type and M ET3 null mutants
(A) linage of cells from stationary culture of AY£7'i-dkol shows that these cells can develop to inter­
mediate forms and metacyclics (m). The image shows three types of intermediates which differ in the 
position of the kinetoplast relative to the nucleus, and shape of the nucleus (see also Table 3 .1): 
(I) kinetoplast on the side of a round nucleus: (3) elongated nucleus and anterior kinetoplast: 
(4) kinetoplast on the side o f elongated nucleus. A stationary epimastigote is also shown (e). Nuclear 
and kinetoplast DNA are stained with TOTO-3 (pseudo-coloured red). <H) Differentiation of cells to 
intermediate forms and metacyclics was determined in stationary phase cultures, eight days after 
addition of (¡race's medium, (iiemsa stained cells were scored based on morphology. Ihe two M hl 3 
knockout cell lines (dkol and dko2) produce significantly fewer metacyclics than the wild-type (WT). 
The dkol cells produce significantly more intermediate forms than W I . Each graph indicates the 
average percentage and the standard deviation in eight cultures. 200 cells were counted for each 
culture.
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To determine if impaired metacyclogenesis was a consequence of the loss of MET3, 
a copy of the gene was re-introduced into both knockout cell lines. Plasmid pTEX- 
MET3-9E10. which encodes full-length MET3, with the c-myc epitope 9E10 at the 
C-terminus, was used for transfection of knockout cpimastigotes. Expression of 
genes from the pTEX vector is constitutive, and high levels of the MET3-9E10 
protein were detected in Western blots from epimastigote lysates of transfected cells 
(Figure 4.35 A). Overexpression of the MET3-9F.10 protein did not affect cpimas- 
tigote growth rates (Figure 4.35B).
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Figure -i.JS: Expression o f  MET3-9EI0 protein in MET3 null muianis
(A) Epimastigotc protein lysates from different cell lines were analysed on Western blots, l ane I: 
wild-type; Iane2: MET3-dkol; lane 3: METJ-dkol pTEX-MET3-9EI0; lane 4: MET3-dko2; lane 3: 
MET} dko2 pTEX-MET3-9EI0. Upper panel: MET3 antiserum detects MET3-9EI0 in comple­
mented knockout cells (lanes .3 and 5). Non-transfected wild-type and knockout cells express no 
MET3 (lanes I, 2 and 4). I.ower panel: The same blot was probed with anti-p-tuhulin antibody as a 
loading control. (B) Overexpression of MET3-9EI0 does not alter the growth rate of epimastigolcs. 
Each point represents the average cell count from two experiments performed in triplicate. Error bars 
indicate standard deviations.
The MET3 dkol cells complemented with MET3-9E10 were analysed systematically 
for their ability to differentiate to metacyclics in vitro. Overexpression of MET3- 
9E10 clearly does not restore the rate of metacyclogenesis to wild-type levels. The 
proportion of metacyclics in the MET3-9E10 complemented cell line is similar to 
that observed in MET3 dkol cultures and significantly lower than in the wild-type 
controls (Table 4.2 and Figure 4.36). The MET3-9E10 complemented cell line pro­
duced slightly more intermediate forms than the wild-type (Figure 4.36), but the 
accumulation was not as marked as in MET3 dkol cultures (Figures 4.34B and 4.36). 
An accumulation of the intermediate cells with elongated nuclei was not apparent in 
the MET3-9E10 complemented cell line. Similarly, complementation o f MET3 dko2 
cells did not result in a noticeable increase in the number of metacyclics. This was 
not systematically quantified, however. In summary, these complementation experi­
ments do not support the hypothesis that it is the loss of MET3 that caused a reduc­
tion in the number of fully developed metacyclics.
Table 4.2: Differentiation ofT. cruzi WT. METi-dko! ami complemented celI line 
T cruzi wild-type (WT), MET3 null mutant (dkol), and dkol complemented with pTEX-MET3-9E10 
were assayed for their ability to differentiate in 20% Grace’s medium. Samples were taken six, eight 
and ten days after addition of Grace's medium, fixed and stained with Giemsa. 200 cells from each 
sample were counted to determine the relative proportion of epimastigotes, intermediates and meta­
cyclics. Each value represents the average percentage of the respective cell type as determined in two 
experiments performed in triplicate. Numbers in brackets indicate standard deviation.
cell type epimastigote intermediate metacyclic
DAY 6 8 10 6 8 10 6 8 10
WT 89.0(2.3)
79.8
(2.2)
77.1
(3.0)
5.6
(16)
9.2
(1.3)
11.0
(1.4)
5.4
(1.4)
11.0
(15)
11.9
(2.4)
dkol 86.8(3.1)
83.3
(18)
83.3
(3.4)
11.7
(3.2)
14.3
(1.4)
14.4
(3.9)
1.6
(0.7)
2.3
(0.8)
2.3
(0.7)
dkol
PTEX-MET3-9E10
87.6
(1.1)
88.3
(2.5)
88.1
(1.5)
11.3
(1.3)
10.8
(2.5)
10.3
(1.7)
1.1
(0.7)
0.8
(0.6)
1.6
(0.4)
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Figure 4.36 Expression o/MET3-9E10 in knockouts Joes not restore wild-type levels o f  metacyclics 
Differentiation o f cells to intermediate forms and metacyclic trypomastigotes in cultures of wild-type 
(WT), MET3 dkol and MET3 dkol pTEX-MET3-9E10. The MET3 knockout cells produce signifi­
cantly fewer metacyclics than the wild-type. The MET3 dkol cells complemented with MET3-9EI0 
produce equally low numbers of metacyclic trypomastigotes. Expression of MET3-9EIO thus does not 
restore the wild-type rate of mctacyclogenesis. Each graph indicates the average percentage and the 
standard deviations from six cultures. 200 cells were counted for each culture.
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4 .4 .4  M E T 3  is not e ssen tia l for c o m p le t io n  o f  the  T. c ru z i  life -c y c le
To verify whether the metacyclics that develop from MET3 knockout cells are 
genuine metacyclics, their ability to infect macrophages was tested in vitro. Qualita­
tively, no difference was observed between the wild-type and MET3 dkol cells in the 
time course and severity of infection when equal numbers of stationary phase cells 
were used to infect macrophages. Like the wild-type controls, MET3 dkol cells can 
invade macrophages, differentiate into amastigotes (Figure 4.37A-B), replicate intra- 
cellularly (Figure 4.37C-D), and emerge as trypomastigotes from the ruptured 
macrophages (Figures 4.37E-F and 4.38C-D).
These results show that MET3 is not essential for development of metacyclics and 
for completion of the life-cycle in vitro. The MET3 knockout mutants are able to 
produce metacyclics that are morphologically indistinguishable from wild-type 
mctacyclics, and they are able to infect macrophages in vitro, replicate as amas­
tigotes and develop into trypomastigotes. The two MET3 knockouts do show a 
significant reduction in the number of metacyclics, compared to wild-type, but ex­
pression of MET3-9E10 does not restore the rate of metacyclogenesis to wild-type 
levels. Furthermore, the two MET3 knockout cell lines dkol and dko2 are dissimilar 
with respect to the production of intermediate forms and the growth rate of epimas- 
tigotes. Therefore, it is very likely that factors other than the loss of MET3 caused the 
differences between clones.
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wild-type MET3 dko1
Figure 4.57: MET3 knockouts can complete the life-cycle in vitro
Mouse macrophages were infected in vitro with stationary phase T. cruzi wild-type or T. cruzi MF73- 
dkol cells as indicated. Representative DIC images of three time points are shown, merged with the 
corresponding images showing the l)NA (stained with IO I0-3, pseudo-coloured red) to visualise the 
T. cruzi kinetoplast and nucleus, and the macrophage nucleus. Panels A and H amastigotes inside a 
mouse macrophage 3 hours after infection. Panels ( ' and I): amastigotes six days after infection. The 
large number of amastigotes inside the macrophage indicates that intracellular replication has 
occurred. Panels E and f  trypomastigotes emerging from ruptured macrophages six days after infec­
tion. Scale bar = 2 pm.
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Figure 4.3X: Wild-type and MET3-</A»/ cell-derived trypomastigotes
Six days post infection, trypomastigotes are abundant in the supernatant of /'. crurz-infected macro­
phages. Wild-type trypomastigote populations are a mix of broad cells with a round nucleus (A) and 
slender cells with an elongated nucleus (B). Most A/ETJ-dkol trypomastigotes are broad (C and D). 
The mean length of nuclei in wild-type is 2.6 pm compared to 2 pm dkol (t-test: p<O.OOI, n 30). 
Panels on the left show kinetoplast <K) and nuclear DNA (N) stained with TOTO-3. Panels on the 
right are merged fluorescence and DIC images. Scale bar = 2 pm.
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4 .4 .5  N u c le a r  m o rp h o lo g y  in M E T 3  null m utants
Trypomastigotes from the supernatant of macrophage cultures infected with MET3 
knockout cells appeared smaller, and more stumpy than trypomastigotes from wild- 
type controls. Trypomastigotes in the mammalian host are pleomorphic, consisting of 
broad trypomastigotes, and slender trypomastigotes (Brener, 1973; Tyler and 
Engman, 2001). The significance of these different forms has remained controversial 
since their first description by Chagas in 1909 (Brener, 1973). Recent research has 
shown that the slender form precedes the broad form (Tyler and Engman, 2001). 
Microscopic examination of fixed MET3 dkol trypomastigotes cells revealed that 
these cells are predominantly broad, with round nuclei (Figure 4.38C-D). In wild- 
type trypomastigote populations on the other hand, a mix of slender cells with elon­
gated nuclei (Figure 4.38B) and broad cells (Figure 4.38A) are observed, similar to 
that described in the literature. To obtain a quantitative measure of the difference 
between the wild-type and the MET3 dkol trypomastigotes, the nuclei of fixed cells 
were measured. The average length of nuclei is significantly greater in wild-type 
than in MET3 dkol cells (mean in wild-type 2.6 pm compared to 2 pm in dkol, 
t-test: p<0.001, n = 30). It remains to be determined whether this accumulation of 
broad trypomastigotes in the MET3 dkol cells is due to the deletion of MET3 or a 
consequence of other differences between cloned cell lines.
In the nuclei of wild-type cells, MET3 expression coincides with elongation of the 
nucleus and dispersal of nucleolar antigens when epimastigotes differentiate to meta- 
cyclics. We therefore investigated whether MET3 is required for remodelling of the 
nuclear and nucleolar structure during metacyclogenesis (section 1.2.2). During 
exponential growth, the nuclei of MET3 knockout epimastigotes are round, with a 
single nucleolus, indistinguishable from wild-type nuclei (Figure 4.39A). As MET3 
knockout cells enter stationary phase, the nucleolar antigen L1C6 disperses (Figure 
4.39B), like in wild-type cells. Upon differentiation to amastigotes, the nucleus 
becomes round again, and a single L1C6 signal is clearly visible in the nucleolus of 
MET3 knockout cells (Figure 4.39C-D). These data show that MET3 is not necessary 
to cause dispersal of nucleolar antigens, and it is not essential for re-assembly of the
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nucleolus in amastigotes. Deletion of MET3 thus does not result in a readily dis­
cernible alteration to nuclear structure in epimastigotes, metacyclics and amastigotes.
In summary,
• We have generated MET3 knockout mutants.
• MET3 is not essential for development. Knockouts can differentiate to meta­
cyclics and complete the life-cycle in vitro.
• Knockouts do show a significant reduction in the number of metacyclics but 
expression of MET3-9E10 does not restore the rate of metacyclogenesis to wild- 
type levels.
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AFigure 4.39: Deletion o/M ET3 has no apparent effect on the dispersal and re-assembly o f the 
nucleolar antigen l. IC6
Images on the left show the merged fluorescence image of LIC6 antibody staining (pseudo-coloured 
red) and l'OTO-3 l)NA staining (pseudo coloured blue). Images on the right show merged images of 
fluorescence and DIC. (A) MET3-<\V.a\ epimastigotes in the log phase o f  growth have a clearly 
defined nucleolus, which is stained with the I.IC6 antibody. (B) In the nucleus of M£7\J-dkol 
epimastigotes in stationary phase, the LIC6 antigen is dispersed. A /£rj-dkol and dko2 stationary 
phase cells (including infectious forms) were used to infect mouse macrophages. Panels C and I) 
show amastigotes that subsequently developed inside the macrophage. The 1. IC6 antigen is con­
centrated again in a single nucleolus. (C) A/£T3-dkol amastigotes, (D) Af£7'3-dko2 amastigotes. 
Scale bar •  2 pm.
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4.5 D ISC U SSIO N
4.5.1 Identification and characterisation of MET3 from T. cruzi CL Brener: 
stage-specific expression and localisation
As a result of this study, we now have detailed information about the expression and 
subcellular localisation of the MET3 protein. MET3 was originally identified in a 
screen for RNAs that are upregulated during metacyclogenesis in T. cruzi strain 
Dm28c (Yamada-Ogatta et al., 2004). Here, we have identified and characterised the 
MET3 homologue of the genome reference strain T. cruzi CL Brener. Surprisingly, 
the MET3-CL coding sequence is slightly shorter than MET3-DM28c. Whether this is 
another example of the genetic diversity of T. cruzi, or due to a sequencing error in 
the MET3-Dm28c sequence remains to be investigated. Northern and Western blot 
analysis was used to show that up-regulation of MET3 expression during metacyclo­
genesis in the CL Brener strain follows a similar pattern to that described for the 
Dm28c strain (Yamada-Ogatta et al., 2004), where it was shown that MET3 protein 
is expressed in metacyclics, but not in log phase epimastigotes. In addition, we 
demonstrate specifically that in CL Brener cells, MET3 protein expression is induced 
before the repositioning of the kinetoplast has been completed. The expression of 
MET3 protein thus clearly distinguishes intermediates and metacyclics from sta­
tionary epimastigotes, and represents a marker for metacyclogenesis in T. cruzi 
strains from both lineages.
We extended protein expression analysis to include the mammalian stages of the 
parasite, which have not been studied in the Dm28c strain. Our immunofluorescence 
results show that in in vitro infection experiments, MET3 disappeared from T. cruzi 
cells soon after entry into the macrophage, but only after the morphological trans­
formation from metacyclic to amastigote had been completed. All macrophage- 
derived trypomastigotes examined in three separate experiments were negative for 
MET3 immuno-staining. A more comprehensive analysis may be undertaken in the 
future to confirm the observed pattern of MET3 expression in the mammalian stages 
by an independent method, for example by comparing the levels of RNA transcripts 
in these stages.
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Cell-derived trypomastigotes have a cell and nuclear morphology very similar to 
metacyclics, and both cell types are infective and non-replicating. However, they 
differ with respect to their commitment to the production o f amastigote forms (Tyler 
and Engman, 2001) and expression of surface proteins (Araya et al., 1994). They 
represent distinct life-cycle stages, but markers to distinguish between these cell 
types are scarce. MET3 represents a new metacyclic-specific marker and will be 
valuable in the study of the infectious forms of T. cruzi.
At present we can only speculate about the mechanisms that regulate MET3 expres­
sion. The results of this study show that stage-regulated MET3 protein expression in 
CL Brener correlates with differences in levels of MET3 RNA, similar to the 
observed pattern in Dm28c (Yamada-Ogatta et al., 2004). A number of stage-regu­
lated T. cruzi genes have been shown to contain regulatory elements within their 3’ 
UTR (D'Orso and Frasch, 2001a; Nozaki and Cross, 1995; Teixeira et al., 1995). 
Based on the size of MET3 transcripts in Northern blots, the estimated size of the 3’ 
UTR is 2.8 kb (Figure 4.9), and it is possible that the steady-state MET3 transcript 
levels are controlled by c/s-acting elements within this long 3’ UTR. Such elements 
may stabilise or destabilise MET3 mRNA in a stage-specific manner. However, 
epimastigotes contain detectable levels of MET3 transcripts, but no detectable pro­
tein (Figure 4.11). This indicates that MET3 expression is regulated at multiple 
levels. There is evidence to suggest that a number o f mRNAs, including MET3- 
Dm28c are selectively recruited to polysomes in differentiating cells (Avila et al., 
2001; Dallagiovanna ct al., 2001; Fragoso et al., 2003; Yamada-Ogatta ct al., 2004). 
The MET3 gene may provide a useful model to further dissect the mechanisms of 
metacyclic-spccific gene expression.
To investigate this further, reporter gene assays could be used to test the hypothesis 
that the MET3 3’UTR contains regulatory elements. This would involve transfection 
of T. cruzi with reporter constructs containing a reporter gene (such as luciferase) 
fused to fragments of the MET3 3’ UTR. Expression levels of different constructs in 
transfected T. cruzi could then be quantified and compared, to localise and identify 
regulatory sequence elements. A comparison between CL Brener and the MET3- 
Dm28c sequences could help to pinpoint conserved sequence elements (or possibly
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RNA secondary structures) that might be important in the regulation of MET3. How­
ever, the extent of the MET3-Dm28c 3’UTR is presently unclear. The MET3-Dm28c 
cDNA deposited in GenBank (metaciclina III, GenBank AF312553) contains both 
the spliced leader sequence at the 5’ end and a poly A tail at the 3’ end, implying that 
this corresponds to the entire mRNA sequence. However, this sequence is only 891 
bp in length, and thus only a third of the size of the CL Brener transcripts. The pub­
lished Dm28c Northern blots unfortunately lack size markers (Yamada-Ogatta et al., 
2004). It will be important to verify the size of the MET3-Dm28c transcripts experi­
mentally, before speculating about the significance of such a large difference in 
transcript length between the strains.
Interestingly, the MET3 knockout experiments suggest that MET3-CL2, is a pseudo­
gene. Wild-type cells contain two MET3 RNA transcripts that differ in size by an 
estimated 0.4 kb. Deletion of the MET3-CL1 allele resulted in a single-knockout cell 
line (skol), which produced only the shorter transcript, and expressed no detectable 
MET3 protein (Figure 4.33). We therefore hypothesise that the MET3 CL-2 trans­
cript is ira/w-spliced at a different position to MET3-CL1, resulting in a shorter 
transcript that is not translated. Amplification of the short MET3 transcript from skol 
by RT-PCR and sequencing of the resulting cDNA will determine whether this 
hypothesis is correct.
4.5.2 Evidence that MET3 associates with nucleolar components
The results from immuno-fluorescence studies presented here and transmission 
electron micrographs of T. cruzi Dm28c (Yamada-Ogatta et al., 2004) clearly estab­
lished that MET3 is a nuclear protein. This is consistent with the presence of mul­
tiple predicted NLS in the MET3 sequence (Figure 4.7). The authors of the Dm28c 
study report that MET3 specifically associated with condensed chromatin (Yamada- 
Ogatta et al., 2004) but given the low resolution of the presented EM images, and the 
lack of any biochemical data, it is not clear how this conclusion was reached. The 
detailed analysis of the subnuclear localisation of MET3 in CL Brener presented here 
provides several lines of evidence to suggest that MET3 is associated with nucleolar 
components.
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Confocal microscopy was used to gain information on the subcellular localisation of 
MET3. Successful purification of recombinant MET3 from E. coli and subsequent 
generation of a MET-specific antiserum provided a tool to visualise native MET3 in 
wild-type T. cruzi. In amastigotes early after macrophage infection, the nucleolus is 
visible in TOTO-3 stained nuclei as area of low DNA staining. In these cells, the 
MET3 signal was clearly confined to the nucleolus. In metacyclics and intermediate 
forms, nucleolar components become dispersed. In these cells, a dispersed MET3 
signal was observed, clustered in areas that stained weakly for DNA. The same 
pattern was observed when the cells were stained for the nucleolar antigen L1C6. 
The extent to which the dispersed antigens co-localise in a single cell remains to be 
determined. This could be achieved by using directly labelled primary antibodies for 
further studies (both MET3 and L1C6 antibodies were raised in mice), or by using a 
different antibody against a nucleolar protein.
In a second set of experiments, a number of transgenic T. cruzi cell lines were cre­
ated which expressed different tagged versions of MET3. Full-length MET3, tagged 
with either a c-myc epitope or GFP, localised exclusively to the nucleolus in epimas- 
tigotes, and the association of tagged MET3 with the nucleolar antigens L1C6 and 
NOG1 was shown directly in double labelling experiments. At the onset of stationary 
phase, these recombinant proteins dispersed in a pattern that was again extremely 
similar to that of L1C6 and native MET3. Because MET3 is not normally expressed 
in epimastigotes, localisation of recombinant MET3 to the epimastigote nucleolus 
does not prove that MET3 is functionally associated with the nucleolus in wild-type 
cells. However, the results from wild-type cells and from cells expressing recombi­
nant MET3 taken together provide strong evidence that MET3 associates with 
nucleolar components under a variety of conditions.
4.5.3 Identification of elements that mediate nucleolar targeting
To gain some insight into the domain structure of the MET3 protein, a number of 
fusion proteins were expressed in T. cruzi to identify elements in the MET3 sequence
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that direct nucleolar localisation. To our knowledge, this is the first detailed analysis 
of nucleolar targeting of a T. cruzi protein.
Expression of a number of fusion proteins identified two sequence elements, located 
at the N- and C-terminus respectively, which can direct GFP-fusion proteins to the 
nucleolus independently of each other (Figure 4.27). A consensus nucleolar localisa­
tion signal does not exist, and the signals that can direct proteins to the nucleolus are 
diverse (Melese and Xue, 1995). However, a number of cases have been documented 
where the domains critical for nucleolar localisation contain multiple clusters of 
basic amino acids (Hoek et al., 2000). The results obtained with the MET3 fusion 
proteins are consistent with this: The N-terminal sequence conforms to the consensus 
of a bipartite NLS, which is two clusters of basic residues separated by 9-12 spacer 
residues (Cokol et al., 2000). The C-terminal sequence also contains two clusters of 
basic residues, separated by 8 spacer residues. There are some similarities between 
the smallest MET3 fragment that conferred specific nucleolar localisation (construct 
14/6, which contains the last 46 amino acids of MET3), and a 32 amino acid domain 
that is sufficient for nucleolar targeting of T. brucei ESAG8 (Hoek et al., 2000). Like 
the C-terminal domain of MET3, this ESAG8 domain contains two clusters of basic 
residues, as well as hydrophobic and a small number of acidic residues. A second 
similarity between the targeting of MET3 and ESAG8 is the fact that all fragments 
tested show either exclusive nucleolar localisation or completely non-specific local­
isation.
A bipartite NLS is also contained within the first 40 amino acids of T. cruzi histone 
H2B. When this fragment was fused to GFP, the fusion protein (H2B40-GFP) local­
ised to the nucleolus in T. brucei (Marchetti et al., 2000) and T. cruzi (Elias et al., 
2001b), while full-length H2B localised to the nucleus (Marchetti et al., 2000). The 
nucleolar localisation of H2B40-GFP is considered to be an experimental artefact 
due to a serendipitous interaction of the fusion protein with unidentified nucleolar 
components. The miss-targeting of H2B40-GFP to the nucleolus highlights one 
caveat o f relying on a single reporter system to determine protein localisation 
(Marchetti et al., 2000). However, it appears highly unlikely that the localisation of 
the MET3 fusion proteins in the present study is due to a similar serendipitous inter­
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action for two reasons. First, two constructs with the c-myc epitope tag instead of 
GFP (constructs MET3-9E10 and 7/8), were also targeted to the nucleolus. By con­
trast, the association of histone H2B40-GFP with the nucleolus was completely 
abolished in an altered context, by fusing H2B40-GFP to P-Gal (Marchetti et al., 
2000). Second, wild-type MET3 in early amastigotes clearly localised to the nucle­
olus, confirming that the MET3 sequence contains the information for nucleolar 
targeting.
Targeting of proteins to membrane bounded organelles such as the mitochondrion, 
nucleus or glycosome typically relies on a specific targeting signal. By contrast, no 
membrane separates the nucleolus from the nucleoplasm. The current consensus is 
that nucleolar localisation is dependent on a protein’s interaction with other nucleolar 
components, and the sequences that mediate nucleolar localisation are more likely to 
act as retention signals rather than classical targeting signals (Carmo-Fonseca et al., 
2000; Melese and Xue, 1995). Based on sequence analysis that identified a region 
reminiscent to a RNA binding motif in the N-terminal half of MET3, we would 
speculate that interaction with a specific nucleolar RNA may cause MET3 to localise 
to the nucleolus. Since a C-terminal element can direct localisation independently, 
MET3 is likely to interact with a number of nucleolar components. Identification of 
factors that interact with MET3 will be a crucial next step in elucidating its function.
4.5.4 Functional analysis of MET3
As a result of genome sequencing projects, the complete catalogue of genes is now 
available for many organisms including T. cruzi. However, a large proportion of 
putative coding sequences have no known function (Hall et al., 2003). In the absence 
of any similarity to previously characterised genes, it is a major challenge for ‘post 
genomic’ research to assign a function to these novel genes. The description o f the 
subcellular localisation of the MET3 protein is a first step towards this goal.
It is important to note that the association of MET3 with nucleolar components does 
not automatically imply a role in ribosome biogenesis. Several exciting studies in 
recent years have put the nucleolus in the spotlight, as it emerged that the nucleolus
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is more than a ‘ribosome factory’. The nucleolus is also a site for modification and 
maturation of various small RNAs and ribonucleoprotein complexes (Gerbi et al., 
2003), and it plays a role in the control of cell proliferation and gene silencing 
(Carmo-Fonseca et al., 2000; Garcia and Pillus, 1999). Comprehensive studies of the 
human nucleolar proteome found that the function of nearly one third of the 271 
detected proteins is unknown, and many proteins in the nucleolus have no obvious 
function in ribosome biogenesis (Andersen et al., 2002; Scherl et al., 2002).
We have attempted to further elucidate the biological function of MET3 by transfec­
tion-based approaches. The results of our studies show that neither the deletion of the 
gene nor the over-expression of the protein results in an easily discernible phenotype. 
The most important question to ask was whether MET3 is essential for differentia­
tion. The answer is clearly negative. The results from the MET3 knockout experi­
ments show that metacyclics can develop in the absence of MET3 expression. These 
metacyclics are infective to macrophages, and can progress through the intracellular 
stages of the T. cruzi life-cycle. MET3 is therefore neither essential for production of 
metacyclics nor for the development of subsequent developmental stages in vitro.
The second question was whether MET3 plays an important role during metacyclo­
genesis, and whether manipulation of MET3 would affect the rate of differentiation. 
The two null mutant cell lines that were examined in detail both showed a significant 
and reproducible reduction in the number of metacyclics that developed compared to 
the parental wild-type population. Initially this suggested that MET3 might play a 
regulatory role during differentiation. If all the results are taken together, however 
two observations suggest that alternative explanations are more likely to account for 
this result.
First, the two MET3 knockout cell lines behave differently with respect to the pro­
duction of intermediate forms. The MET3 dkol cells accumulate high numbers of 
intermediate forms in stationary cultures. Such an accumulation of intermediate 
forms is not apparent in dko2 cells. Southern blots are consistent with a single inte­
gration of the targeting fragments into the MET3 locus and revealed no differences 
between dkol and dko2 cells. The genetic manipulation itself is thus unlikely to
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account for the differences between dkol and dko2. These differences could be due 
to variations between individual cells in the parental wild-type population. Clonal 
propagation of transfected cells would have brought such variations to light. During 
the process of transfection and selection, those cells that are able to proliferate under 
stress conditions have a strong selective advantage over those cells that readily and 
irreversibly differentiate to non-dividing metacyclics. The reduced rate of meta­
cyclogenesis in the dkol and dko2 cell lines may therefore be a consequence of this 
selection, and not caused by the loss of MET3. More importantly, expression o f  an 
ectopic copy of MET3 (MET3-9E10) failed to complement the phenotype of the 
knockouts. This also suggests that the reduced rate of metacyclic development in the 
null mutants was not caused by the deletion of MET3.
However, there are a number of potential technical problems that could account for 
the failure of pTEX-MET3-9E10 to complement the loss of MET3. The simplest 
explanation would be that the c-myc tag at the C-terminus of the protein interferes 
with its function. This can be tested by replacing MET3-9E10 with an untagged 
version of MET3. Two other important differences between the expression of native 
MET3 and expression of MET3-9E10 from the pTEX vector are the levels and the 
timing of expression. As Figure 4.35 shows, MET3-9E10 is expressed at very high 
levels in epimastigotes, and the presence of higher molecular weight bands indicates 
that there may be modified forms of the protein. There could be mechanisms for 
modifying the MET3 protein that prevent it from performing its function at the 
wrong time in the life-cycle. In short, expression of MET3-9E10 from the pTEX 
vector does not closely resemble wild-type MET3-expression. A better strategy for 
complementation of the null mutants may be the re-insertion of the MET3 coding 
sequence, flanked by the MET3 5’ and 3’ UTR, which are likely to contain the ele­
ments that mediate stage-specific expression. A neomycin phosphotransferase gene 
could be used for selection, and one of the two drug selectable marker genes already 
integrated in the MET3 locus could serve as a targeting sequence.
At present, we cannot exclude the possibility that integration of the knockout con­
struct may have affected the expression of genes flanking MET3. This could also 
explain why ectopic expression of MET3-9E10 does not complement the phenotype,
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yet provides no explanation for the differences between dkol and dko2 cells. At 
present, nothing is known about the expression of the protein kinase downstream, 
and the pyrroline-5-carboxylate dehydrogenase (P5CDH) upstream of MET3. 
Interestingly, studies on the effect of intermediary metabolites on T. cruzi 
differentiation discovered that substances which inhibit P5CDH also inhibit 
metacyclogenesis (Krassneret al., 1990, see also section 1.4.2). It might therefore be 
worth comparing transcript levels between wild type and knockout cells to see if 
there is any evidence of P5CDH down-regulation in the knockout cells.
A number of T. cruzi cell lines were generated that constitutively over-expressed 
c-myc and GFP tagged versions of MET3. The results prove that MET3 can be 
expressed at high levels in epimastigotes without any apparent deleterious effect on 
the cells. Over-expression of MET3-9E10 in MET3 knockout cells clearly did not 
affect the growth rate and the rate of metacyclogenesis (Figure 4.35). Epimastigotes 
that express tagged versions of MET3 in a wild-type background appeared no 
different from wild-type epimastigotes, which do not express any form of MET3. 
The rate of metacyclogenesis was not investigated systematically, since this cons­
titutive expression system was considered suboptimal to conduct such studies. By 
inserting the MET3 coding sequence into vector pTcINDEX (Figure 1.5), a vector 
(pTclNDEX-MET3) has now been constructed that facilitates tetracycline-inducible 
protein expression in a CL Brener cell line (Martin Taylor, submitted for publi­
cation). This will provide a system to study the effect of inappropriate MET3 
expression in a controlled manner.
4.5.5 Approaches to test the predicted nucleic acid binding activity and identify 
molecules that interact with MET3
The analysis of the knockout cell lines was complicated by the absence of a hypothe­
sis concerning the exact biochemical function of the MET3 protein. The specific 
subnuclear localisation of MET3 suggests that it can interact with one or several 
nucleolar components. MET3 may interact with nucleic acids or proteins, either 
individually, or as part of a larger ribonucleoprotein complex. It will be essential to
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identify those interacting factors in order to understand the biochemical function of 
MET3 and its role during metacyclogenesis.
Based on the results from sequence analysis presented in this study, it seems prob­
able that MET3 could bind RNA or DNA directly. The MET3 sequence has features 
characteristic of RNA binding proteins, yet it does not belong to any previously 
characterised protein family. With its basic nature (pi >11), and high proportion of 
serine and arginine residues, MET3 resembles proteins found in splicing or spliceo- 
some associated factors in metazoan cells, which are rich in SR dipeptides and often 
contain RRM domains (Bickmore and Sutherland, 2002; Bimey et al., 1993). Yet, 
MET3 is clearly distinct from the small number of trypanosomatid SR proteins with 
putative roles in /raws-splicing that have been described to date (Ismaili et al., 1999; 
Manger and Boothroyd, 1998; Portal et al., 2003). MET3 contains nine SR or RS 
dipeptides and a domain reminiscent of the RRM submotif RNP-1. It is not clear 
what constitutes a minimal SR domain, but most previously characterised proteins 
contain more than nine (Bimey et al., 1993). Moreover, structural predictions for 
MET3 are only partially compatible with the requirements for RRM domains. While 
their sequence conservation is low, the 3D structures of the RRM domains are highly 
conserved, and arranged in the order pi-al-P2-p3-a2-p4. RNP1 lies in the p3 
strand, and the conserved aromatic residues protrude from the p-shcet to interact 
with the RNA (Bimey et al., 1993). The RNP-1-like domain in MET3 is predicted to 
form a P-sheet, consistent with this conserved structure, but the predicted overall 2D 
structure predictions for MET3 do not fit the RRM domain structure. However, 
RNP-1 submotifs are also found in some RNA binding protein that are not of the 
RRM type (Bimey ct al., 1993).
To determine whether MET3 represents a novel type of RNA (or DNA) binding 
protein, it will be necessary to investigate its biochemical properties experimentally. 
As a result of the present study a number of expression constructs and cell lines are 
available that will facilitate these studies. Preliminary experiments have shown that 
when T. cruzi protein extracts are prepared at physiological salt concentration, a 
large proportion of MET3 is associated with the insoluble fraction. At high salt 
concentrations (0.5-1.2M NaCl) MET3 is completely soluble. This is consistent with
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nucleic acid binding activity. Simple in vitro binding assays, using single-stranded 
DNA or homoribopolymers (poly(A), poly(C), poly(G), poly(U)) could prove 
directly whether MET3 can bind to nucleic acids. Such approaches have been used to 
characterise a number of other trypanosomatid RNA-binding proteins, including 
Nopp44/46 (Das et al., 1996), p34/37 (Zhang and Williams, 1997) and members of 
the T. crnzi RRM type RNA-binding family, including TcUBPl (De Gaudenzi et al., 
2003). Preliminary experiments to test whether recombinant MET3 (expressed in E. 
coli) binds to ssDNA sepharose have so far provided no evidence for binding activity 
(data not shown). A wider range of conditions will have to be tested however, before 
definitive conclusions can be drawn. MET3 may be part of a multi-protein complex 
or require specific modifications in order to perform its function. It may therefore be 
necessary to use T. cruzi extracts rather than protein purified from E. coli.
Provided that nucleic acid binding activity is confirmed in vitro, the crucial and 
possibly most difficult step will be to identify the substrate to which MET3 binds in 
T. cruzi cells. A widely used PCR-based approach to identify RNA substrates that 
bind to a protein of interest is the SELEX method (Systematic Evolution of Ligands 
by Exponential enrichment) (Tuerk and Gold, 1990). An alternative approach allows 
the identification of mRNAs associated with a protein, using cellular extracts. This 
method combines an mRNA co-purification assay with differential display (Rodgers 
et al., 2002). Once candidate substrates have been identified, there is a variety of 
affinity-based methods to test the specificity of the interactions in detail, such as gel 
shift and RNA protection assays and Southwestern blot. To verify whether an inter­
action occurs in in vivo, RT-PCR can be performed on RNAs co-immunoprecipitated 
with the protein (see for example De Gaudenzi et al., 2003).
To gain further insight into the function of MET3, it will be important to identify 
proteins that interact with it. There are a number of methods to identify putative 
MET3 binding proteins, such as the yeast two-hybrid system, or co-immunoprecipi- 
tation. Since Western blot analysis suggests the presence of modified forms of MET3 
(Figure 4.24), and a number of potential phosphorylation sites in the MET3 sequence 
were identified we speculate that MET3 may be phosphorylatcd. Given the nucleolar 
localisation of MET3 and the presence of four potential casein kinase 2 (CK2) sites
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in MET3 (Figure 4.6), CK2 is a possible candidate. In many organisms, multiple 
nucleolar proteins are phosphorylated by CK2. In T. brucei, it has been shown that 
the CK.2 catalytic subunit CK2a accumulates in the nucleolus, and phosphorylates 
the nucleolar RNA binding Nopp44/46 in vitro (Park et al., 2002). Interestingly, it 
has been reported that in mammalian cells CK2 localises to the nucleolus specifically 
under conditions of stress (Gerber et al., 2000).
4.5.6 Does the T. cruzi nucleolus function as a stress-sensor?
In the course o f  studying the localisation of MET3, we discovered that the dispersal 
of nucleolar antigens is a feature common to all non-dividing T. cruzi cells, including 
stationary phase epimastigotes. This finding extends previous observations which 
reported the dispersal of nuclear antigens in trypomastigote nuclei (Elias et al., 
2001b). The results from this study provide no evidence that MET3 plays a causal 
role in the structural changes that occur in the nucleus during differentiation. Dele­
tion of MET3 did not result in any discernible alteration in nuclear morphology, and 
it did not affect the reversible dissociation of the nucleolar antigen L1C6 (Figure 
4.39). Conversely, overexpression of MET3 had no effect on the epimastigote 
nucleus, as judged by its appearance under the light microscope.
However, this finding raises interesting questions with regard to the signal that trig­
gers metacyclogenesis, and suggests experiments that may shed new light on the 
elusive mechanism. Alterations in nucleolar structure are a hallmark of cellular stress 
responses (Welch and Suhan, 1985). Nucleolar fragmentation occurs for instance in 
heat shocked (Liu et al., 1996), apoptotic (Wyllie et al., 1981) and senescent cells 
(Sinclair et al., 1997). A recent study has now proposed a convincing model which 
postulates that the nucleolus itself functions as a cellular ‘stress sensor’ (Olson, 
2004; Rubbi and Milner, 2003). Cells respond to a variety of cellular stresses with 
the stabilisation of the tumor suppressor p53, which induces cell cycle arrest or 
apoptosis. The mechanism by which a diverse range of stimuli can trigger p53 stabi­
lisation has long eluded researchers. Rubbi and Millner (2003) showed that the sta­
bilisation o f p53 is correlated with nucleolar disruption and nucleolar disruption
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alone is able to stabilise p53. In other words, nucleolar disruption is the common 
mechanism by which cellular stress triggers the protective p53 response.
Based on this concept of a ‘cellular stress sensor’ it is tempting to speculate that the 
disassembly of the nucleolus might provide a crucial signal required to trigger meta­
cyclogenesis. A variety of different conditions has been shown to promote metacy­
clogenesis (section 1.4.2). Yet, despite thorough investigations in a number of 
laboratories, a signal that is both necessary and sufficient to trigger differentiation 
has not been defined. However, the common denominator of metacyclogenesis in­
ducing conditions is that they are highly likely to induce cellular stress. The 
following observations correlate conditions that promote metacyclogenesis with the 
impairment of nucleolar structure and function. First, in our studies, the dispersal of 
nucleolar antigens, and the development of metacyclics coincided at the beginning of 
stationary phase. Second, a previous study has shown that transcription of ribosomal 
DNA is strongly down-regulated in all non-dividing T. cruzi cells, including meta­
cyclics and cell-derived trypomastigotes (Elias et al., 2001b).
In order to gain mechanistic insight into metacyclogenesis, it will be important to 
determine whether nucleolar disruption occurs under all conditions that induce meta­
cyclogenesis, and to test whether metacyclogenesis can be induced directly by 
causing nucleolar disruption. There are a number of physical and chemical agents 
that disrupt the nucleolus in other cells, including heat shock, the anti tumor drug 
camptothecin (a topoisomerase I inhibitor), 5,6-dichloro-l-P-D-ribofuranosyl- 
benzimidazole (DRB, a casein kinase II inhibitor) and bleomycin (Rubbi and Milner, 
2003). It will be interesting to test these for their effect on T. cruzi epimastigotes.
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5. THE M E T 2  GENE
The MET2 gene was identified in a screen for RNA transcripts that are upregulated 
in metacyclics in the T. cruzi strain DM28c (Krieger et al., 1999; Yamada-Ogatta et 
al., 2004). The corresponding protein appears to be associated with the kinetoplast of 
metacyclics in this strain (Yamada-Ogatta et al., 2004). Its function is unknown, as 
there is no apparent relatedness to other genes. Our aim was to determine if MET2 is 
also a marker for metacyclics in the CL Brener strain, and to use transfection-based 
approaches to investigate the function of MET2. Section 5.1 describes the identifica­
tion of MET2 homologues from T. cruzi CL Brener, which are located adjacent to the 
putative centromere of chromosome 3 (Obado et al., in press). The level of MET2 
RNA increases dramatically during metacyclogenesis (section 5.2). MET2 therefore 
represents another useful marker in further analysis of T. cruzi differentiation in the 
CL Brener strain. To address MET2 function, we aimed to create null mutants. This 
requires deletion of three copies of MET2 from the CL Brener genome. Section 5.3 
describes the successful generation o f MET2 double knockout cell lines. Preliminary 
results concerning the localisation o f the MET2 protein in CL Brener (Section 5.4) 
are consistent with an association with the kinetoplast.
5.1 CHARACTERISATION OF MET2 FROM CL BRENER
5.1.1 Identification of two distinct MET2 alleles
To identify and analyse the CL Brener homologues of MET2, we employed essen­
tially the same strategies as for the identification of MET3 (sec chapter 4). BLAST 
searches of GcnBank and GeneDB using the MET2 cDNA sequence from T. cruzi 
strain Dm28c (metaciclina II, GenBank: AF312552) found two CL Brener cosmids 
from the T. cruzi genome project that contain the MET2 locus (Figure 5.1). The 
cosmids were derived from chromosome 3 (Andersson et al., 1998). Sequence diver­
gence between the two cosmids indicated that they were probably derived from two 
different homologucs o f chromosome 3. Throughout this work, the MET2 sequences 
from CL Brener are referred to as MET2-CLlol7 and MET2-CL39p3, according to
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the identifier of the respective cosmid clone. The MET2 gene from strain Dm28c is 
referred to as MET2-Dm28c. A pair-wise comparison of MET2-CLlol 7, MET2- 
CL39p3 and MET2-Dm28c revealed a nucleotide identity of 96% between each pair. 
This level of heterogeneity between allelic copies was also found in the MET3 gene 
(section 4.1.1), and similar values have been reported for a number of other CL 
Brener genes (Bromley et al., 2004; Machado and Ayala, 2001; Tran et al., 2003). In 
addition to nucleotide mismatches scattered throughout the MET2 gene, the inter- 
genic sequences also contain frequent deletions and insertions (Figure 5.1), including 
a 0.3 kb insertion in the MET2-39p3 locus, close to the 5’ UTR (Figure 5.3B). These 
sequence differences allowed the design of allele-specific targeting vectors for gene 
deletion by homologous recombination (section 5.3). More significantly, we found a 
frameshift in the MET2-Dm28c ORF relative to the ORF common to both CL Brener 
alleles. The frameshifl is caused by the insertion of a thymine at position 666 in 
MET2-Dm28c, which is not present in either of the two CL Brener alleles (Figure 
5.1). This was confirmed experimentally by sequencing PCR fragments derived from 
CL Brener genomic DNA. Downstream of the frameshift, the MET2-Dm28c se­
quence is still highly similar to the CL Brener sequences, including a TAG codon at 
position 884, which aligns with the predicted stop codon in the CL Brener sequences. 
There is a strong possibility that the MET2-Dm28c sequence in the database contains 
a sequencing error.
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loi 7 
39p9 
Dm2 8 c
GACACATTCAGTATCAGTAAGAGAGAATTCGTGTGTTTTCA -1
...........................................  -1
ACAGTTTCTGTACTATATT.....................................C ..... 60
1017 
39p9 
Dm2 8 c 
PCR
ATQATTCCCTGCCGCTCCAACCAACAACAGCATCAAAACATCTCCAAAACGAGGCGAAGC 6 0
ATG...............................................T ......G ....  60
ATO...............................................T ......G ..... 120
loi 7 
3 9p9 
Dm28c 
PCR
GCTTATAACTTTACGGACTTTTGCGACGGACGAAATTCATCTGCACCGATGCGTTCTGTC 120
1017
39p9
Dm28c
PCR
GTTGCTGGCGACGCTGGAAAGGAGCAATGTTCACAGCAGCAGAATGGTGATTTGGTTGTC 180 
............A ......................................... GC....... 180
loi 7 
39p9 
Dm2 8 c 
PCR
ATGACTGATATCATGGAAAGAACAGGTGCATCCACATCTGCCGAACGTGAAACGAATTGC 24 0
1017 
39p9 
Dm2 8 c 
PCR
AGTGAACGTTCTTTGCTAGAGGACAATATAATTCCGGTGTTAAGCATGAGCGAACTTACA 300
loi 7 
3 9p9 
Dm28c 
PCR
ACAGTGTGTCCACAATTCATCGCTACACCGACCATCGCCACCCCAAATACCCCCAATTGT 360
1017
39p9
Dm28c
PCR
TCTCATTTTAATGCTGCCACTCCTTGTTTGGAGAAATCGCCATTATTATCCTCTTCTTTT 4 20
1017 
3 9p9 
Dm28c 
PCR
TCTGCTTCGCCGTCAGGATGCGAAGATGAAAAAAGTCTGGGATATTCTGCAGCTGTCTTT 4 80
loi 7 
3 9p9 
Dm2 8 c 
PCR
GAATCCGATGGAGAGAAGGATGATGACTGTGATTCCTTGAAAAGCGCTGACAAAACTAAA 54 0
loi 7 
3 9p9 
Dm28c 
PCR
CTCAAGGCACCTTATCTCATTAACAAATCCCCTGGCTCCATTGCTGCAATTGAATTGGCG 600
loi 7 
3 9p9 
Dm28c 
PCR
TTGTT - GACAAACTCAAAGGAGGATGAGCATACGCAGTCGGATGGGGCATGCTCGATTGA 6 59
loi 7 
3 9p9 
Dm28c
CAAGGATTTGGAGTCTGCACTGGAGGAACAAGGGGGTTACGOCACCTGGAACTTGGTGAC 719
loi 7 
3 9p9 
Dm2 8 c
GTCGCGTCTGAAAGCAGTGCATCTTCGTCACATGGCGCACAAGTATGCATTGGAAGTTGT 779
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lol 7 
39p9 
Dm2 8 c
TCGTCAACGCTATGGAGGCAGGATTATAGATGATTCATCTAAGTAOCTTTTAAAGGACAT 83 9
G TAGT
TAGT
839
900
lol 7 
39p9 
Dm28c
TGTGATTTGTGCTATGGAGGAGGATTCTTCTCCCTTTTCCCTTTTGTTTGAAAAGAAAAG 8 99 
...............................................................-- 897
A AAAAAAAAAA 960
lol 7 
39p9 
Dm2 8 c
AAAAAAAACACGTGCCTTGAGAG T T T T T T T T T T T G C G T G T C T T T T G  95Q
CC........C ............  957
970
GTTGTTTTT
AAAAAAAAAA
lol 7 
39p9
-TTTTTT 1009
G T G GG 1017
lol 7 
39p9
GTTTGCGTGTTTGTGCCTTTCCCTCCTTTTTTTTTTTTTTTTTTTTTTGGGGGAA - AT AT 106 8 
............. G .......... GG....................... TT.A. . .T. . . . 1077
lol 7 
39p9
ATATTTATATTTAAATATTTTTATATAGTAAAATAAAAAAATATTATTATTATTATTATT
............. T ..................T...T.C.T.....................
1128
1137
Figure 5.1: Alignment o f  MET2 DNA sequences
The MET2 gene was found on two cosmids derived from T. cruzi CL Brener chromosome 3: cosmids 
l o l 7 (GenBank:AF052831, Andersson et al., 1998) and 39p3 (GenBank: AC096913). Sequence 
divergence indicates that they are derived from two different homologues o f  chromosome 3. This 
sequence alignment compares the CL Brener genomic sequences with the cDNA sequence of MET2- 
Dm28c (metaciclina //, GenBank:AF312552) and a fragment obtained by sequencing a cloned PCR 
fragment from CL Brener (PCR). The predicted start and stop codons of the MET2 gene are marked 
with bold letters. This alignment reveals a frameshift at position 666 in MET2-Dm28c (highlighted). 
The spliced leader sequence at the 5' end, and the putative poly-A tail at the 3* end of the MET2- 
Dm28c cDNA sequence are underlined. Sequencing o f a RT-PCR derived cDNA fragment of MET2- 
C Ll (section 2.3.3) confirmed the splice acceptor site. Note how the putative poly-A tail in MET3- 
Dm28c aligns with an A-rich stretch in the genomic sequences from CL Brener. A dot (.) denotes 
nucleotides identical to the MET2CL-lo/7 sequence. Gaps are marked with a dash (-). Two potential 
regulatory ARE motifs downsstream of MET2 are highlighted in grey.
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5.1.2 The MET2 gene is located adjacent to the putative 
centromere of chromosome 3
Both cosmids spanning the MET2 genomic locus are derived from chromosome 3. 
(Andersson et al., 1998). In CL Brener, this chromosome is present in three copies, 
which differ in size. A smaller homologue of approximately 0.6 Mb is present in two 
copies. CL Brener cells harbour an additional larger homologue of approximately 
1 Mb, which is present in only one copy (Obado et al., in press). The nature of the 
400 kb insertion remains to be characterised. The size difference between homo­
logous chromosomes may reflect the fact that CL Brener is a hybrid strain (Machado 
and Ayala, 2001).
To confirm the chromosomal location of MET2 experimentally, Southern blots of CL 
Brener chromosomes separated by pulse field gel electrophoresis, were hybridised 
with a MET2 probe. The result shows that both the 0.6 Mb and 1 Mb homologues of 
chromosome 3 contain the MET2 gene and that no closely related sequences are 
found on other chromosomes (Figure 5.2). In T. cruzi Dm28c, MET2 hybridised only 
to a 0.65 Mb chromosome (Yamada-Ogatta et al., 2004). Southern blot analysis of 
genomic DNA, probed with the MET2 coding sequence, shows that MET2 is a 
‘single copy gene’, with three allelic copies in CL Brener (Figure 5.3A). The MET2 
probe detects two bands in genomic DNA digested with restriction enzymes that do 
not cut within the MET2 coding sequence. A fainter band corresponds to the MET2 
gene on the 1 Mb chromosome, and a stronger band corresponds to the MET2 gene 
on the 0.6 Mb chromosome, which is present in two copies. This interpretation is 
consistent with the restriction maps derived from genomic sequence information 
(Figure 5.3B and data not shown). It is also supported by analysis of DNA from 
single knockout mutants (section 5.3), where deletion of MET2 from the 1 Mb chro­
mosome results in the disappearance of the weaker band from genomic Southern 
blots (Figure 5.9).
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Figure 5.2: Localisation o/MET2 on chromosome 3 (CHEFE)
Chromosomes o f T. cruzi CL Brener were separated by CHEFE (lane 1). Saccharomyces cerevisiae 
chromosomes were run as size markers (lane M). A blot of the gel, probed with the MET2 coding 
sequence. This shows two bands that correspond to the 0.6 Mb and 1 Mb homologues o f  chromosome 
3 (lane 2). Numbers on the left indicate size in megabases (Mb).
Figure 5.3 (overleaf): Restriction map o f the MET2 locus
Genomic DNA from T. cruzi CL Brener was digested with restriction enzymes as indicated above 
each lane. (A) Southern blot probed with MET2. The banding pattern is consistent with a single copy 
gene with three alleles. The fainter band is derived from MET2-CL39p3 (present in one copy), the 
stronger band from MET2-CLIol7 (two copies). Numbers on the left indicate size in kb. (B) Restric­
tion map of the MET2-CLIol7 locus, derived from genomic sequence information and confirmed by 
the Southern blot. Numbers indicate nucleotide positions. The first nucleotide in the MET2 start codon 
was designated position *1’. The site of a 0.3 kb insertion in the MET2-CL39p3 locus is indicated. An 
A'ho 1 site contained within this insertion is marked (X).
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Analysis of a 93.4 kb genomic contig that spans the MET2 locus (Andersson et al.,
1998) revealed an interesting location of the MET2 gene (Figure 5.4), in close 
proximity to the putative centromere (Obado et al., in press). The arrangement of 
genes in large polycistronic transcription units is a peculiar feature of kinetoplastid 
genomes (section 1.6.1), which may be related to the mechanisms by which gene 
expression is controlled. The coding sequences contained within the 93.4 kb contig 
are arranged in two directional clusters, which are transcribed in opposite directions 
(Andersson et al., 1998). The point at which the transcription units diverge is referred 
to as the strand switch region. Interestingly, the MET2 gene lies very close to this 
strand switch (Figure 5.4). MET2 is the second gene in the cluster on the shorter arm 
of the chromosome, and the MET2 ORF is flanked on either side by long intergenic 
regions of low sequence complexity. The intergenic sequence downstream of MET2 
is characterised by repeats consisting mainly of A and T. These include single 
nucleotide runs (mainly T), runs o f AT dinucleotides, and repeated units of patterns 
of up to 8 nucleotides were identified using the program Repeat Finder (Benson,
1999) .
The strand switch region (approx 20 kb) is made up largely of degenerate retro- 
elements and the DNA sequence is characterised by a high GC content (Andersson et 
al., 1998; Ghedin et al., 2004). This region has recently been shown to comprise a 
putative centromere, i.e. the element that confers mitotic stability (Obado et al., in 
press).
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(A) Schematic representation of chromosome 3 from T. c ru zi CL Brener. Chromosome 3 is trisomic in this strain. A smaller homologue of 0.6 Mb is present in two 
copies, and a larger homologue of 1 Mb is present in one copy. Black double arrows represent telomeric repeats. Open arrows indicate the position o f  the Strand 
sw itch, and show the direction of transcription. The 16 kb strand switch region is composed predominantly of degenerate retroelements (hatched boxes) belonging to 
the VIPER SIRE and LITc families (Obado et al., in press). (B) Enlarged view of the strand switch region of chromosome 3 which contains the putative centromere 
(Obado et al.. in press). Coding sequences (blue arrows) cluster on the same strand, and the strand switch separates two divergent clusters. M E T2 is the second gene 
on the short arm of chromosome 3. The M E T2 ORF is flanked on either side by approximately 5 kb of intergenic sequence. The chromosome 3 specific genes G P I  
and i 'P I  were used as probes in Southern blots.
5.1.3 MET2 is only found in T. cruzi
The gene order in trypanosomatids is highly conserved (Bringaud et al., 1998; 
Ghedin et al., 2004). The first large-scale comparative study o f kinetoplastid chro­
mosomes found a high level of synteny between T. cruzi, T. brucei and L. major 
chromosomes, and identified chromosomal segments homologous to the T. cruzi 
chromosome 3 strand switch region on L. major chromosome 12 and T. brucei 
chromosome 1 (Ghedin et al., 2004). Despite this high conservation of genes be­
tween kinetoplastid species, we found no sequences related to MET2 in the syntenic 
loci o f  T. brucei and L. major. MET2 is located on the shorter arm of T. cruzi chro­
mosome 3 (to the left of the strand switch, see Figure 5.4), where more divergence 
was observed between the species than on the longer arm (Ghedin et al., 2004). 
Searches of kinetoplastid genomes in GeneDB have identified no sequences that 
appear to be related to MET2, other than the CL Brener alleles. Similarly, BLAST 
searches of GenBank have identified no sequences similar to MET2 in any other 
organisms. MET2 is thus another T. cn/z/-specific gene.
5.1.4 MET2 protein sequence analysis
The derived sequence of the CL Brener MET2 protein is 274 amino acids long, with 
a calculated mass of 29.8 kDa, and a pi of 5.13. The protein sequence derived from 
MET2-Dm28c (GenBank: AAK37448) contains only 208 amino acids. When the 
reading frame of the MET2-Dm28c gene is shifted at position 666 (where this 
sequence contains an additional thymine not present in CL Brener; Figure 5.1), trans­
lation of nucleotides 677 to 886 results in a protein sequence nearly identical to the 
predicted CL Brener MET2 protein (Figure 5.5). This is a further indication that the 
frameshift in the MET2-Dm28c cDNA sequence may be due to a sequencing error.
Bioinformatic analysis of the MET2 amino acid sequence shows that the protein is 
rich in serines (12.8%). There is a strikingly regular spacing o f cysteines (H2N-3-C- 
23-C-21-C-29-C-22-C-16-C-8-C-17-C-22-C-46-C-57-COOH). These arc predicted 
to form five cysteine bonds (Vullo and Frasconi, 2004). Since cysteine bonds arc 
usually found in extracellular and membrane proteins, and MET2 contains no high-
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scoring hydrophobic or transmembrane segments, the relevance of this prediction is 
uncertain. A Prosite scan identified only patterns that occur frequently in any protein, 
and no conserved motifs. PSORT II predicts mitochondrial or nuclear localisation 
with similar probabilities. A cleavage site for mitochondrial pre-sequence is found at 
position 29 in MET2-CLlol7 (RRS|AY) and at position 28 in MET2-CL39p3 and 
MET2-Dm28c (TRG|SD). Mitochondrial localisation is also predicted by the 
program TargetP (Emanuelsson et al., 2000). MET2 contains no predicted nuclear 
localisation signals. In short, sequence analysis supports a possible mitochondrial 
localisation of MET2. The likely biological function of MET2 cannot be easily 
inferred from sequence analysis.
CLlol7 MIPCRSNQQQHQNISKTRRSAYNFTDFCDGRNSSAPMRSVVAGDAGKEQCSQQQNGDLVV 60
CL39p3 ............... N..G.D___ E .......... V .......T ............ A.. 60
Dm28c ............... N..G.D................ S ........... F....... A.I 60
CLlol7 MTDIMERTGASTSAERETNCSERSLLEDNIIPVLSMSELTTVCPQFIATPTIATPNTPNC 120
CL39p3 ...........................K..K........F.......W .... A ..... F 120
Dm2 8 c .............. D........... K.S.........F.......VV............. 120
CLlol7 SHFNAATPCLEKSPLLSSSFSASPSGCEDEKSLGYSAAVFESDGEKDDDCDSLKSADKTK 180
CL39p3 , Y..... C..R....... Y............................ V......... 180
Dm2 8 c .Y..... F........ P.............................. V.... G... 180
CLlol7 LKAPYLINKSPGSIAAIELALLTNSKEDEHTQSDGACSIDKDLESALEEQGGYGTWNLVT 240
CL39p3 ....... T............................. G ............... H... 240
Dm28c ....... T........... FDKL.GG* 208
Dm28c (2 ) .............................S.H... 240
CLlol7 SRLKAVHLRHMAHKYALEVVRQRYGGRIIDDSSK* 274
CL39p3 ........................D....... ♦ 274
Dm28c (2) ................................. * 274
Figure 5.5: Alignment o f predicted MET2 protein sequences
C L Iol7  and CL39p3 are translations of two distinct MF.T2 alleles from T cruzi Cl. Brener. I)m28c 
corresponds to GenBank entry AAK37448 (translation of nucleotides 1-687 of the MKT2-I)m28c 
cIJNA, reading frame I). Dm28c (2) is the translation of nucleotides 667-886 of the MLT2-I)m28c 
cDNA (reading frame 2). This alignment suggests that the truncation of MliT2-l)m28c relative to the 
CL Brener sequences could he due to a simple sequencing error. A dot (.) denotes amino acids identi­
cal to the CL-lol 7 sequence. A star (•) denotes a stop codon.
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scoring hydrophobic or transmembrane segments, the relevance of this prediction is 
uncertain. A Prosite scan identified only patterns that occur frequently in any protein, 
and no conserved motifs. PSORT II predicts mitochondrial or nuclear localisation 
with similar probabilities. A cleavage site for mitochondrial pre-sequence is found at 
position 29 in MET2-CLlol7 (RRS|AY) and at position 28 in MET2-CL39p3 and 
MET2-Dm28c (TRG|SD). Mitochondrial localisation is also predicted by the 
program TargetP (Emanuelsson et al., 2000). MET2 contains no predicted nuclear 
localisation signals. In short, sequence analysis supports a possible mitochondrial 
localisation of MET2. The likely biological function of MET2 cannot be easily 
inferred from sequence analysis.
CLlol7 MIPCRSNQQQHQNISKTRRSAYNFTDFCDGRNSSAPMRSVVAGDAGKEQCSQQQNGDLVV 60
CL39p3 ................N..G.D....E.......... V .......T ............ A.. 60
Dm28c ................N..G.D................. S ........... F....... A.I 60
CLlol7 MTDIMERTGASTSAERETNCSERSLLEDNII PVLSMSELTTVCPQFIATPTIATPNTPNC 120
CL39p3 ............................K..K........ F....... W .....A .....F 120
Dm2 8 c ...............D ........... K.S......... F....... VV............  120
CLlol7 SHFNAATPCLEKSPLLSSSFSASPSGCEDEKSLGYSAAVFESDGEKDDDCDSLKSADKTK 180
CL39p3 . Y ......C..R........ Y ............................... V .........  180
Dm28c . Y ......F......... P................................. V .....G... 180
CLlol7 LKAPYLINKSPGSIAAIELALLTNSKEDEHTQSDGACSIDKDLESALEEQGGYGTWNLVT 240
CL39p3 ........ T ................................ G .................H... 240
Dm28c ........ T ............ FDKL.GG* 208
Dm28c(2)  S.H... 240
CLlol7 SRLKAVHLRHMAHKYALEVVRQRYGGRIIDDSSK* 274
CL39p3 .......................... D ........ * 274
Dm28c(2) .....................................* 274
Figure 5.5: Alignment ofpredicted MET2 protein sequences
CLIol7 and CL39p3 are translations of two distinct MET2 alleles from T. cruzi CL. Brener. Dm28c 
corresponds to GenBank entry AAK37448 (translation of nucleotides 1-687 o f  the MET2-Dm28c 
cDNA. reading frame I ). Dm28c (2) is the translation o f nucleotides 667-886 o f  the MET2-Dm28c 
cDNA (reading frame 2). This alignment suggests that the truncation o f MET2-Dm28c relative to the 
Cl. Brener sequences could be due to a simple sequencing error. A dot (.) denotes amino acids identi­
cal to the CL-lol 7 sequence. A star (*) denotes a stop codon.
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5.2 MET2 RNA TRANSCRIPTS ARE UPREGULATED DURING 
METACYCLOGENESIS
MET2 was initially identified in a screen for RNA transcripts that are enriched in 
metacyclics of T. cruzi strain Dm28c (Yamada-Ogatta et al„ 2004). We established 
by Northern blot analysis that MET2 is also upregulated in CL Brener cells in sta­
tionary phase (Figure 5.6). The stage-specificity of MET2 RNA transcripts is rather 
striking. A band of approximately 5 kb hybridises strongly with RNA samples from 
cultures containing 24% metacyclics but only very weakly with those containing 6% 
metacyclics, and no signal is detected in epimastigote RNA. This resembles closely 
the pattern observed in strain Dm28c, where MET2 RNA detected exclusively in 
fully developed metacyclics (Yamada-Ogatta et al., 2004). The MET2 RNA tran­
script thus represents a very specific marker for T. cruzi metacyclics.
Interestingly, the estimated size of the MET2 transcript detected in Northern blots of 
CL Brener RNA is considerably larger than the size of the MET2-Dm28c cDNA 
deposited in GenBank, which is only 970 bp. The MET2-Dm2Hc cDNA from the 
database contains both the spliced leader sequence at the 5’ end and a poly A tail at 
the 3’ end, suggesting that it represents the entire mRNA sequence. However, when 
this cDNA sequence is aligned with the CL Brener genomic sequences spanning the 
MET2 locus, the putative poly-A tail of MET2-Dm28c aligns with an A-rich stretch 
of genomic sequence (Figure 5.1). The method used to clone the MET2 cDNA from 
the Dm28c strain involved synthesis of the first cDNA strand using an oligo-dTu 
primer (Krieger and Goldenberg, 1998). Since this primer will bind to stretches of A 
nucleotides as present in the 3’UTR of MET2, it is very likely that the reported 
MET2-Dm2Hc ‘cDNA' sequence represents a truncated fragment.
The factors regulating the stage-specificity of MET2 RNA levels remain to be deter­
mined. It is interesting to note that the derived 3’ UTR of MET2-lol7 contains 
several AU rich sequences in its 3’UTR. In the intergenic sequence downstream of 
the MET2 stop codon, a total of nine AU-rich sequences were found that correspond 
either to the AUUUA motif or the UUAUUUA(U/A)(U/A) motif (Chen and Shyu, 
1995). The two AUUUA motifs closest to the stop codon are highlighted in Figure
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5.1. AU-rich elements (ARE) are cis- acting elements in the 3’UTR that regulate 
gene expression in a number of eukaryotes, including T. cruzi (Chen and Shyu, 1995; 
Di Noia et al„ 2000). Whether they are involved in the stabilisation of the MET2 
transcript is an open question.
Figure 5.6: Stage-specific expression »/MET2 RNA
Northern blot analysis of RNA extracted from cultures containing different proportions o f meta- 
cyclics. I.ane I: log-phase epimastigotes; lane 2: 6% metacyclics; lane .1: 24% metacyclics. (A) A 
transcript of approximately 5 kb is detected with a MF.T2 probe in samples containing 24% meta­
cyclics. A faint 5 kb band is also seen in the sample containing 6% metacyclics. No MET2 transcript 
is detected in epimastigote RNA. (B) gpH2. a gene known to be upregulated in metacyclics. (C) RNA 
loading was controlled by ethidium bromide staining of the ribosomal RNA bands (I8S, 24Stt and 
24SP) prior to blotting. lOpg RNA was loaded per lane. Numbers on the right indicate size in bases.
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5.3 GENERATION OF MET2 DOUBLE KNOCKOUT CELL LINES
To address the function of MET2 in metacyclics, we aimed to generate MET2 null 
mutants. The only available method to generate a loss of function mutant of an un­
characterised gene in T. cruzi is by gene deletion, which is a very slow process in this 
organism. Since MET2 is not expressed in epimastigotes, it seems unlikely that this 
gene will be required for cell survival and replication in the epimastigote stage. It 
was therefore deemed feasible to delete all three alleles from the genome. This sec­
tion describes the successful generation o f several double knockout clones. In these 
cells, two copies of MET2 were deleted from the genome of T. cruzi CL Brener by 
successive replacement with drug selectable marker genes (Figures 2.2 and 5.7). The 
sequences flanking the MET2 ORF are divergent between the different alleles, and 
each construct was designed to target a specific allele.
Figure S. 7: Strategy used to delete the MET2 gene
(A) The selectable marker gene (e.g. NEO) is flanked by (JAPDH intergenic sequences (black lines) 
containing the splice acceptor site and polyadenylation signals for processing of the RNA, and by 
sequences homologous to the MET2 locus (blue lines). The targeting construct is a linear fragment 
obtained by restriction digest of pkoMET2(39p3)-NEO with Sac I (S) and Kpn I (K). (B) The endo­
genous MET2 locus. The open arrows on the left indicate the location of the strand switch and show 
the direction of transcription. Crosses symbolise the crossover event. (C) Integration by homologous 
recombination has replaced the MET2 gene with the targeting construct. Cells where integration of 
NEO has occurred are selected using the drug G418.
193
Figure 5.H: Generation o f  MET2 single knockout clone B
Southern blot of T. cruzi CL Brener chromosomes, separated by CHEFE. WT: wild-type. Lanes A and 
B: G4l8-resistant T. cruzi clones A and B, derived from transfection with pkoMET2-NEO. The blot 
was hybridised successively with probes to  genes present on chromosome 3: MET2, GPI, and UP 1, 
and with a NEO  probe, as indicated. The expected I Mb and 0.6 Mb bands are detected with 
chromosome 3 specific genes in WT. In clone B (sko-B), the MET2 probe fails to hybridise with the 
I Mb chromosome (*), indicating that integration of the NEO gene has resulted in deletion o f one 
copy of MET2. The UP! and GPI probes detect no difference between WT and sko-B. Clone A shows 
an unexpected chromosome pattern. Failure to detect the I Mb band with any of the chromosome 3 
specific genes (It) indicates that the I Mb chromosome is missing. A strong signal in the well is 
detected with MET2 and UP I, but not with GPI. This suggests that the missing I Mb chromosome 
may have undergone a rearrangement, and the resulting entity shows altered mobility in pulse field 
gels reminiscent of circular DNA fragments.
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Figure 5.9: Genomic Southern him «/MET2 single knockout clone
(A) Ethidium bromide stained genomic DNA of wild-type T. cruzi CL Brener (WT), and two clones 
derived from transfection with pkoMET2-NEO (A and sko-B). The DNA was digested with Eco Rl 
(I) or Eco RV (V) as indicated above each lane, and resolved on a 0.8% agarose gel. (B) Southern blot 
probed with MET2. The probe detects two fragments in WT DNA that are absent in sko-B (>I0 kb 
Eco Rl, and 2.1 kb Eco RV; arrows). This demonstrates that in sko-B the MET2-39p3 allele has been 
deleted. In clone A, deletion of MET2 has not occurred. An increase in signal intensity in the >10 kb 
Eco Rl, and 2.1 kb Eco RV fragment indicates that in these cells the copy number o f  the MET2-39p3 
allele has increased. Numbers on the left indicate size in kb.
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Figure 5.10: Generation o f  MET2 single knockout clones C and D
Southern blot of T. cruzi CL Brener chromosomes, separated by CHEFE. WT: wild-type. Lanes C and 
D: A/KC'-resistant T. cruzi clones C and D, derived from transfection with pkoMET2-HYG. The HYG 
probe hybridises to the 0.6 Mb chromosome in clones C and D, suggesting correct integration of the 
targeting construct. The MET2 probe hybridises with the two remaining gene copies on the I Mb and 
0.6 Mb chromosome.
5.3.1 Deletion of the first MET2 allele
After the first round of transfection, drug resistant clones were analysed for integra­
tion of the targeting construct into the MET2 locus. Chromosome Southern blots 
showed that in three clones integration o f the drug selectable marker gene into the 
expected chromosome 3 homologue had occurred, resulting in the deletion of one 
copy of MET2. These single knockout clones were named sko-B, sko-C and sko-D. 
In sko-B (Figure 5.8), a NEO probe hybridises with the 1 Mb chromosome. The 
MET2 probe only hybridises to the 0.6 Mb homologue, indicating that the allele has 
been deleted from the 1 Mb homologue. This was confirmed by a genomic Southern 
blot of sko-B (Figure 5.9), where one of the MET2 bands found in wild-type cells 
had disappeared. In sko-C and sko-D, a HYG probe hybridises with the 0.6 Mb 
chromosome (Figure 5.10). Because the 0.6 Mb homologue is present in two copies, 
the MET2 probe still hybridises with both chromosome 3 homologues.
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Two cell lines (NEO resistant clone A and HYG resistant ko-HYGl) showed unex­
pected alterations in chromosome numbers. This involved the disappearance of the 
1 Mb band from chromosome Southern blots, and evidence o f a circular amplicon 
derived from this chromosome, as discussed in section 5.4
5.3.2 Deletion o f a second MET2 allele
The single knockout cells were subsequently transfected with pko-MET2-PAC. Four 
of the resulting double drug resistant cell lines were analysed by probing chromo­
some Southern blots with PAC and MET2 probes (Figure 5.11). The PAC probe 
hybridises to the 0.6 Mb homologue, as expected, in all four clones. Hybridisation 
with the MET2 probe shows that only one copy of the gene remains in each clone. 
Thus, four MET2 double knockout cell lines were obtained: those derived from sko- 
B were named dko-BC and dko-BE; those derived from sko-C were named dko-CA 
and dko-CD. A third round of transfection was done to delete the remaining copy of 
MET2. These cells are currently undergoing selection. Once the null mutants are 
available, their ability to differentiate to metacyclics will be tested.
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Figure 5.11: Generation o f MET2 double knockout clones
Southern blot of T. crtci CL Brener chromosomes, separated by CHEFE. WT: wild-type. Lanes B and C: single knockout 
clones. Lanes BC, BE, CA and CD: double knockout clones. Hybridisation of the blot with PAC demonstrates integration of 
the targeting construct into the 0.6 Mb chromosome. Hybridisation of the blot with MET2 confirms deletion of a second MET2 
allele in the double knockout clones. In dko-BC and dko-BE, one of the MET2 alleles on the 0.6 Mb homologue remains. In 
dko-CA and dko-CD. the MET2 allele on the 1 Mb homologue remains.
5.4 TARGETING THE MET2 LOCUS PRODUCED INTERESTING 
CHROMOSOMAL ABNORMALITIES
Targeting of pkoMET2-NEO to the MET2 locus on the 1 Mb homologue yielded one 
drug resistant cell line (clone A), which displayed unexpected alterations to chromo­
some 3. In Southern blot of chromosomes from clone A (Figure 5.9), the NEO probe 
hybridises to a chromosome of 0.6 Mb, and not as expected to one of 1 Mb. More 
unexpectedly, three probes specific to chromosome 3 (MET2, UP1 and GPI) all fail 
to detect the 1 Mb chromosome in this clone. In addition, to the expected signal from 
the 0.6 Mb homologue, MET2 and UP1 (but not GPI) hybridise strongly with the 
well. The strong hybridisation signal in the well is seen neither in the wild type 
controls, nor in sko-B where the NEO gene has correctly integrated into the 1 Mb 
chromosome (Figure 5.9). In clone A, the signal in the well may be due to the pres­
ence of a circular amplicon, that has arisen from parts of the 1 Mb homologue. The 
suggestion that the 1 Mb chromosome has undergone a rearrangement, and has not 
been entirely lost from the cells is supported by Southern blot analysis of clone A 
(Figure 5.10). A MET2 probe detects the same restriction fragments in a Southern 
blot of clone A genomic DNA and wild type DNA. However, in clone A, the restric­
tion fragment derived from the MET2 gene on the 1 Mb chromosome shows a strong 
increase in signal intensity. Taken together, the data from clone A suggest the fol­
lowing: the 1 Mb chromosome has undergone a change which (i) alters its mobility 
in pulse field gels and (ii) has led to an increase in the copy number of the MET2 
gene.
Disappearance of the 1 Mb homologue of chromosome 3 was also observed in one 
cell line transfected with the construct pkoMET2-HYG, which was designed to 
integrate into the 0.6 Mb chromosome (data not shown). More significantly, in ex­
periments unrelated to MET2, other manipulations of the centromeric region of 
chromosome 3 have resulted in clones with a chromosome pattern very similar to 
clone A (Sam Obado and John Kelly, unpublished data). Experiments are underway 
to verify whether exactly the same rearrangement has occurred in completely inde­
pendent experiments, and to determine the nature of the putative amplicon.
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5.5 EXPRESSION OF RECOMBINANT MET2
In order to investigate expression and localisation of MET2 protein, two strategies 
were pursued: (i) using recombinant MET2 purified from a bacterial expression 
system to raise specific antisera in mice, and (ii) expression of epitope tagged MET2 
in T. cruzi.
5.5.1 Expression of recombinant MET2 in E. coli
A bacterial expression system was chosen for production of recombinant MET2. 
Expression vector pTrcHis-met2 was generated by cloning a fragment encoding 
amino acids 2-213 of the MET2 coding sequence into vector pTrcHis C to produce 
pTrcHis-met2 (section 2.3.4). E. coli BL21 were transformed with pTrcHis-met2 and 
expression of the recombinant protein was induced with IPTG, as described in 
section 2.4.2. Western blots of E. coli lysates were screened for expression o f the 
27 kDa recombinant proteins. Recombinant MET2 was expressed at high levels 
2 hours after induction, and found predominantly in the insoluble fraction. Expres­
sion of the protein at 18°C or 4°C instead of 37°C did not yield higher proportions of 
soluble protein (data not shown). After addition of 1% Triton X-100 to the lysis 
buffer, a small part of protein was found in the soluble fractions. We were thus able 
to purify soluble MET2 under native conditions on a Ni-NTA agarose column 
(Figure 5.12) as described in section 2.4.3.
5.5.2 Antisera from mice immunised with recombinant MET2 
fail to detect the protein
Attempts to raise MET2 antibodies (section 2.4.4) yielded negative results. Antisera 
from three mice did not detect the 27 kDa recombinant protein in Western blots 
(Figure 5.13A). A cross-reacting band of 50 kDa present in Western blots was found 
to be non-specific, as it was also detected by the pre-immune sera (Figure 5.13B). An 
additional 75 kDa band detected with serum from mouse 2 only, also appears to be 
unrelated to MET2. The antibody against the Xpress epitope tag detects low levels of 
higher molecular weight bands, which could represent multimeric forms of MET2.
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However, these bands run slightly lower than the 75 kDa band detected with serum 
from mouse 2. None of the mouse sera detected any proteins in T. cru:i extracts that 
migrate at the size of MET2. or that show any stage-specificity (not shown).
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Figure 5.12: Expression and purification o f  recombinant MET2
A fragment of MET2 (coding for amino acids 2-213) was cloned into the expression vector pTrcHis, 
to yield a recombinant protein 6xHis-MET2 fused in-frame with an N-terminal 6x His tag and an 
Xpress epitope tag (6xHis-MET2). Recombinant protein was expressed in E. coli BL21, and purified 
under native conditions using a Ni-NTA agarose column. Left panel: Western blot of eluted protein 
probed with the anti-Xpress antibody. The protein was eluted from the column using increasing 
concentrations o f imidazole, as indicated above each lane. L: crude E. coli extract. Right panel: 
Coomassie-stained 6xHis-MET2 (arrow), eluted with 500 mM imidazole. Numbers on the left 
indicate molecular size in kilo Daltons.
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Figure 5.13: Immunisation o f mice yields no MET2 specific antiserum
Purified 6xHis-MET2 was used to immunise three mice. Serum from these mice was tested on 
Western blots of the purified protein (£. coli lysates fractionated on Ni-NTA columns). (A) Lanes 1-3: 
sera from three different mice fail to detect purified 6xHis-MET2 on a Western blot. An unidentified 
SO kDa band is detected with all sera. A band o f  approximately 75 kDa is only detected with serum 
from mouse 2. These unidentified bands could represent E. coli proteins that were eluted together with 
6xHis-MET2 from the Ni-NTA column. Lane X: The anti-Xpress antibody detects 6xHis-MET2 in 
these samples (positive control). (B) Pre-immune sera from the same three mice also detect a SO kDa 
band in Western blots of recombinant 6xHis-MET2. This shows that these bands are not related to 
MET2. Numbers on the left indicate molecular sizes in kilo Daltons.
5.5.3 Localisation of epitope tagged MET2 T cruzi epimastigotes
In order to determine the subcellular location of MET2 protein in T. cruzi without the 
aid of specific antibodies, we pursued an epitope tagging strategy. Episomal expres­
sion vector pTEX-MET2-9E10 was constructed for this purpose (section 2.3.4; 
Figure 2.1), and transfected into T. cruzi epimastigotes. Cells resistant to G418 were 
readily obtained. Southern blot analysis confirmed that these cells harbour intact 
pTEX-MET2-9E 10 plasmids (not shown). Paraformaldehyde fixed cells were stained 
with a monoclonal anti c-myc antibody for immunofluorescence detection of MET2- 
9E10. Only a small subset of cells stained positive with the antibody. The signal in
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these cells is concentrated adjacent to, or overlapping with the kinetoplast (Figure 
5.14). Unfortunately, none of the metacyclics that developed in these cultures stained 
positive for c-myc. The c-myc antibody failed to detect MET2-9E10 in Western blots 
(not shown). A likely explanation for this is that due to the small proportion of cells 
that expressed the protein, the amount present in the sample remained below the 
detection limit.
These results show that MET2-9E10 associates with the kinetoplast (or structures 
adjacent to the kinetoplast), when expressed in epimastigotes. The MET2-Dm28c 
protein was found associated with the metacyclic kinetoplast in electron microscopy 
studies (Yamada-Ogatta et al., 2004). Our results are consistent with this. A possible 
reason for the low levels of MET2-9E10 expression in transfected epimastigotes 
could be that MET2 expression is incompatible with cell proliferation. Alternatively, 
it may be that the C-terminus, including the c-myc tag is removed by processing. 
Native MET2 in Dm28c detected on a Western blot is only 14 kDa. Future, localisa­
tion studies will therefore utilise an inducible expression system (Figure 1.5), which 
has only recently become available (Martin Taylor, unpublished). This will also 
allow us to determine the effect of MET2 overexpression in a controlled manner.
DNA c-myc merged phase
Figure 5.14: Localisation o f MET2-9EI0 in epimastigotes
T. cruzi epimastigotes transfected with pTEX-MET2-9EI0 were fixed and labelled with anti-c-myc 
antibody to detect recombinant MET2-9EI0. A signal adjacent to the kinetoplast is detected in a small 
subset of cells. Kinetoplast (K) and nuclear DNA (N) is stained with TOTO-3. Scale bar = 2 pm.
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5.6 DISCUSSION
5.6.1 MET2 RNA transcripts are upregulated during metacyclogenesis
The results of this study show that expression of MET2 in T. cruzi CL Brener is 
stage-specific, and follows a similar pattern to that of the T. cruzi Dm28c homologue 
(Yamada-Ogatta et al., 2004). Northern blot analysis showed that the level of MET2 
RNA transcripts was strongly upregulated in stationary cultures of T. cruzi CL 
Brener, and that it correlates with a high number of metacyclics in the sample. Inter­
estingly, the up-regulation of MET2 transcripts, was much more pronounced than 
that of MET3 (chapter 4). While low levels of MET3 RNA were readily detected in 
Northern blots of epimastigote RNA, neither CL Brener (Figure 5.6) nor Dm28c 
epimastigotes (Yamada-Ogatta et al., 2004), contained detectable levels of the MET2 
transcript.
We could not test directly whether the MET2 transcripts in RNA from stationary 
phase cells were derived exclusively from metacyclics. This is because attempts to 
separate CL Brener metacyclics from stationary epimastigotes and intermediate 
forms failed to provide pure samples of either cell type (see section 3.3.4). However, 
in T. cruzi Dm28c, the MET2 transcript was only detected in RNA from metacyclics, 
but not in differentiating epimastigotes (Yamada-Ogatta et al., 2004). It is therefore 
likely that the MET2 RNA transcript detected in the CL Brener samples is also de­
rived from metacyclics. As yet, the levels of MET2 transcripts in amastigotes and 
trypomastigotes have not been analysed in either T. cruzi strain. It will be straight 
forward to close this gap by hybridising Northern blots of amastigote and trypomas- 
tigote RNA with a MET2 probe.
Based on the results of the Northern blot analysis, the 3’UTR of MET2 from CL 
Brener is estimated to extend over 4 kb. We would speculate that elements that 
control stage-specificity of MET2 expression are contained within this long 3’UTR. 
Examination of the sequence downstream of the MET2 stop codon identified nine 
AU-rich elements (ARE) similar to those that have been shown to control RNA 
stability in a number of eukaryotes including T. cruzi (Di Noia et al., 2000). ARE-
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binding proteins which recognise AUUUA repeats in cytokine RNAs can exert both 
stabilising and destabilising effects (Chen et al., 2002). T. cruzi contains at least one 
developmentally regulated RNA binding protein (TcUBP-1) that regulates expres­
sion of ARE containing genes. TcUBI-1 recognises the AU-rich instability element 
in the T. cruzi small mucin gene family TcSMUG, and overexpression of TcUBP-1 
decreases the half life of TcSMUG derived transcripts (D'Orso and Frasch, 2001b). 
However, in TcSMUG, the AU-rich element results in destabilisation and decreased 
translation efficiency of the transcript in metacyclics (Di Noia et al., 2000). This is 
the opposite of the metacyclic stage-specific up-regulation of the MET2 transcript. 
To test whether the AU-rich sequences in the MET2 3’UTR play a role in mediating 
stage-specificity, mutational analysis of the 3’UTR in conjunction with a reporter 
gene assay may be undertaken (as discussed in section 4.5.1). Such a strategy could 
also identify other determinants of MET2 RNA stability. Whether ARE elements can 
stabilise RNA transcripts in metacyclics at all, and whether they are involved spe­
cifically in the stabilisation of the MET2 transcript remains to be shown.
The genomic location of the MET2 gene may also affect its expression. MET2 is 
located on chromosome 3, close to a strand switch (Andersson et al., 1998), and 
flanked on either side by nearly 5 kb of low complexity sequence. This strand switch 
region has been the subject of intense investigation. A chromosome fragmentation 
approach has demonstrated that it contains the elements that mediate mitotic stability 
o f this chromosome. The evidence thus far suggests that this putative T. cruzi cen­
tromere is a regional feature, and not determined by DNA sequence alone (Obado et 
al., in press). This would imply some sort of epigenetic modification of the chroma­
tin in this region. A detailed dissection of the T. cruzi centromere is currently under­
way. These studies should provide information as to the nature of these modifica­
tions, and how they affect the expression of MET2 and other genes within this 
region.
It has been speculated that regulatory elements that control transcription are located 
within this strand switch region of T. cruzi chromosome 3 (Andersson ct al., 1998). 
One strand switch region on a trypanosomatid chromosome that has been analysed 
experimentally is that of L. major chromosome 1 (Martincz-Calvillo ct al„ 2003).
206
The results of nuclear run-on assays suggest that pol II transcription initiates in a 
single region of <100 bp, located within the strand switch region between two diver­
gent gene clusters. However, the sequence of this <100 bp area that contains a puta­
tive bidirectional promoter is not particularly conserved in the homologous regions 
in the genome of other Leishmania species. Similarly, no sequence conservation is 
evident between the chromosome 1 strand switch region as a whole, and other strand 
switch regions in L. major chromosomes (Martinez-Calvillo et al., 2003). This lack 
o f  a consensus sequence makes the prediction o f putative transcription initiation sites 
in T. cruzi chromosomes difficult. It will be important to test experimentally whether 
such a transcriptional start site is located within the strand switch of T. cruzi chromo­
some 3.
Since MET2 is only the second gene in the polycistronic transcription unit, it will be 
o f  interest to determine where transcription is initiated in relation to MET2. We have 
reported in the present study the generation of several MET2 gene deletion mutants. 
The targeting constructs that were used to delete copies of MET2 contained no pro­
moter to drive transcription of the drug selectable marker gene, yet drug resistant 
epimastigotes were readily obtained. This indicates that in replicating cells, the 
MET2 locus is accessible to the transcriptional machinery, and we would speculate 
that transcription of the marker gene occurs as a result o f run through pol II tran­
scription. However, this will need to be tested experimentally. Nuclear run-on assays 
may be used to measure transcription of the genes within or in close proximity to the 
strand switch, similar to the analysis of L. major chromosome 1 (Martinez-Calvillo et 
al., 2003) and should determine if there is any transcription from the MET2 locus in 
wild-type epimastigotes.
5.6.2 Localisation of epitope tagged MET2 in epimastigotes
Two completely independent lines of evidence suggest that the MET2 protein is 
associated with the kinetoplast. In EM studies conducted by Yamada-Ogatta (2004) 
native MET2 was found associated with the kinetoplast in metacyclics of T. cruzi 
Dm28c. In this study, an epitope tagging strategy and immunofluorescence micro­
scopy were used to determine the localisation of c-myc tagged MET2 (MET2-9E10)
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in epimastigotes. The protein was found adjacent to, or partially overlapping with, 
the kinetoplast DNA. However, the fact that the MET2-9E10 protein was detected in 
only a very small subset of epimastigotes transfected with pTEX-MET2-9E10 makes 
it difficult to base firm conclusions on these data.
A number of reasons may account for the failure to detect recombinant MET2-9E10 
using antibodies against the epitope tag. First, the pTEX vector which was used in 
the present study for overexpression of MET2 in epimastigotes is designed for con­
stitutive overexpression (Kelly et al., 1992), which is not optimal to study a devel­
opmental^ regulated protein. If MET2 is detrimental to epimastigotes, then consti­
tutive expression is likely to result in the selection of mutants that can down-regulate 
MET2 expression. Previous examples of proteins that could not be expressed in 
epimastigotes using the pTEX vector include the mucin surface proteins (Allen, 
2000) and the mitochondrial protein BPP1 (Bromley, 2002; Bromley et al., 2004). In 
these studies, detailed investigations were undertaken to determine the RNA levels of 
the drug selectable marker gene and the gene of interest. Such studies were not pur­
sued here, because this would not have contributed directly to the aim of this study, 
which was to gain information about the localisation and function of the MET2 
protein. Furthermore, the availability of an inducible expression system will now 
allow us to conduct better controlled studies.
Second, the coding sequence of MET2 may contain information that prevents the 
protein from being expressed in the epimastigote stage. However, if this was the 
case, metacyclics that develop from pTEX-MET2-9E10 transfected epimastigotes 
should express the recombinant protein. Yet none of the metacyclics that developed 
in these populations expressed MET2-9E10 at detectable levels. Finally, we cannot 
completely exclude the possibility that the recombinant protein was expressed but 
could not be detected under the conditions used. The protein could have been ex­
creted from the cell and was therefore not detected in fixed cells or Western blots of 
cell extracts. Alternatively, the C-terminus of the protein, including the epitope tag 
may be removed in the mature protein. The T. cruzi Dm28c wild type MET2 protein 
detected in a Western blot was only 14 kDa, rather than 27kDa as expected from the 
full-length MET2 sequence (Yamada-Ogatta et al., 2004). This suggests that proces­
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sing of the protein occurs, but currently no further information is available as to the 
mechanisms involved.
Taken together, the data obtained in the present study, and the data from Yamada- 
Ogatta (2004) suggest association of MET2 with the kinetoplast. This is compatible 
with bioinformatic analysis, which predicts mitochondrial localisation. This will 
have to be substantiated with further evidence, however. It will be a priority to 
generate antibodies against MET2 in order to study the expression and localisation of 
the wild-type protein. Inducible expression systems for T. cruzi have recently 
become available (DaRocha et al., 2004, Martin Taylor, unpublished), which will be 
used to address any further questions concerning the localisation of MET2 and the 
effects of overexpression of the protein.
5.6.3 Functional analysis of MET2
Because such a low proportion of epimastigotes expressed detectable levels of 
MET2-9E10, these cells were not used for detailed phenotypic analysis. The induc­
ible expression system will be used to test the effect of MET2 induction on replicat­
ing epimastigotes.
To determine whether MET2 is essential for development of metacyclics, we are in 
the process of generating null mutants. We have reported here the generation of cell 
lines that had two copies of the MET2 gene deleted. Gene deletion by homologous 
recombination is a slow process in T. cruzi. This is further complicated here by the 
fact that the MET2 gene is present in three copies in the CL Brener genome. Yet, this 
is the only method by which loss of MET2 function can be tested. Since expression 
of MET2 is highly stage-specific, it is unlikely that the gene is essential in epimas­
tigotes. It was therefore considered feasible to generate viable knockouts. The results 
presented here demonstrate that all three chromosomal loci can be targeted using the 
specific constructs built as part of this work. It is therefore expected that a third 
round of transfection will yield null mutants.
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As the function of MET2 is unknown, the analysis of prospective null mutants poses 
a challenge. The obvious first test will be to analyse whether these cells can differ­
entiate to metacyclics, and whether they can complete the entire life-cycle.
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6. CONCLUDING REMARKS
MET2 and MET3 represent two novel metacyclic-specific markers that will facilitate 
dissection of T. cruzi metacyclogenesis. The precise function of these genes remains 
elusive, but a number of interesting questions have arisen as a result of this study. 
Three main areas to follow up are outlined below.
I. Further investigation o f the function and regulation o f MET2 and MET3.
To gain insight into the function of MET2 it will be a priority to delete the third allele 
(section 5.3), and analyse the resulting null mutants for their ability to develop into 
metacyclic trypomastigotes and progress through the life-cycle, similar to the analy­
sis of the MET3 knockouts (section 4.4). A challenge of this work, has been to design 
informative experiments to analyse genes of unknown function. As any genome 
sequenced to date contains a high proportion of novel genes, similar challenges are 
bound to arise frequently in post genomics research. What we present here is a first 
description of MET3 knockout mutants. Clearly, more information on the bio­
chemical properties of the encoded proteins will inform the design of more sophisti­
cated experiments to characterise the knockouts. To gain such additional infor­
mation, and ultimately determine the function of MET3 in the metacyclic nucleus, it 
will be essential to identify putative nucleolar interaction partners. Specifically, as 
outlined in section 4.5.5, the hypothesis may be tested that MET3 is a nucleic acid 
binding protein.
No attempts were made to study the mechanism by which MET2 and MET3 are 
regulated. To do this, transfection-based approaches, using reporter gene constructs 
can be used to test the hypothesis that elements within the 3’UTR of these genes may 
determine stage specificity, as outlined in sections 4.5.1 and 5.6.1. In addition, sub­
stances that inhibit transcription and protein synthesis can be tested on their effect on 
MET2 and MET3 expression. Specifically, treatment o f cells with actinomycin D, 
which has previously been used to blocks transcription in T. cruzi (Abuin et al., 
1999; Coughlin et al., 2000) can be used to assess the relative stability of the MET2
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and MET3 transcripts in different life-cycle stages. To determine whether there are 
any labile protein factors in epimastigotes that destabilise the RNA transcripts, the 
cells could be treated with the protein synthesis inhibitor cycloheximide. Such ex­
periments should determine whether similar or different mechanisms control MET2 
and MET3 expression, and they may provide insight into mechanism of metacyclic- 
specific gene expression.
2. The T. cruzi nucleolus and its role in metacyclogenesis.
In order to gain insight into the structural changes that occur in the T. cruzi nucleus 
during differentiation, it will be essential to analyse cells by electron microscopy. 
Immunogold labelling o f thin sections can be used to visualise the precise location of 
the MET3 protein. This may determine whether the protein is associated with par­
ticular nucleolar sub-structures. In addition, it will be important to study the fate of 
the rDNA during dispersal. This can be achieved by in situ hybridisation with rDNA 
probes to assess the extent to which dispersal of antigens actually reflects disruption 
o f the actual nucleolar structure. Is nucleolar dispersal a signal required to trigger 
metacyclogenesis? Manipulation of the nucleolar structure using chemical agents (as 
discussed in section 4.5.6) may test this hypothesis.
3. A robust in vitro metacyclogenesis assay.
Finally, it remains a priority to improve the experimental system to study metacyclo­
genesis in vitro. A main consideration in future experiments will be the choice of 
T. cruzi strain. A conclusion from this work is that the CL Brener strain is not an 
ideal model. The fact that the CL Brener strain is partially trisomic complicates 
genetic manipulation, as evident in the generation of the MET2 knockout cell lines 
that requires deletion o f three alleles. It will be important to choose a strain that 
consistently produces high numbers of metacyclics, as has been reported for example 
for the Dm28c strain in TAU medium (section 3.1.3). In addition, the catalogue of 
metacyclic-specific markers needs to be further expanded to facilitate a molecular 
description of the regulatory mechanisms that control this important transition in the 
T. cruzi life-cycle.
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